Aarsland D, Marsh L, Schrag A (2009) Neuropsychiatric symptoms in Parkinson’s disease. Mov Disord 24:2175–2186
PubMedPubMedCentralCrossRefAarsland D, Påhlhagen, Ballard CG et al (2012) Depression in Parkinson disease – epidemiology, mechanisms and management. Nat Rev Neurol 8:35–47
CrossRefAbbass A, Kisely S, Kroenke K (2009) Short-term psychodynamic psychotherapy for somatic disorders. Psychother Psychosom 78:265–274
PubMedCrossRefÅberg MA, Waern M, Nyberg J et al (2012) Cardiovascular fitness in males at age 18 and risk of serious depression in adulthood: Swedish prospective population-based study. Br J Psychiatry 201:352–359
PubMedCrossRefAbrahamian H, Hofmann P, Prager R, Toplak H (2009) Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group). Neuropsychiatr Dis Treat 5:261–266
PubMedPubMedCentralCrossRefAbreu-Silva EO, Todeschini AB (2014) Depression and its relation with uncontrolled hypertension and increased cardiovascular risk. Curr Hypertens Rev 10:8–13
PubMedCrossRefAdelöw C, Andersson T, Ahlbom A, Tomson T (2012) Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy. Neurology 78:396–401
PubMedCrossRefAdili F, Larijani B, Haghighatpanah M (2006) Diabetic patients: psychological aspects. Ann N Y Acad Sci 1084:329–349
PubMedCrossRefAdinolfi LE, Nevola R, Lus G et al (2015) Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. World J Gastroenterol 21:2269–2280
PubMedPubMedCentralCrossRefAgorastos A, Lederbogen F, Otte C (2015) Behandlung der Depression bei koronarer Herzerkrankung. Nervenarzt 86:375–387
PubMedCrossRefAgyemang C, Goosen S, Anujuo K, Ogedegbe G (2012) Relationship between post-traumatic stress disorder and diabetes among 105,180 asylum seekers in the Netherlands. Eur J Public Health 22:658–662
PubMedCrossRefAhrens CL, Manno EM (2014) Neurotoxicity of commonly used hepatic drugs. Handb Clin Neurol 120:675–682
PubMedCrossRefAl Hayek AA, Robert AA et al (2015) Predictive risk factors for fear of hypoglycemia and anxiety-related emotional disorders among adolescents with type 1 diabetes. Med Princ Pract 24:222–230
PubMedCrossRefAlbus C (2014) A stepwise psychotherapy intervention to reduce risk in coronary artery disease (spirr-cad) – results of a randomised, controlled multicentre trial. J Psychosom Res 76:495
CrossRefAlbus C, Beutel ME, Deter HC et al (2011) A stepwise psychotherapy intervention for reducing risk in coronary artery disease (spirr-cad) – rationale and design of a multicenter, randomized trial in depressed patients with cad. J Psychosom Res 71:215–222
PubMedCrossRefAlbus C, Ladwig KH, Herrmann-Lingen C (2014) Psychokardiologie: praxisrelevante Erkenntnisse und Handlungsempfehlungen. Dtsch Med Wochenschr 139:596–601
PubMedCrossRefAldea M, Craciun L, Tomuleasa C, Crivii C (2014) The role of depression and neuroimmune axis in the prognosis of cancer patients. J BUON 19:5–14
PubMedAldenkamp AP (2011) Antiepileptic drugs and cognitive disorders. In: Trimble MR, Schmitz B (Hrsg) The neuropsychiatry of epilepsy, 2. Aufl. Cambridge University Press, Cambridge, S 153–164
CrossRefAlexopoulos GS, Wilkins VM, Marino P et al (2012) Ecosystem focused therapy in poststroke depression: a preliminary study. Int J Geriatr Psychiatry 27:1053–1060
PubMedPubMedCentralCrossRefAli S, Stone MA, Peters JL, Davies MJ, Khunti K (2006) The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 23:1165–1173
PubMedCrossRefAli S, Stone M, Skinner TC et al (2010) The association between depression and health related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev 26:75–89
PubMedCrossRefAlkhuja S (2013) Anxiety disorders in patients with COPD. Respir Care 58, e131
PubMedCrossRefAlmeida OP, Waterreus A, Hankey GJ (2006) Preventing depression after stroke: results from a randomized placebo-controlled trial. J Clin Psychiatry 67:1104–1109
PubMedCrossRefAl-Omari A, Cowan J, Turner L, Cooper C (2013) Antidepressant prophylaxis reduces depression risk but does not improve sustained virological response in hepatitis C interferon recipients without depression at baseline: a systematic review and meta-analysis. Can J Gastroenterol 27:575–581
PubMedPubMedCentralCrossRefAlonso A, Rodríguez A, Logroscino G, Hernán MA (2009) Use of antidepressants and the risk of Parkinson’s disease: a prospective study. J Neurol Neurosurg Psychiatry 80:471–674
Alonso J, de Jonge P, Lim CC et al (2014) Association between mental disorders and subsequent adult onset asthma. J Psychiatr Res 59:179–188
PubMedCrossRefAlper K, Schwartz KA, Kolts RL, Khan A (2007) Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 15:345–354
CrossRefAmelink M, Hashimoto S, Spinhoven P et al (2014) Anxiety, depression and personality traits in severe, prednisone-dependent asthma. Respir Med 108:438–444
PubMedCrossRefAnagnostis P, Athyros VG, Tziomalos K et al (2009) Clinical review. The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. Clin Endocrinol Metab 94:2692–2701
CrossRefAnanthakrishnan AN (2015) Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci 60:290–298
PubMedCrossRefAnanthakrishnan AN, Gainer VS, Perez RG et al (2013a) Psychiatric co-morbidity is associated with increased risk of surgery in Crohn’s disease. Aliment Pharmacol Ther 37:445–454
PubMedPubMedCentralCrossRefAnanthakrishnan AN, Khalili H, Pan A et al (2013b) Association between depressive symptoms and incidence of Crohn’s disease and ulcerative colitis: results from the Nurses’ Health Study. Clin Gastroenterol Hepatol 11:57–62
PubMedCrossRefAndersen J, Aabro E, Gulmann N et al (1980) Antidepressive treatment in Parkinson’s disease: a controlled trial of the effect of nortriptyline in patients with Parkinson’s disease treated with L-DOPA. Acta Neurol Scand 62:210–219
PubMedCrossRefAndersen G, Vestergaard K, Lauritzen L (1994) Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 25:1099–1104
PubMedCrossRefAndersen BL, DeRubeis RJ, Berman BS et al (2014) Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol 32:1605–1619
PubMedPubMedCentralCrossRefAnderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078
PubMedCrossRefAndrade CP, Cruz MC, Urrutia M et al (2010) Evaluation of depressive symptoms in patients with chronic renal failure. J Nephrol 23:168–174
PubMedAnguiano L, Mayer DK, Piven ML, Rosenstein D (2012) A literature review of suicide in cancer patients. Cancer Nurs 35:E14–E26
PubMedCrossRefAntonini A, Tesei S, Zecchinelli A et al (2006) Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson’s disease and depression: effect on quality of life. Mov Disord 21:1119–1122
PubMedCrossRefArmento ME, Stanley MA, Marsh L et al (2012) Cognitive behavioural therapy for depression and anxiety in Parkinson’s disease: a clinical review. J Parkinsons Dis 2:135–151
PubMedAro P, Storskrubb T, Ronkainen J et al (2006) Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol 163:1025–1034
PubMedCrossRefArolt V, Fein A, Driessen M et al (1998) Depression and social functioning in general hospital in-patients. J Psychosom Res 45:117–126
PubMedCrossRefArreola R, Becerril-Villanueva E, Cruz-Fuentes C et al (2015) Immunomodulatory effects mediated by serotonin. J Immunol Res 2015:354957
PubMedPubMedCentralAsmundson GJG, Katz J (2009) Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art. Depress Anxiety 26:888–901
PubMedCrossRefAtlantis E, Vogelzangs N, Cashman K, Penninx BJ (2012) Common mental disorders associated with 2-year diabetes incidence: the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord 142(suppl):30–35
CrossRefAtlantis E, Fahey P, Cochrane B, Smith S (2013) Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest 144:766–777
PubMedCrossRefAuslander GK, Buchs A (2002) Evaluating and activity intervention with hemodialysis patients in Israel. Soc Work Health Care 35:407–423
PubMedCrossRefAvila A, Cardona X, Martin Baranera M et al (2003) Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial. J Clin Psychopharmacol 23:509–513
PubMedCrossRefAvramovic M, Stefanovic V (2012) Health-related quality of life in different stages of renal failure. Artif Organs 36:581–589
PubMedCrossRefAyerbe L, Ayis S, Wolfe CDA, Rudd AG (2013) Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry 202:14–21
PubMedCrossRefAyerbe L, Ayis S, Crichton S et al (2014a) The long-term outcomes of depression up to 10 years after stroke; the South London Stroke Register. Neurol Neurosurg Psychiatry 85:514–521
CrossRefAyerbe L, Ayis SA, Crichton S et al (2014b) Natural history, predictors and associated outcomes of anxiety up to 10 years after stroke: the South London Stroke Register. Age Ageing 43:542–547
PubMedCrossRefBagary M (2011) Epilepsy, antiepileptic drugs and suicidality. Curr Opin Neurol 24:177–182
PubMedCrossRefBahmanyar S, Sparen P, Mittendorfer Rutz E, Hultman CM (2009) Epidemiol Community Health 63:1016–1021
CrossRefBakshi R, Czarnecki D, Shaikh ZA et al (2000) Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport 11:1153–1158
PubMedCrossRefBallard N, Robley L, Barrett D et al (2006) Patients’ recollections of therapeutic paralysis in the intensive care unit. Am J Crit Care 15:86–94
PubMedBaraldi S, Hepgul N, Mondelli V, Pariante CM (2012) Symptomatic treatment of interferon-α-induced depression in hepatitis C: a systematic review. J Clin Psychopharmacol 32:531–543
PubMedCrossRefBaranyi A, Meinitzer A, Stepan A et al (2013) A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection. Psychother Psychosom 82:332–340
PubMedCrossRefBarnard K, Peveler RC, Holt RI (2013) Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review. Diabetes Care 36:3337–4532
PubMedPubMedCentralCrossRefBarone P, Scarzella L, Marconi R et al (2006) Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease: a national multicenter parallel-group randomized study. J Neurol 253:601–607
PubMedCrossRefBarone P, Poewe W, Albrecht S et al (2010) Pramipexole for the treatment of depressive symptoms in patients with Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:573–580
PubMedCrossRefBarrera I, Spiegel D (2014) Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression. Int Rev Psychiatry 26:31–43
PubMedCrossRefBarry JJ, Ettinger AB, Friel P et al (2008) Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 13:1–29
CrossRefBarsky AJ, Orav EJ, Bates DW (2005) Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 62:903–910
PubMedCrossRefBarth J, Paul J, Harter M, Bengel J (2005) Inpatient psychotherapeutic treatment for cardiac patients with depression in Germany – short term results. Psychosoc Med 2:Doc04
Bass C (2007) Cardiorespiratory disorders. In: Lloyd GG, Guthrie E (Hrsg) Handbook of liaison psychiatry. Cambridge University Press, Cambridge, S 365–389
CrossRefBaumeister H, Hutter N, Bengel J (2011) Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev 9, CD008012
PubMedBaumeister H, Hutter N, Bengel J (2014) Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review. Diabet Med 31:773–786
PubMedCrossRefBautovich A, Katz I, Smith M et al (2014) Depression and chronic kidney disease: a review for clinicians. Aust N Z J Psychiatry 48:530–541
PubMedCrossRefBeach SR, Kostis WJ, Celano CM et al (2014) Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. J Clin Psychiatry 75:e441–e449
PubMedCrossRefBel LG, Vollebregt AM, Van der Meulen-de Jong AE et al (2015) Sexual dysfunctions in men and women with inflammatory bowel disease: the influence of IBD-related clinical factors and depression on sexual function. J Sex Med 12:1557–1567
PubMedCrossRefBeliles K, Stoudemire A (1998) Psychopharmacologic treatment of depression in the medically ill. Psychosomatics 39:2–19
CrossRefBenedict RH, Zivadinov R (2011) Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 7:332–342
PubMedCrossRefBenkert I, Hippius H (2015) Kompendium der psychiatrischen Pharmakotherapie, 10. Aufl. Springer, Berlin/Heidelberg
Benton TD, Blume J, Crits-Christoph et al (2013) Depression and medical illness. In: Charney DS, Sklar P, Buxbaum JD, Nestler EJ (Hrsg) Neurobiology of mental illness, 4. Aufl. Oxford University Press, Oxford, S 496–507
Berg D, Supprian T, Hofmann E et al (1999) Depression in Parkinson’s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 246:1186–1193
PubMedCrossRefBerkman LF, Blumenthal J, Burg M et al (2003) Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 289:3106–3116
PubMedCrossRefBeutel M, Weiner H (1993) Trauer und Depression nach einem Objektverlust. Forum Psychoanal 9:224–239
Beyenberg S, Mitchell AJ, Schmidt D et al (2005) Anxiety in patients with epilepsy: systtematic review and suggestions for clinical management. Epilepsy Behav 7:161–171
CrossRefBhandari NJ, Jain T, Marolda C, ZuWallack RL (2013) Comprehensive pulmonary rehabilitation results in clinically meaningful improvements in anxiety and depression in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 33:123–127
PubMedCrossRefBhogal SK, Teasell R, Foley N, Speechley M (2004) Lesion location and poststroke depression systematic review of the methodological limitations in the literature. Stroke 35:794–802
PubMedCrossRefBienvenu OJ, Gellar J, Althouse BM et al (2013) Post-traumatic stress disorder symptoms after acute lung injury: a 2-year prospective longitudinal study. Psychol Med 43:2657–2671
PubMedCrossRefBienvenu OJ, Colantuoni E, Mendez-Tellez PA et al (2015) Cooccurrence of and remission from general anxiety, depression, and posttraumatic stress disorder symptoms after acute lung injury: a 2-year longitudinal study. Crit Care Med 43:642–653
PubMedPubMedCentralCrossRefBird ST, Crenstil V, Temple R et al (2014) Cardiac safety concerns remain for citalopram at dosages above 40 mg/day. Am J Psychiatry 171:17–19
PubMedCrossRefBlackburn-Munro G, Blackburn-Munro RE (2001) Chronic pain, chronic stress and depression: coincidence or consequence. J Neuroendocrinol 13:1009–1023
PubMedCrossRefBlackburn-Munro G, Blackburn-Munro R (2003) Pain in the brain: are hormones to blame? Trends Endocrinol Metab 14:20–27
PubMedCrossRefBlakemore A, Dickens C, Guthrie E et al (2014) Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 9:501–512
PubMedPubMedCentralCrossRefBlumenthal JA, Babyak MA, O’Connor C et al (2012a) Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA 308:465–474
PubMedPubMedCentralBlumenthal JA, Sherwood A, Babyak MA et al (2012b) Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the upbeat (understanding the prognostic benefits of exercise and antidepressant therapy) study. J Am Coll Cardiol 60:1053–1063
PubMedPubMedCentralCrossRefBoesen EH, Johansen C (2008) Impact of psychotherapy on cancer survival: time to move on? Curr Opin Oncol 20:372–377
PubMedCrossRefBogner HR, Morates KH, Post EP, Bruce ML (2007) Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care 30:3005–3010
PubMedPubMedCentralCrossRefBogosian A, Chadwick P, Windgassen S et al (2015) Distress improves after mindfulness training for progressive MS: a pilot randomised trial. Mult Scler 21:1184–1194
PubMedCrossRefBomasang-Layno E, Fadlon I, Murray AN, Himelhoch S (2015) Antidepressive treatments for Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 21:833–842
PubMedCrossRefBombardier CH, Blake KD, Ehde DM et al (2004) Alcohol and drug abuse among persons with multiple sclerosis. Mult Scler 10:35–40
PubMedCrossRefBomhof-Roordink H, Seldenrijk A, van Hout HPJ et al (2015) Associations between life stress and subclinical cardiovascular disease are partly mediated by depressive and anxiety symptoms. J Psychosom Res 78:332–339
PubMedCrossRefBonaz BL, Bernstein CN (2013) Brain-gut interactions in inflammatory bowel disease. Gastroenterology 144:36–49
PubMedCrossRefBondy B (2007) Common genetic factors for depression and cardiovascular disease. Dialogues Clin Neurosci 9:19–28
PubMedPubMedCentralBorson S, McDonald G, Gayle T et al (1992) Improvement in mood, physical symptoms, and functions with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 33:190–201
PubMedCrossRefBourgeois JA, Hilty DM, Chang CH et al (2004) Poststroke neuropsychiatric illness: an integrated approach to diagnosis and management. Curr Treat Opt Neurol 6:403–420
CrossRefBower JH, Grossardt BR, Maraganore DM et al (2010) Anxious personality predicts an increased risk of Parkinson’s disease. Mov Disord 25:2105–2113
PubMedPubMedCentralCrossRefBoyd AD, Riba M (2007) Depression and pancreatic cancer. J Natl Compr Canc Netw 5:113–116
PubMedBoye B, Lundin KE, Jantschek G et al (2011) INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn’s disease? A randomized controlled trial. Inflamm Bowel Dis 17:1863–1873
PubMedCrossRefBoyes AW, Girgis A, D’Este CA et al (2013) Prevalence and predictors of the short-term trajectory of anxiety and depression in the first year after a cancer diagnosis: a population-based longitudinal study. J Clin Oncol 31:2724–2729
PubMedCrossRefBoyko EJ, Seelig AD, Jacobson IG et al (2013) Sleep characteristics, mental health, and diabetes risk: a prospective study of US military service members in the Millennium Cohort Study. Diabetes Care 36:3154–3161
PubMedPubMedCentralCrossRefBozzini S, Gambelli P, Boiocchi C et al (2009) Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms. Int J Mol Med 24:813–818
PubMedCrossRefBraak H, Rüb U, Gai P, Del Tredici K (2003) Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517–536
PubMedCrossRefBradley SM, Rumsfeld JS (2015) Depression and cardiovascular disease. Trends Cardiovasc Med pii:S1050-1738(15)00039
Braun S, Kleynen M, van Heel T et al (2013) The effects of mental practice in neurological rehabilitation; a systematic review and meta-analysis. Front Hum Neurosci 7:390
PubMedPubMedCentralCrossRefBreitbart W (2011) Do antidepressants reduce the effectiveness of tamoxifen? Psychooncology 20:1–4
PubMedCrossRefBreitbart W, Rosenfeld B, Pessin H et al (2000) Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA 284:2907–2911
PubMedCrossRefBrenes GA (2003) Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 65:963–970
PubMedCrossRefBrintzenhofe-Szoc KM, Levin TT, Li Y et al (2009) Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics 50:383–391
PubMedCrossRefBrodaty H, Withall A, Altendorf A, Sachdev PS (2007) Rates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: the Sydney stroke study. Am J Geriatr Psychiatry 15:477–486
PubMedCrossRefBrown LF, Kroenke K (2009) Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 50:440–447
PubMedPubMedCentralCrossRefBrown JH, Paraskevas F (1982) Cancer and depression: cancer presenting with depressive illness: an autoimmune disease? Br J Psychiatry 141:227–232
PubMedCrossRefBrown ES, Varghese FP, McEwen BS (2004) Association of depression with medical illness: does cortisol play a role? Biol Psychiatry 55:1–9
PubMedCrossRefBrown ES, Vornik LA, Khan DA, Rush AJ (2007) Bupropion in the treatment of outpatients with asthma and major depressive disorder. Int J Psychiatry Med 37:23–28
PubMedCrossRefBrown AD, Barton DA, Lambert GW (2009) Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs 23:583–602
PubMedCrossRefBrown RG, Landau S, Hindle JV et al (2011) Depression and anxiety related subtypes in Parkinson’s disease. Neurol Neurosurg Psychiatry 82:803–809
CrossRefBrown ES, Howard C, Khan DA, Carmody TJ (2012) Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study. Psychosomatics 53:75–80
PubMedCrossRefBruggimann L, Annoni JM, Staub F et al (2006) Chronic posttraumatic stress symptoms after nonsevere stroke. Neurology 66:513–516
PubMedCrossRefBrunner EJ, Chandola T, Marmot MG (2007) Prospective effect of job strain on general and central obesity in the Whitehall II study. Am J Epidemiol 165:828–837
PubMedCrossRefBrydon L, Strikea PC, Bhattacharyyaa MR et al (2010) Hostility and physiological responses to laboratory stress in acute coronary syndrome patients. J Psychosom Res 68:109–116
PubMedPubMedCentralCrossRefBull SJ, Huezo-Diaz P, Binder EB et al (2009) Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry 14:1095–1104
PubMedCrossRefBurn MN, Nawacki E, Siddique J et al (2013) Prospecitve examination of anxiety and depression before and during confirmed and pseudoexacerbations in patients with multiple sclerosis. Psychosom Med 75:76–82
CrossRefButnoriene J, Bunevicius A, Norkus A, Bunevicius R (2014) Depression but not anxiety is associated with metabolic syndrome in primary care based community sample. Psychoneuroendocrinology 40:269–276
PubMedCrossRefCalam R, Gregg L, Goodman R (2005) Psychological adjustment and asthma in children and adolescents: the UK Nationwide Mental Health Survey. Psychosom Med 67:105–110
PubMedCrossRefCalapai G, Casciaro M, Miroddi M et al (2014) Montelukast-induced adverse drug reactions: a review of case reports in the literature. Pharmacology 94:60–70
PubMedCrossRefCampayo A, de Jonge P, Roy JF et al (2010) Depressive disorder an incident diabetes mellitus: the effect of characteristics of depression. Am J Psychiatry 167:580–588
PubMedCrossRefCampbell Burton CA, Holmes J, Murray J et al (2011) Interventions for treating anxiety after stroke. Cochrane Database Syst Rev 12, CD008860
PubMedCapuron L, Miller AH (2004) Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 56:819–824
PubMedCrossRefCapuron L, Miller AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 130:226–238
PubMedPubMedCentralCrossRefCapuron L, Gumnick JF, Musselman DL et al (2002) Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26:643–652
PubMedCrossRefCapuron L, Raison CL, Musselman DL et al (2003) Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry 160:1342–1345
PubMedCrossRefCapuron L, Pagnoni G, Drake DF et al (2012) Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry 69:1044–1053
PubMedPubMedCentralCrossRefCardamone L, Salzberg MR, O’Brine TJ, Jones NC (2013) Antidepressants therapy in epilepsy: can treating the comorbidities affect the underlying disorder? Br J Pharmacol 168:1531–1554
PubMedPubMedCentralCrossRefCargiulo T (2007) Understanding the health impact of alcohol dependence. Am J Health Syst Pharm 64(suppl 3):5–11
CrossRefCarney C (1999) Endocrine disorders. In: Robinson RG, Yates WR (Hrsg) Psychiatric treatment of the medically ill. Marcel Dekker, New York/Basel, S 155–180
Carney RM, Freedland KE (2009a) Treatment-resistant depression and sudden cardiac death. J Am Coll Cardiol 54:958–959
PubMedCrossRefCarney RM, Freedland KE (2009b) Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry 166:410–417
PubMedPubMedCentralCrossRefCarney RM, Freedland KF (2012) Is there a high-risk subtype of depression in patients with coronary heart disease? Curr Psychiatry Rep 14:1–7
PubMedPubMedCentralCrossRefCarney CP, Jones L, Woolson RF (2003) Relationship between depression and pancreatic cancer in the general population. Psychosom Med 65:884–888
PubMedCrossRefCaron A, Weissman MM (2006) Interpersonal psychotherapy in the treatment of depression in medical patients. Prim Psychiatry 13:43–50
Carson AJ, MacHale S, Allen K et al (2000) Depression after stroke and lesion location: a systematic review. Lancet 356:122–126
PubMedCrossRefCarson A, Zeman A, Myles L, Sharpe M (2007) Neurological disorders. In: Lloyd GG, Guthrie E (Hrsg) Handbook of liaison psychiatry. Cambridge University Press, Cambridge, S 305–364
CrossRefCarta MG, Angst J, Moro MF et al (2012) Association of chronic hepatitis C with recurrent brief depression. J Affect Disord 141:361–366
PubMedCrossRefCassem EH (1990) Depression and anxiety secondary to medical illness. Psychiatr Clin North Am 13:597–612
PubMedCassem EH (1995) Depressive disorders in the medically ill. Psychosomatics 36:2–10
CrossRefCazzola M, Segreti A, Calzetta L, Rogliani P (2013) Comorbidities of asthma: current knowledge and future research needs. Curr Opin Pulm Med 19:36–41
PubMedCrossRefCelano CM, Freudenreich O, Fernandez-Robles C et al (2011) Depressogenic effects of medications: a review. Dialogues Clin Neurosci 13:109–125
PubMedPubMedCentralCelano CM, Suarez L, Mastromauro C, Januzzi JL, Huffman JC (2013) Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease. Circ Cardiovasc Qual Outcomes 6:498–504
PubMedCrossRefChan R, Steel Z, Brooks R, Heung T et al (2011) Psychosocial risk and protective factors for depression in the dialysis population: a systematic review and meta-regression analysis. J Psychosom Res 71:300–310
PubMedCrossRefChandola T, Brunner E, Marmot M (2006) Chronic stress at work and the metabolic syndrome: prospective study. BMJ 332:521–525
PubMedPubMedCentralCrossRefChaudhuri KR, Odin P (2010) The challenge of non-motor symptoms in Parkinson’s disease. Prog Brain Res 184:325–341
PubMedCrossRefChaudhuri KR, Schapira AHV (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464–474
PubMedCrossRefChaytor N, Ciechanowski P, Miller JW et al (2011) Long-term outcomes from the PEARLS randomized trial for the treatment of depression in patients with epilepsy. Epilepsy Behav 20:545–549
PubMedCrossRefChen P, Kales HC, Weintraub D et al (2007) Depression in veterans with Parkinson’s disease: frequency, co-morbidity, and healthcare utilization. Int J Geriatr Psychiatry 22:547–548
Chen Y, Chen X, Mok VC et al (2009) Poststroke depression in patients with small subcortical infarcts. Clin Neurol Neurosurg 111:256–260
PubMedCrossRefChida Y, Steptoe A (2009) The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol 53:936–946
PubMedCrossRefChida Y, Hamer M, Wardle J, Steptoe A (2008) Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 5:466–475
PubMedCrossRefChochinov HM, Wilson KG, Enns M et al (1994) Prevalence of depression in the terminally ill: effects of diagnostic criteria and symptom threshold judgements. Am J Psychiatry 4:537–540
Chollet F, Tardy J, Albucher J et al (2011) Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 10:123–130
PubMedCrossRefChollet F, Ackert B, Raposo N et al (2013) Use of antidepressant medications to improve outcomes after stroke. Curr Neurol Neurosci Rep 13:318
PubMedCrossRefChristensen AJ, Moran PJ, Wiebe JS et al (2002) Effect of a behavioural self-regulation intervention on patient adherence in hemodialysis. Health Psychol 21:393–397
PubMedCrossRefChrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 5:374–381
PubMedCrossRefChwastiak L, Ehde DM, Gibbons LE et al (2002) Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 159:1862–1868
PubMedCrossRefCiechanowski P, Russo J, Katon W et al (2006) Where is the patient? The association of psychosocial factors and missed primary care appointments in patients with diabetes. Gen Hosp Psychiatry 28:9–17
PubMedCrossRefCiechanowski P, Chaytor N, Miller J et al (2010) PEARLS depression treatment for individuals with epilepsy: a randomized controlled trial. Epilepsy Behav 19:225–231
PubMedCrossRefClark DC, von Ammon Cavanaugh S, Gibbons RD (1983) The core symptoms of depression in medical and psychiatric patients. J Nerv Ment Dis 171:705–713
PubMedCrossRefClark DA, Cook A, Snow D (1998) Depressive symptom differences in hospitalized, medically ill, depressed psychiatric inpatients and nonmedical controls. J Abnorm Psychol 107:38–48
PubMedCrossRefClarke DM (2011) Psychological adaptation, demoralization and depression in people with cancer. In: Kissane DW, Maj M, Sartorius N (Hrsg) Depression and cancer. Wiley-Blackwell, Chichester, S 37–50
Clarke DM, Kissane DW (2002) Demoralisation: its phenomenology and importance. Aust N Z J Psychiatry 36:733–742
PubMedCrossRefClarke DM, McKenzie DP, Marshall RJ, Smith GC (1994) The construction of a brief casefinding instrument for depression in the physically ill. Integrat Psychiatry 10:117–123
Clarke DM, Mackinnon AJ, Smith GC et al (2000) Dimensions of psychopathology in the medically ill: a latent trait analysis. Psychosomatics 41:418–425
PubMedCrossRefClarke DM, Smith GC, Dowe DL, McKenzie DP (2003) An empirically-derived taxonomy of common disstress syndromes in the medically ill. J Psychosom Res 54:323–330
PubMedCrossRefClarke DM, Cook KE, Coleman KJ, Smith GC (2006) A qualitative examination of the experience of depression in hospitalized medically ill patients. Psychopathology 39:303–312
PubMedCrossRefClayton PJ, Lewis CE (1981) The significance of secondary depression. J Affect Disord 3:25–35
PubMedCrossRefCleary RA, Thompson PJ, Fox Z, Foong J (2012) Predictors of psychiatric and seizure outcome following temporal love epilepsy surgery. Epilepsia 53:1705–1712
PubMedCrossRefCoakeley S, Martens KE, Almeida QJ (2014) Management of anxiety and motor symptoms in Parkinson’s disease. Expert Rev Neurother 14:937–946
PubMedCrossRefCoffman K, Levenson JL (2005) Lung disease. In: Levenson JL (Hrsg) Textbook of psychosomatic medicine. American Psychiatric Publishing, Washington, DC/London, S 445–464
Cohen LM, Levy NB, Tessier EG, Germain MJ (2005) Renal disease. In: Levenson JL (Hrsg) Textbook of psychosomatic medicine. American Psychiatric Publishing, Washington, DC/London, S 483–493
Cohen SD, Norris L, Acquaviva K et al (2007) Screening, diagnosis, and treatment of depression in patients with endstage renal disease. Clin J Am Soc Nephrol 2:1332–1342
PubMedCrossRefCohen BE, Marmar CR, Neylan TC (2009) Posttraumatic stress disorder and health-related quality of life in patients with coronary heart disease: findings from the heart and soul study. Arch Gen Psychiatry 66:1214–1220
PubMedPubMedCentralCrossRefCohen-Cole SA, Stoudemire A (1987) Major depression and physical illness. Special considerations in diagnosis and biologic treatment. Psychiatr Clin North Am 10:1–17
PubMedCole MG, Bellavance F (1997) Depression in elderly medical inpatients: a meta-analysis of outcomes. Can Med Assoc 157:1055–1060
Colgan SM, Faragher EB, Whorwell PJ (1988) Controlled trial of hypnotherapy in relapse prevention of duodenal ulceration. Lancet 1:1299–1300
PubMedCrossRefCoogan PF, Yu J, O’Connor GT et al (2014) Depressive symptoms and the incidence of adult-onset asthma in African American women. Ann Allergy Asthma Immunol 112:333–338
PubMedPubMedCentralCrossRefCooke L, Wardle (2006) Depression and obesity. In: Steptoe A (Hrsg) Depression and physical illness. Cambridge University Press, Cambridge, S 238–261
CrossRefCosci F, Nardi AE, Griez EJ (2014) Nicotine effects on human affective functions: a systematic review of the literature on a controversial issue. CNS Neurol Disord Drug Targets 13:981–991
PubMedCrossRefCosta D, Mogos I, Toma T (1985) Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand 72(Suppl 329):85–92
CrossRefCostanzo ES, Sood AK, Lutgendorf SK (2011) Biobehavioral influences on cancer progression. Immunol Allergy Clin North Am 31:109–132
PubMedPubMedCentralCrossRefCotter G, Milo-Cotter O, Rubinstein D, Shemesh E (2006) Posttraumatic stress disorder: a missed link between psychiatric and cardiovascular morbidity? CNS Spectr 11:129–136
PubMedCrossRefCoventry PA, Bower P, Keyworth C et al (2013) The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One 8, e60532
PubMedPubMedCentralCrossRefCowan MJ, Freedland KE, Burg MM et al (2008) Predictors of treatment response for depression and inadequate social support – the ENRICHD randomized controlled trial. Psychother Psychosom 77:27–37
PubMedCrossRefCraske MG, Waters AM (2005) Panic disorder, phobias, and generalized anxiety disorder. Annu Rev Clin Psychol 1:197–225
PubMedCrossRefCreed F (1997) Assessing depression in the context of physical illness. In: Robertson MM, Katona CLE (Hrsg) Depression and physical illness. Wiley, Chichester, S 3–19
Creed F (2006) Gastrointestinal disease. In: Blumenfield M, Strain JJ (Hrsg) Psychosomatic medicine. Lippincott, Williams & Wilkins, Philadelphia, S 145–156
Creed F, Dickens C (2006) Depression in the medically ill. In: Steptoe A (Hrsg) Depression and physical illness. Cambridge University Press, Cambridge, S 3–18
CrossRefCreed F, Olden KW (2005) Gastrointestinal disorders. In: Levenson JL (Hrsg) Textbook of psychosomatic medicine. American Psychiatric Publishing, Washington, DC/London, S 465–481
Creed F, Morgan R, Fiddler M et al (2002) Depression and anxiety impair health-related quality of life and are associated with increased costs in general medical inpatients. Psychosomatics 43:302–309
PubMedCrossRefCrone CC, Gabriel GM, DiMartini A (2006) An overview of psychiatric issues in liver disease for the consultation-liaison psychiatrist. Psychosomatics 47:188–205
PubMedCrossRefCukierman-Yaffee T (2009) The relationship between dysglycemia and cognitive dysfunction. Curr Opin Investig Drugs 10:70–74
PubMedCukor D, Coplan J, Brown C (2007) Depression and anxiety in urban hemodialysis patients. Clin J Am Soc Nephrol 2:484–490
PubMedCrossRefCukor D, Coplan J, Brown C et al (2008a) Anxiety disorders in adults treated by hemodialysis: a single-center study. Am J Kidney Dis 52:128–136
PubMedCrossRefCukor D, Coplan J, Brown C et al (2008b) Course of depression and anxiety diagnosis in patients treated with hemodialysis: a 16-month follow-up. Clin J Am Soc Nephrol 3:1752–1758
PubMedPubMedCentralCrossRefCukor D, Ver Halen N, Fruchter Y (2013) Anxiety and quality of life in ESRD. Semin Dial 26:265–268
PubMedCrossRefCukor D, Ver Halen N, Asher DR et al (2014) Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis. J Am Soc Nephrol 25:196–206
PubMedCrossRefCumming TB, Churilov L, Skoog I et al (2010) Little evidence for different phenomenology in poststroke depression. Acta Psychiatr Scand 121:424–430
PubMedCrossRefCurrier MB, Nemeroff CB (2014) Depression as a risk factor for cancer: from pathophysiological advances to treatment implications. Annu Rev Med 65:203–221
PubMedCrossRefda Silva TM, Munhoz RP, Alvarez C et al (2008) Depression in Parkinson’s disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. J Affect Disord 111:351–359
PubMedCrossRefDafer RM, Rao M, Shareef A, Sharma A (2008) Poststroke depression. Top Stroke Rehabil 15:13–21
PubMedCrossRefDahl AA (2010) Link between personality and cancer. Future Oncol 6:691–707
PubMedCrossRefDahl OP, Stordal E, Lydersen S, Midgard R (2009) Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway. Mult Scler 15:1495–1501
PubMedCrossRefDalton SO, Mellemkjaer L, Olsen JH et al (2002) Depression and cancer risk: a register-based study of patients hospitalized with affective disorders. Denmark, 1969–1993. Am J Epidemiol 155:1088–1095
PubMedCrossRefDantzer R, O’Conner JC, Freund GG et al (2008a) From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Rev Neurosci 9:46–57
CrossRefDantzer R, O’Connor JC, Greund GG et al (2008b) From inflammation to sickness and depression: when the immune system subjugates the brain. Neuroscience 9:46–57
PubMedPubMedCentralDantzer R, Meagher MW, Cleeland CS (2012) Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol 9:414–426
PubMedPubMedCentralCrossRefDavey A, Elias MF, Robbins MA et al (2013) Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory. Nephrol Dial Transplant 28:1810–1819
PubMedCrossRefDavid AS, Fleminger S, Kopelman MD, Lovestone S, Mellers JDC (2009) Lishman’s organic psychiatry. A textbook of neuropsychiatry, 4. Aufl. Wiley-Blackwell, Oxford
Davidson KW (2008) Emotional predictors and behavioral triggers of acute coronary syndrome. Cleve Clin J Med 75(suppl 2):15–19
CrossRefDavidson KW, Rieckmann N, Clemow L et al (2010) Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med 170:600–608
PubMedPubMedCentralCrossRefDavidson KW, Bigger JT, Burg MM et al (2013) Centralized, stepped patients preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med 173:997–1004
PubMedPubMedCentralCrossRefDavies SJ, Allgulander C (2013) Anxiety and cardiovascular disease. Mod Trends Pharmacopsychiatri 29:85–97
PubMedCrossRefDavydow DS, Desai SV, Needham DM, Bienvenu OJ (2008) Psychiatric morbidity in survivors of the acute respiratory distress syndrome: a systematic review. Psychosom Med 70:512–519
PubMedCrossRefde Abajo FJ (2011) Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients. Drugs Aging 28:345–367
PubMedCrossRefde Araújo Filho GM, Gomes FL, Mazetto L et al (2012) Major depressive disorder as a predictor of a worse seizure outcome one year after surgery in patients with temporal lobe epilepsy and mesial temporal sclerosis. Seizure 21:619–623
PubMedCrossRefde Godoy DV, de Godoy RF (2003) A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 84:1154–1157
PubMedCrossRefde Jonge P, Kempen GIJM, Sanderman R et al (2006) Depressive symptoms in elderly patients after a somatic illness event. Psychosomatics 47:33–42
PubMedCrossRefde Jonge P, Mangano D, Whooley MA (2007) Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the heart and soul study. Psychosom Med 69:735–739
PubMedPubMedCentralCrossRefde Jonge P, Alonso J, Stein DJ et al (2014) Associations between DSM-IV mental disorders and diabetes mellitus: a role for impulse control disorders and depression. Diabetologia 57:699–709
PubMedPubMedCentralCrossRefde Miranda Azevedo R, Roest AM, Hoen PW, de Jonge P (2014) Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis. Psychol Med 44:2689–2703
PubMedCrossRefde Ryck A, Brouns R, Fransen E et al (2013) A prospective study on the prevalence and risk factors of poststroke depression. Cerebrovasc Dis Extra 3:1–13
PubMedPubMedCentralCrossRefde Vries AM, Forni V, Voellinger R, Stiefel F (2012) Alexithymia in cancer patients: review of the literature. Psychother Psychosom 81:79–86
PubMedCrossRefDelisle VC, Abbey SE, Beck AT et al (2012) The influence of somatic symptoms on Beck Depression Inventory scores in hospitalized postmyocardial infarction patients. Can J Psychiatry 57:752–758
PubMedDen Heijer T, Vermeer SE, van Dijk EJ et al (2003) Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46:1604–1610
CrossRefDenollet J, Pedersen SS (2009) Anger, depression, and anxiety in cardiac patients: the complexity of individual differences in psychological risk. Am Coll Cardiol 53:947–949; Denollet J, de Jonge P, Kuyper A et al (2009) Depression and type D personality represent different forms of distress in the Myocardial INfarction and Depression – Intervention Trial (MIND-IT). Psychol Med 39:749–756
Denollet J, Freedland KE, Carney RM et al (2013) Cognitive-affective symptoms of depression after myocardial infarction: different prognostic importance across age groups. Psychosom Med 75:701–708
PubMedCrossRefDerogatis LR, Wise TN (Hrsg) (1989) Anxiety and depressive disorders in the medical patient. American Psychiatric Press, Washington, DC
Desaive P, Ronson A (2008) Stress spectrum disorders in oncology. Curr Opin Oncol 20:378–385
PubMedCrossRefDeschênes SS, Burns RJ, Schmitz N (2015) Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: findings from the 2012 Canadian Community Health Survey – Mental Health (CCHS-MH). J Psychosom Res 78:137–142
PubMedCrossRefDeshmukh VM, Toelle BG, Usherwood T et al (2007) Anxiety, panic and adult asthma: a cognitive-behavioral perspective. Respir Med 101:194–202
PubMedCrossRefDeshmukh VM, Toelle BG, Usherwood T et al (2008) The association of comorbid anxiety and depression with asthma-related quality of life and symptom perception in adults. Respirology 13:695–702
PubMedCrossRefDeshpande SN, Sundaram KR, Wig NN (1989) Psychiatric disorders among medical inpatients in an Indian hospital. Br J Psychiatry 154:504–509
PubMedCrossRefDesmarais JE, Looper KJ (2009) Interactions between tamoxifen and antidepressants via cytochrome P4502D6. J Clin Psychiatry 70:1688–1697
PubMedCrossRefDetka J, Kurek A, Basta-Kaim A et al (2013) Neuroendocrine link between stress, depression and diabetes. Pharmacol Rep 65:1591–1600
PubMedCrossRefDetweiler-Bedell JB, Friedman MA, Leventhal H et al (2008) Integrating co-morbid depression and chronic physical disease management: identifying and resolving failures in self-regulation. Clin Psychol Rev 28:1426–1446
PubMedPubMedCentralCrossRefDeuschle M (2013) Effects of antidepressants of glucose metabolism and diabetes mellitus type 2 in adults. Curr Opin Psychiatry 26:60–65
PubMedCrossRefDeuschle M, Schweiger U (2012) Depression und Diabetes mellitus Type 2. Nervenarzt 83:1410–1422
PubMedCrossRefDevine EC, Pearcy J (1996) Meta-analysis of the effects of psychoeducational care in adults with chronic obstructive pulmonary disease. Patient Educ Couns 29:167–178
PubMedCrossRefDevos D, Dujardin K, Poirot I et al (2008) Comparison of desipramine and citalopram treatments for depression in Parkinson’s disease: a double-blind, randomized, placebo-controlled study. Mov Disord 23:850–857
PubMedCrossRefDi Marco F, Santus P, Centanni S (2011) Anxiety and depression in asthma. Curr Opin Pulm Med 17:39–44
PubMedCrossRefDickson DW, Fujishiro H, Orr C et al (2009) Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord 3:1–5
CrossRefDinkel A (2015) Progredienzangst und spezifische krankheitsbezogene Ängste. In: Rief W, Henningsen P (Hrsg) Psychosomatik und Verhaltensmedizin. Schattauer, Stuttgart, S 79–84
Dismuke CE, Hernandez-Tejada MA, Egede LE (2014) Relationship of serious psychological distress to quality of life in adults with diabetes. Int J Psychiatry Med 48:135–146
PubMedCrossRefDissanayaka NN, Sellbach A, Matheson S et al (2010) Anxiety disorder in Parkinson’s disease: prevalence and risk factors. Mov Disord 25:838–845
PubMedCrossRefDissanayaka NN, White E, O’Sullivan JD et al (2014) The clinical spectrum of anxiety in Parkinson’s disease. Mov Disord 29:967–975
PubMedCrossRefDivo M, Cote C, de Torres JP et al (2012) Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186:155–161
PubMedCrossRefDobkin RD, Allen LA, Menza M (2006) A cognitive-behavioral treatment package for depression in Parkinson’s disease. Psychosomatics 47:259–263
PubMedCrossRefDobkin RD, Allen LA, Menza M (2007) Cognitive-behavioral therapy for depression in Parkinson’s disease: a pilot study. Mov Disord 22:946–952
PubMedCrossRefDobkin RD, Menza M, Bienfait KL (2008) CBT for the treatment of depression in Parkinson’s disease: a promising non-pharmacological approach. Expert Rev Neurother 81:27–35
CrossRefDobkin RD, Menza M, Allen LA et al (2011a) Cognitive-behavioural therapy for depression in Parkinson’s disease: a randomized, controlled trial. Am J Psychiatry 168:1066–1074
PubMedPubMedCentralCrossRefDobkin RD, Menza M, Allen LA et al (2011b) Telephone-based cognitive-behavioral therapy for depression in Parkinson’s disease. J Geriatr Psychiatry Neurol 24:206–214
PubMedPubMedCentralCrossRefDoerfler LA, Paraskos JA (2005) Post-traumatic stress disorder in patients with coronary artery disease: screening and management implications. Can J Cardiol 21:689–697
PubMedDonnchadha SÓ, Burke T, Bramham J et al (2013) Symptom overlap in anxiety and multiple sclerosis. Mult Scler 19:1349–1354
CrossRefDouglas I, Smeeth L, Irvine D (2011) The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study. Br J Clin Pharmacol 71:116–120
PubMedPubMedCentralCrossRefDoyle F, McGee H, Conroy R et al (2015) Systematic review and individual patient data meta-analysis of sex differences in depression and prognosis in persons with myocardial infarction: a MINDMAPS study. Psychosom Med 77:419–428
PubMedCrossRefDrayer RA, Piraino B, Reynolds CF et al (2006) Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk. Gen Hosp Psychiatry 28:306–312
PubMedCrossRefDrevets WC, Price JL, Furey ML (2008) Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 213:93–118
PubMedPubMedCentralCrossRefDrossman DA, Thompson WG (1992) The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med 116:1009–1016
PubMedCrossRefDruss BG, Rosenheck RA, Sledge WH (2000) Health and disability costs of depressive illness in a major US corporation. Am J Psychiatry 157:1274–1278
PubMedCrossRefDuarte PS, Miyazaki MC, Blay SL, Sesso R (2009) Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney Int 76:414–421
PubMedCrossRefDuBois CM, Lopez OV, Beale EE et al (2015) Relationships between positive psychological constructs and health outcomes in patients with cardiovascular disease: a systematic review. Int J Cardiol 195:265–280
PubMedPubMedCentralCrossRefDuelli R, Kuschinsky W (2001) Brain glucose transporters: relationship to local energy demand. News Physiol Sci 16:71–76
PubMedDuffy SA, Ronis DL, Valenstein M et al (2007) Depressive symptoms, smoking, drinking, and quality of life among head and neck cancer patients. Psychosomatics 48:142–148
PubMedCrossRefDumbreck S, Flynn A, Nairn M et al (2015) Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ 350:h949
PubMedPubMedCentralCrossRefDunn SL, Corser W, Stommel M, Holmes-Rovner M (2006) Hopelessness and depression in the early recovery period after hospitalization for acute coronary syndrome. J Cardiopulm Rehabil 26:152–159
PubMedCrossRefEaton WW (2006) The consequences of psychopathology in the Baltimore Epidemiologic Catchment Area follow-up. In: Eaton WW (Hrsg) Medical and psychiatric comorbidity over the course of life. American Psychiatric Publishing, Washington, DC/London, S 21–36
Eaton WW, Armenian HK, Gallo JJ et al (1996) Depression and risk for onset of type II diabetes: a prospective, population-based study. Diabetes Care 19:1097–1102
PubMedCrossRefEcheverry D, Duran, Bonds C et al (2009) Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care 32:2156–2160
PubMedPubMedCentralCrossRefEckert A (2009) Spezielle Arzneimittelinteraktionen. Ther Umschau 66:485–492
CrossRefEdmondson D, Newman JD, Whang W, Davidson KW (2013) Emotional triggers in myocardial infarction: do they matter? Eur Heart J 34:300–306
PubMedCrossRefEdwards LE, Mezuk B (2012) Anxiety and risk of type 2 diabetes: evidence from the Baltimore Epidemiologic Catchment Area Study. J Psychosom Res 73:418–423
PubMedPubMedCentralCrossRefEgede LE, Ellis C (2010) Diabetes and depression: global perspectives. Diabetes Res Clin Pract 87:302–312
PubMedCrossRefEgede LE, Nietert PJ, Zhent D (2005) Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 28:1339–1345
PubMedCrossRefEhret M, Sobieraj DM (2014) Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis. Int J Clin Pract 68:255–261
PubMedCrossRefEhrt U, Bronnick K, Leentjens AF et al (2006) Depressive symptom profile in Parkinson’s disease: a comparison with depression in elderly patients without Parkinson’s disease. Int J Geriatr Psychiatry 21:252–258
PubMedCrossRefEjiofor S, Turner AM (2013) Pharmacotherapies for COPD. Clin Med Insights Circ Respir Pulm Med 7:17–34
PubMedPubMedCentralEkmann A, Osler M, Avlund K (2012) The predictive value of fatigue for nonfatal ischemic heart disease and all-cause mortality. Psychosom Med 74:464–470
PubMedCrossRefElderon L, Whooley MA (2013) Depression and cardiovascular disease. Prog Cardiovasc Dis 55:511–523
PubMedCrossRefElias MF, Dore GA, Davey A (2013) Kidney disease and cognitive function. Contrib Nephrol 179:42–57
PubMedCrossRefEmery CF, Schein RL, Hauck ER, MacIntyre NR (1998) Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol 17:232–240
PubMedCrossRefEnescu A, Mitrut P, Balasoiu M et al (2015) Psychosocial issues in patients with chronic hepatitis B and C. Curr Health Sci J 40:93–96
Engel GL (1967) A psychological setting of somatic disease: the giving up-given up complex. Proc Royal Soc Med 60:553–555
Epstein SA, Hicks D (2005) Anxiety disorders. In: Levenson JL (Hrsg) Textbook of psychosomatic medicine. American Psychiatric Publishing, Washington, DC/London, S 251–270
Erdley SD, Gellis ZD, Bogner HA et al (2014) Problem-solving therapy to improve depression scores among older hemodialysis patients: a pilot randomized trial. Clin Nephrol 82:26–33
PubMedEriksson M, Glader EL, Norrving B, Asplund K (2015) Poststroke suicide attempts and completed suicides: a socioeconomic and nationwide perspective. Neurology 84:1732–1738
PubMedPubMedCentralCrossRefEskes GA, Lanctôt KL, Herrmann N et al (2015) Canadian stroke best practice recommendations: mood, cognition and fatigue following stroke practice guidelines, update 2015. Int J Stroke 10:1130–1140
PubMedCrossRefEsler M (2009) Heart and mind: psychogenic cardiovascular disease. J Hypertens 27:692–695
PubMedCrossRefEttinger AB, Reed ML, Goldberg JF, Hischfeld RM (2005) Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology 65:535–540
PubMedCrossRefEvangelista O, McLaughlin MA (2009) Review of cardiovascular risk factors in women. Gend Med 6:17–36
PubMedCrossRefEvans DL, Charney DS, Lewis L et al (2005) Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58:175–189
PubMedCrossRefEvon DM, Ramcharran D, Belle SH et al (2009) Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study. Am J Gastroenterol 104:2949–2958
PubMedCrossRefEwusi-Mensah I, Saunders JB, Wodak AD et al (1983) Psychiatric morbidity in patients with alcoholic liver disease. Br Med J 287:1417–1419
CrossRefFaller H (2004) Psychotherapie bei somatischen Erkrankungen. Krankheitsmodelle und Therapiepraxis – störungsspezifisch und schulenübergreifend. Thieme, Stuttgart
Faller H, Schuler M, Richard M et al (2013) Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol 31:782–793
PubMedCrossRefFan VS, Meek PM (2014) Anxiety, depression, and cognitive impairment in patients with chronic respiratory disease. Clin Chest Med 35:399–409
PubMedCrossRefFan H, Yu W, Zhang Q et al (2014) Depression after heart failure and risk of cardiovascular and all-cause mortality: a meta-analysis. Prev Med 63:36–42
PubMedCrossRefFarrokhi F, Abedi N, Beyene J (2014) Association between depression and mortality in patients receiving long-term dialysis: a systematic review and meta-analysis. Am J Kidney Dis 63:623–635
PubMedCrossRefFarvid MS, Qi L, Hu FB et al (2014) Phobic anxiety symptom scores and incidence of type 2 diabetes in US men and women. Brain Behav Immun 36:176–182
PubMedCrossRefFaust AH, Halpern LF, Danoff-Burg S, Cross RK (2012) Psychosocial factors contributing to inflammatory bowel disease activity and health-related quality of life. Gastroenterol Hepatol 8:173–181
Fava GA (1994) Affective disorders and endocrine disease. New insights from psychosomatic studies. Psychosomatics 35:341–353
PubMedCrossRefFava GA, Sonino N (1996) Depression associated with medical illness. CNS Drugs 5:175–189
CrossRefFava GA, Trombini G, Barbara L et al (1985) Depression and gastrointestinal illness: the joint use of biological and clinical criteria. Am J Gastroenterol 80:195–199
PubMedFava GA, Sonino N, Wise TN (1988) Management of depression in medical patients. Psychother Psychosom 49:81–102
PubMedCrossRefFava GA, Porcelli P, Rafanelli C et al (2010) Anxiety disorders in the medically ill. J Clin Psychiatry 71:910–914
PubMedCrossRefFavreau H, Bacon SL, Labrecque M, Lavoie KL (2014) Prospective impact of panic disorder and panic-anxiety on asthma control, health service use, and quality of life in adult patients with asthma over a 4-year follow-up. Psychosom Med 76:147–155
PubMedCrossRefFedoroff JP, Starkstein SE, Parikh RM et al (1991) Are depressive symptoms non-specific in patients with acute stroke? Am J Psychiatry 148:1172–1176
PubMedCrossRefFeinstein A (2006) Mood disorders in multiple sclerosis and the effects on cognition. J Neurol Sci 245:63–66
PubMedCrossRefFeinstein A (2007) Neuropsychiatric syndromes associated with multiple sclerosis. J Neurol 254(suppl 2):II73–II76
PubMedFeinstein A (2011) Multiple sclerosis and depression. Mult Scler 17:1276–1281
PubMedCrossRefFeinstein A, O’Connor P, Feinstein K (2002) Multiple sclerosis, interferon beta-1b and depression: a prospective investigation. J Neurol 249:815–820
PubMedCrossRefFeinstein A, Roy P, Lobaugh N et al (2004) Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 62:586–590
PubMedCrossRefFeinstein A, Magalhaes S, Richard JF, Audet B, Moore C (2014) The link between multiple sclerosis and depression. Nat Rev Neurol 10:507–517
PubMedCrossRefFeldman E, Mayou R, Hawton K et al (1987) Psychiatric disorder in medical inpatients. QJM 63:405–412
PubMedFernie BA, Kollmann J, Brown RG (2015) Cognitive behavioural interventions for depression in chronic neurological conditions: a systematic review. J Psychosom Res 78:411–419
PubMedCrossRefFeroze U, Martin D, Kalantar-Zadeh K et al (2012) Anxiety and depression in maintenance dialysis patients: preliminary data of a cross-sectional study and brief literature review. J Ren Nutr 22:207–210
PubMedCrossRefFerrer P, Ballarín E, Sabaté M et al (2014) Antiepileptic drugs and suicide: a systematic review of adverse effects. Neuroepidemiology 42:107–120
PubMedCrossRefFiedorowicz JG (2014) Depression and cardiovascular disease: an update on how course of illness may influence risk. Curr Psychiatry Rep 16:492
PubMedPubMedCentralCrossRefFiest KM, Dykeman J, Patten SB et al (2013) Depression in epilepsy: a systematic review and meta-analysis. Neurology 80:590–599
PubMedPubMedCentralCrossRefFink G (2011) Stress controversies: post-traumatic stress disorder, hippocampal volume, gastroduodenal ulceration. J Neuroendocrinol 23:107–117
PubMedCrossRefFinkelstein FO, Wuerth D, Finkelstein SH (2010) An approach to addressing depression in patients with chronic kidney disease. Blood Purif 29:121–124
PubMedCrossRefFinsterer J, Wahbi K (2015) CNS-disease affecting the heart: brain-heart disorders. J Neur Sci 345:8–14
Fisch MJ, Loehrer PJ, Kristeller J et al (2003) Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 21:1937–1943
PubMedCrossRefFisher L, Chesla CA, Mullan JT et al (2001) Contributors to depression in Latino and European-American patients with type 2 diabetes. Diabetes Care 24:1751–1757
PubMedCrossRefFisk JD, Morehouse SA, Brown MG et al (1998) Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. Can J Neurol Sci 25:230–235
PubMedCrossRefFitzgerald P, Li M, Grassi L, Rodin G (2014) Pharmacotherapy of depression in cancer patients. In: Grassi L, Riba M (Hrsg) Psychopharmacology in oncology and palliative care. Springer, Berlin/Heidelberg, S 145–161
Flachenecker P, Bihler I, Weber F et al (2004) Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler 10:165–169
PubMedCrossRefFlaster M, Sharma A, Rao M (2013) Poststroke depression: a review emphasizing the role of prophylactic treatment and synergy with treatment for motor recovery. Top Stroke Rehabil 20:139–150
PubMedCrossRefFleminger S (2009) Cerebrovascular disorders. In: David SA, Fleminger S, Kopelman MD, Lovestone S, Meller JDC (Hrsg) Lishman’s organic psychiatry, 4. Aufl. Wiley-Blackwell, Oxford, S 473–542
CrossRefFoley P, Lawler A, Chandran S, Mead G (2014) Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 85:709–710
PubMedCrossRefFolkman S, Greer S (2000) Promoting psychological well-being in the face of serious illness: when theory, research and practice inform each other. Psychooncology 9:11–19
PubMedCrossRefForster A, Young J (1996) Specialist nurse support for patients with stroke in the community: a randomised controlled trial. BMJ 312:1642–1646
PubMedPubMedCentralCrossRefFoster GR, Goldin RD, Thomas HC (1998) Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 27:209–212
PubMedCrossRefFosbøl EL, Gislason GH, Poulsen HE et al (2009) Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used. Circ Heart Fail 2:582–590
PubMedCrossRefFragoso YD, Frota ER, Lopes JS et al (2010) Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis. Clin Neuropharmacol 33:312–316
PubMedCrossRefFrank JD (1974) Psychotherapy: the restoration of morale. Am J Psychiatry 131:271–274
PubMedCrossRefFrasure-Smith N, Lespérance F (2010) Depression and cardiac risk: present status and future directions. Heart 96:173–176
PubMedCrossRefFreedland KE, Carney RM (2013) Depression as a risk factor for adverse outcomes in coronary heart disease. BMC Med 11:131
PubMedPubMedCentralCrossRefFreedland KE, Carney RM, Lustman PJ et al (1992) Major depression in coronary artery disease patients with vs. without prior history of depression. Psychosom Med 54:416–421
PubMedCrossRefFreedland KE, Skala JA, Carney RM et al (2009) Treatment of depression after coronary artery bypass surgery. A randomized controlled trial. Arch Gen Psychiatry 66:387–396
PubMedCrossRefFregni F, Pascual-Leone A (2007) Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS. Nat Clin Pract Neurol 3:383–393
PubMedCrossRefFregni F, Santos CM, Myczkowski ML et al (2004) Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 75:1171–1174
PubMedPubMedCentralCrossRefFregni F, Ono CR, Santos CM et al (2006) Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD. Neurology 66:1629–1637
PubMedCrossRefFreitas TH, Andreoulakis E, Alves GS et al (2015) Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel disease. World J Gastroenterol 21:6713–6727
PubMedPubMedCentralCrossRefFrick E, Tyroller M, Panzer M (2007) Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre. Eur Cancer Care 16:130–136
CrossRefFriedman M, Rosenman RH (1959) Association of specific overt behavior pattern with blood and cardiovascular findings; blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. JAMA 169:1286–1296
CrossRefFrisina PG, Tenenbaum HR, Borod JC, Foldi NS (2008) The effects of antidepressants in Parkinson’s disease: a meta-analysis. Int J Neurosci 118:667–682
PubMedCrossRefFrühwald S, Gatterbauer E, Rehak P, Baumhackl U (2003) Early fluoxetine treatment of poststroke depression. A three-month double-blind, placebo-controlled study with an open-label long-term follow up. J Neurol 250:1432–1459
Fuller-Thomson E, Brennenstuhl S (2009) The association between depression and epilepsy in a nationally representative sample. Epilepsia 50:1051–1058
PubMedCrossRefFuller-Thomson E, Lateef R, Sulman J (2015) Robust association between inflammatory bowel disease and generalized anxiety disorder: findings from a nationally representative Canadian study. Inflamm Bowel Dis 21:2341–2348 (im Druck)
Gabbs MG, Barry JJ (2005) The link between mood disorders and epilepsy: why is it important to diagnose and treat? Adv Stud Med 5:572–578
Gahr M, Zeiss R, Lang D et al (2015) Hepatotoxicity associated with agomelatine and other antidepressants: disproportionality analysis using pooled pharmacovigilance data from the Uppsala Monitoring Centre. J Clin Pharmacol 55(7):768–773
PubMedCrossRefGaitatzis A, Carroll K, Majeed A, Sander JW (2004) The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 45:1613–1622
PubMedCrossRefGaitatzis A, Sisodiya SM, Sander JW (2012) The somatic comorbidity of epilepsy: a weight but often unrecognized burden. Epilepsia 53:1282–1293
PubMedCrossRefGallo JJ, Armenian HK, Ford DE et al (2010) Major depression and cancer: the 13-year follow-up of the Baltimore epidemiologic catchment area sample (United States). Cancer Causes Control 11:751–758
CrossRefGalperin TA, Cronin AJ, Leslie KS (2014) Cutaneous manifestations of ESRD. Clin J Am Soc Nephrol 9:201–218
PubMedCrossRefGander ML, von Kanel R (2006) Myocardial infarction and post-traumatic stress disorder: frequency, outcome, and atherosclerotic mechanisms. Eur J Cardiovasc Prev Rehabil 13:165–172
PubMedCrossRefGandy M, Sharpe L, Perry KN (2012) Psychosocial predictors of depression and anxiety in patients with epilepsy: a systematic review. J Affect Disord 140:222–232
PubMedCrossRefGandy M, Sharpe L, Perry KN (2013) Cognitive behaviour therapy for depression in people with epilepsy: a systematic review. Epilepsia 54:1734–1741
CrossRefGao YH, Zhao HS, Zhang FR et al (2015) The relationship between depression and asthma: a meta-analysis of prospective studies. PLoS One 10, e0132424
PubMedPubMedCentralCrossRefGarssen B (2004) Psychological factors and cancer development: evidence after 30 years of research. Clin Psychol Rev 24:315–338
PubMedCrossRefGary RA, Dunbar SB, Higgins MK et al (2010) Combined exercise and cognitive behavioural therapy improves outcomes in patients with heart failures. J Psychosom Res 69:119–131
PubMedPubMedCentralCrossRefGeorge CF, Bayliff CD (2003) Management of insomnia in patients with chronic obstuctive pulmonary disease. Drugs 63:379–387
PubMedCrossRefGerrits MM, van Oppen P, van Marwijk HW et al (2013) The impact of chronic somatic diseases on the course of depressive and anxiety disorders. Psychother Psychosom 82:64–66
PubMedCrossRefGhaffar O, Feinstein A (2007) The neuropsychiatry of multiple sclerosis: a review of recent developments. Curr Opin Psychiatry 20:278–285
PubMedCrossRefGhazi-Noori S, Chung TH, Deane K et al (2009) Therapies for depression in Parkinson’s disease (Review). Cochrane Database Syst Rev CD003465
Gillespie CF, Nemeroff CB (2005) Hypercortisolemia and depression. Psychosom Med 67(Suppl 1):26–28
CrossRefGilliam FG, Black KG, Carter J et al (2009) Depression and health outcomes in epilepsy: a randomized trial. Presented at the 61st annual meeting of the American Academy of Neurology, 25 Apr–2 May 2006, Seattle
Glassman AH (2005) Does treating post-myocardial infarction depression reduce medical mortality? Arch Gen Psychiatry 62:711–712
PubMedCrossRefGlassman A (2008) Depression and cardiovascular disease. Pharmacopsychiatry 41:221–225
PubMedCrossRefGlassman AH, Shapiro PA (1998) Depression and the course of coronary artery disease. Am J Psychiatry 155:4–11
PubMedCrossRefGlassman AH, Rodriguez AI, Shapiro PA (1998) The use of antidepressant drugs in patients with heart disease. J Clin Psychiatry 59(Suppl 10):16–21
PubMedGlassman AH, O’Connor CM, Califf RM et al (2002) For the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288:701–709
PubMedCrossRefGlassman AH, Bigger JT Jr, Gaffney M (2009) Psychiatric characteristics associated with long term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 66:1022–1029
PubMedCrossRefGlazer KM, Emery CF, Frid DJ, Banyasz RE (2002) Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation. J Cardiopulm Rehabil 22:40–46
PubMedCrossRefGold SM, Irwin MR (2009) Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Immunol Allergy Clin North Am 29:309–320
PubMedPubMedCentralCrossRefGolden J, O’Dwyer AM, Conroy RM (2005) Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry 27:431–438
PubMedCrossRefGolden SH, Lazo M, Carnethon M et al (2008) Examining a bidirectional association between depressive symptoms and diabetes. JAMA 299:2751–2759
PubMedPubMedCentralCrossRefGoldston K, Baillie AJ (2008) Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches. Clin Psychol Rev 28:288–306
PubMedCrossRefGoodhand JR, Greig FI, Koodun Y et al (2012) Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study. Inflamm Bowel Dis 18:1232–1239
PubMedCrossRefGoodwin RD (2012) Asthma and suicide: current knowledge and future directions. Curr Psychiatry Rep 14:30–35
PubMedCrossRefGoodwin RD, Stein MB (2002) Generalized anxiety disorder and peptic ulcer disease among adults in the United States. Psychosom Med 64:862–866
PubMedGoodwin RD, Stein MB (2003) Peptic ulcer disease and neuroticism in the United States adult population. Psychother Psychosom 72:10–15
PubMedCrossRefGoodwin RD, Stein MB (2004) Association between childhood trauma and physical disorders among adults in the United States. Psychol Med 34:509–520
PubMedCrossRefGoodwin R, Marusic A, Hoven C (2003) Suicide attempts in the United States: the role of physical illness. Soc Sci Med 56:1783–1788
PubMedCrossRefGoodwin RD, Fischer ME, Goldberg J (2007) A twin study of post-traumatic stress disorder symptoms and asthma. Am J Respir Crit Care Med 176:983–987
PubMedCrossRefGoodwin RD, Keyes KM, Stein MB, Talley NJ (2009) Peptic ulcer and mental disorders among adults in the community: the role of nicotine and alcohol use disorders. Psychosom Med 71:463–468
PubMedPubMedCentralCrossRefGoodwin RD, Talley NJ, Hotopf M et al (2013) A link between physician-diagnosed ulcer and anxiety disorders among adults. Ann Epidemiol 23:189–192
PubMedCrossRefGoodwin RD, Hottinger K, Pena L et al (2014) Asthma and mental health among youth in high-risk service settings. J Asthma 51:639–644
PubMedCrossRefGordon GH, Michiels TM, Mahutte CK, Light RW (1985) Effect of desipramine on control of ventilation and depression scores in patients with severe chronic obstructive pulmonary disease. Psychiatry Res 15:25–32
PubMedCrossRefGore-Felton C, Spiegel D (2000) Group psychotherapy for medically ill patients. In: Stoudemire A, Fogel BS, Greenberg DB (Hrsg) Psychiatric care of the medical patient, 2. Aufl. Oxford University Press, Oxford, S 41–49
Grade C, Redford B, Chrostowski J et al (1998) Methylphenidate in early postroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 79:1047–1050
PubMedCrossRefGraham I, Atar D, Borch-Johnsen K et al (2007) Eurpean guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovcasc Prev Rehabil 14(suppl 2):1–113
CrossRefGrassi L, Riba M (2012) Clinical psycho-oncology. An international perspective. Wiley-Blackwell, Chichester
CrossRefGrassi L, Biancosino B, Marmai L et al (2007) Psychological factors affecting oncology conditions. Adv Psychosom Med 28:57–71
PubMedCrossRefGrassi L, Nanni MG, Uchitomi Y, Riba M (2011) Pharmacotherapy in people with cancer. In: Kissane DW, Maj M, Sartorius N (Hrsg) Depression and cancer. Wiley-Blackwell, Chichester, S 151–176
Grawe K (1998) Psychologische Therapie. Hogrefe, Göttingen
Greer S (1994) Psycho-oncology: its aims, achievements, and future tasks. Psychooncology 3:87–101
CrossRefGriffiths TL (2000) Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 355(9211):1280
Grigg-Damberger MM, Ralls F (2014) Sleep disorders in adults with epilepsy: past, present, and future directions. Curr Opin Pulm Med 20:542–549
PubMedCrossRefGrimstad T, Norheim KB, Isaksen K et al (2015) Fatigue in newly diagnosed inflammatory bowel disease. Colitis pii:jjv091
Grippo AJ, Johnson AK (2009) Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 12:1–21
PubMedPubMedCentralCrossRefGrootenhuis MA, Maurice-Stam H, Derkx BH, Last BF (2009) Evaluation of a psychoeducational intvervention for adolescents with inflammatory bowel disease. Eur J Gastroenterol Hepatol 21:430–435
PubMedCrossRefGross AL, Gallo JJ, Eaton WW (2010) Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample. Cancer Causes Control 21:191–199
PubMedCrossRefGrossman P, Kappos L, Gensicke H et al (2010) MS quality of life, depression, and fatigue improve after mindfulness training. Neurology 75:1141–1149
PubMedPubMedCentralCrossRefGudmundsson G, Gislason T, Janson C et al (2005) Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 26:414–419
PubMedCrossRefGulliksson M, Burell G, Vessby B et al (2011) Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: secondary prevention in uppsala primary health care project (suprim). Arch Intern Med 171:134–140
PubMedCrossRefGuloksuz S, Wichers M, Kenis G et al (2013) Depressive symptoms in Crohn’s disease: relationship with immune activation and tryptophan availability. PLoS One 8, e60435
PubMedPubMedCentralCrossRefGuo Y, Musselman DL, Manatunga A et al (2006) The diagnosis of major depression in patients with cancer: a comparative approach. Psychosomatics 47:376–384
PubMedCrossRefGuthrie E, Sensky T (2007) The role of psychological treatments. In: Lloyd GG, Guthrie E (Hrsg) Handbook of liaison psychiatry. Cambridge University Press, Cambridge, S 795–817
CrossRefHackam DG, Mrkobrada M (2012) Selective serotonin reuptake inhibitors and brain haemorrhage: meta-analysis. Neurology 79:1862–1865
PubMedCrossRefHackett ML, Anderson CS, House AO, Halteh C (2008) Interventions for preventing depression after stroke (Review). Cochrane Database Syst Rev 3, CD003689
PubMedHackett ML, Yang M, Anderson CS et al (2010) Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst Rev 17, CD00369
Hajós M, Fleishaker JC, Filipiak-Reisner JK et al (2004) The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. CNS Drug Rev 10:23–44
PubMedCrossRefHalaris A (2013) Inflammation, heart disease, and depression. Curr Psychiatry Rep 15:400
PubMedCrossRefHallas CN, Howard C, Theadom A, Wray J (2012) Negative beliefs about breathlessness increases panic for patients with chronic respiratory disease. Psychol Health Med 17:467–477
PubMedCrossRefHamer M, Chida Y, Molloy GJ (2009) Psychological distress and cancer mortality. J Psychosom Res 66:255–258
PubMedCrossRefHamid H, Ettinger AB, Mula M (2011) Anxiety symptoms in epilepsy: salient issues for future research. Epilepsy Behav 22:63–68
PubMedCrossRefHanly PJ, Ahmed SB (2014) Sleep apnea and the kidney: is sleep apnea a risk factor for chronic kidney disease? Chest 146:1114–1122
PubMedCrossRefHansen BH, Hanash JA, Rasmussen A et al (2012) Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD). J Psychosom Res 72:11–16
PubMedCrossRefHare DL, Toukhsati SR, Johansson P, Jaarsma T (2014) Depression and cardiovascular disease: a clinical review. Eur Heart J 35:1365–1372
PubMedCrossRefHaroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:137–162
PubMedCrossRefHarris E, Barraclough B (1994) Suicide as an outcome for medical disorders. Medicine 73:281–296
PubMedCrossRefHarrison J, Maguire P (1994) Predictors of psychiatric morbidity in cancer patients. Br J Psychiatry 165:593–598
PubMedCrossRefHärter MC, Conway KP, Merikangas KR (2003) Associations between anxiety disorders and physical illness. Eur Arch Psychiatry Clin Neurosci 253:313–320
PubMedCrossRefHasan SS, Clavarino AM, Dingle K et al (2015) Diabetes mellitus and the risk of depressive and anxiety disorders in Australian women: a longitudinal study. J Womens Health 24:889–898
CrossRefHasler G, Gergen PJ, Kleinbaum DG et al (2005) Asthma and panic in young adults: a 20-year prospective community study. Am J Respir Crit Care Med 171:1224–1230
PubMedPubMedCentralCrossRefHaukka J, Sankila R, Klaukka T et al (2009) Incidence of cancer and antidepressant medication: record linkage study. Int J Cancer 126:285–296
CrossRefHausteiner C, Klupsch D, Emeny R et al (2010) Clustering of negative affectivity and social inhibition in the community: prevalence of type D personality as a cardiovascular risk marker. Psychosom Med 72:163–171
PubMedCrossRefHayes SN (2009) Broken-hearted women: the complex relationship between depression and cardiovascular disease. Womens Health 5:709–725
Heaney LG, Conway E, Kelly C, Gamble J (2005) Prevalence of psychiatric morbidity in a difficult asthma population: relationship to asthma outcome. Respir Med 99:1152–1159
PubMedCrossRefHedayati SS, Finkelstein FO (2009) Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis 54:741–752
PubMedPubMedCentralCrossRefHedayati SS, Yalamanchili V, Finkelstein FO (2012) A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int 81:247–255
PubMedCrossRefHeesen C, Nawrath L, Reich C et al (2006) Fatigue in multiple sclerosis: an example for cytokine-mediated sickness behaviour. J Neurol Neurosurg Psychiatry 77:34–39
PubMedPubMedCentralCrossRefHeesen C, Gold SM, Huitinga I, Reul JM (2007) Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis – a review. Psychoneuroendocrinology 32:604–618
PubMedCrossRefHeesen C, Solari A, Giordano A, Kasper J, Köpke S (2011) Decisions on multiple sclerosis immunotherapy: new treatment complexities urge patient engagement. J Neurol Sci 306:192–197
PubMedCrossRefHeesen C, Köpke S, Kasper J, Poettgen J, Tallner A, Mohr DC, Gold SM (2012) Behavioral interventions in multiple sclerosis: a biopsychosocial perspective. Expert Rev Neurother 12:1089–1100
PubMedCrossRefHem E, Loge JH, Haldorsen T, Ekeberg Ø (2004) Suicide risk in cancer patients from 1960 to 1999. J Clin Oncol 22:4209–4216
PubMedCrossRefHener T, Weisenberg M, Har-Even D (1996) Supportive versus cognitive-behavioral intervention programs in achieving adjustment to home peritoneal kidney dialysis. J Consult Clin Psychol 64:731–741
PubMedCrossRefHenriques SG, Fráguas R, Iosifescu DV et al (2009) Recognition of depressive symptoms by physicians. Clinics 64:629–635
PubMedPubMedCentralCrossRefHenry JL, Lalloo C, Yashpal K (2008) Central poststroke pain: an abstruse outcome. Pain Res Manage 13:41–49
CrossRefHesdorffer DC, Hauser WA, Ludvigsson P et al (2006) Depression and attempted suicide as risk factors for incident unprovoked seizures and epilepsy. Ann Neurol 59:35–41
PubMedCrossRefHesdorffer DC, Ishihara L, Mynepalli L et al (2012) Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol 72:184–191
PubMedCrossRefHicks DW, Raza H (2005) Facilitating treatment of anxiety disorders in patients with comorbid medical illness. Curr Psychiatry Rep 7:228–235
PubMedCrossRefHietanen P, Lonnqvist J (1991) Cancer and suicide. Ann Oncol 2:19–23
PubMedHill K, Geist R, Goldstein RS, Lacasse Y (2008) Anxiety and depression in end-stage COPD. Eur Respir J 31:667–677
PubMedCrossRefHimmerich H, Fulda S, Linseisen J et al (2008) Depression, comorbidities and the TNF-alpha system. Eur Psychiatry 23:421–429
PubMedCrossRefHo N, Sommers MS, Lucki I (2013) Effects of diabetes on hippocampal neurogenesis: links to cognition and depression. Neurosci Biobehav Rev 37:1346–1362
PubMedPubMedCentralCrossRefHofmann SG, Sawyer AT, Witt AA, Oh D (2010) The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. J Consult Clin Psychol 78:169–183
PubMedPubMedCentralCrossRefHofmann M, Köhler B, Leichsenring F, Kruse J (2013) Depression as a risk factor for mortality in individuals with diabetes: a meta-analysis of prospective studies. PLoS One 8, e79809
PubMedPubMedCentralCrossRefHolland JC, Friedlander MM (2006) Oncology. In: Blumenfield M, Strain JJ (Hrsg) Psychosomatic medicine. Lippincott, Williams & Wilkins, Philadelphia, S 121–144
Holland JC, Morrow GR, Schmale A et al (1991) A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol 9:1004–1011
PubMedHolland JC, Romano SJ, Heiligenstein JH et al (1998) A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 7:291–300
PubMedCrossRefHolsboer F, Ising M (2010) Stress hormone regulation: biological role and translation into therapy. Annu Rev Psychol 61:81–109
PubMedCrossRefHolt RIG, Katon WJ (2012) Dialogue on diabetes and depression: dealing with the double burden of co-morbidity. J Affect Disord 142(suppl):1–3
CrossRefHong X, Currier GW, Zhao X et al (2009) Posttraumatic stress disorder in convalescent severe acute respiratory syndrome patients: a 4-year follow-up study. Gen Hosp Psychiatry 31:546–554
PubMedCrossRefHonig A, Kuyper AM, Schene AH et al (2007) Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med 69:606–613
PubMedCrossRefHoppe C, Elger CE (2011) Depression in epilepsy: a critical review from a clinical perspective. Nat Rev Neruol 7:462–472
CrossRefHorowitz MJ (1976) Stress response syndromes. Jason Aronson, New York
Horowitz MJ (2011) Stress response syndromes. PTSD, grief, adjustment, and dissociative disorders, 5. Aufl. Jason Aronson, Lanham/Boulder/New York/Toronto/Plymouth
Horst S, Chao A, Rosen M et al (2015) Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease. Dig Dis Sci 60(2):465–470
PubMedCrossRefHosseini SH, Espahbodi F, Mirzadeh Goudarzi SM (2012) Citalopram versus psychological training for depression and anxiety symptoms in hemodialysis patients. Iran J Kidney Dis 6:446–451
PubMedHouse A, Hackett M, Anderson C (2000) Effectiveness of antidepressants and psychological therapies for the prevention and treatment of depression in patients with stroke. In: Proceeding of the Royal College of Physicians of Edinburgh, consensus conference on stroke treatment and service delivery, Edinburgh, 7–8 Nov 2000
Huang X, Song L, Li T (2001) The effect of social support on type II diabetes with depression. Chin J Clin Psychol 9:187–189
Huang CJ, Chiu HC, Lee MH, Wang SY (2011) Prevalence and incidence of anxiety disorders in diabetic patients: a national population-based cohort study. Gen Hosp Psychiatry 33:8–15
PubMedCrossRefHuang Y, Wei X, Wu T, Chen R, Guo A (2013) Collaborative care for patients with depression and diabetes mellitus: a systematic review and meta-analysis. BMC Psychiatry 13:260
PubMedPubMedCentralCrossRefHuffman JC, Mastromauro CA, Boehm JK et al (2011) Development of a positive psychology intervention for patients with acute cardiovascular disease. Heart Int 6:47–54
CrossRefHuffman JC, Celano CM, Beach SR et al (2013) Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol. Article ID 695925
Hynninen MJ, Bjerke N, Pallesen S, Bakke PS, Nordhus IH (2010) A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med 104:986–994
PubMedCrossRefIacovides A, Siamouli M (2008) Comorbid mental and somatic disorders: an epidemiological perspective. Curr Opin Psychiatry 21:417–421
PubMedCrossRefIessa N, Murray ML, Curran S, Wong IC (2011) Asthma and suicide-related adverse events: a review of observational studies. Eur Respir Rev 20:287–292
PubMedCrossRefIhle-Hansen H, Thommessen B, Fagerland MW et al (2014) Effect on anxiety and depression of a multifactorial risk factor intervention program after stroke and TIA: a randomized controlled trial. Aging Ment Health 18:540–546
PubMedCrossRefIovieno N, Tedeschini E, Ameral VE, Rigatelli M, Papakostas GI (2011) Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials. Int Clin Psychopharmacol 26:69–74
PubMedCrossRefIrwin MR (2013) Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes. Curr Psychiatry Rep 15:404
PubMedCrossRefIshihara L, Brayne C (2006) A systematic review of depression and mental illness preceding Parkinson’s disease. Acta Neurol Scand 113:211–220
PubMedCrossRefIskandar HN, Cassell B, Kanuri N et al (2014) Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease. J Clin Gastroenterol 48:423–429
PubMedPubMedCentralIwata M, Ota KT, Duman RS (2013) The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun 31:105–114
PubMedCrossRefJackson JC, Pandharipande PP, Girard TD et al (2014) Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study. Lancet Respir Med 2:369–379
PubMedPubMedCentralCrossRefJacob EL, Gatto NM, Thompson A et al (2010) Occurrence of depression and anxiety prior to Parkinson’s disease. Parkinsonism Relat Disord 16:476–581
CrossRefJain A, Lolak S (2009) Psychiatric aspects of chronic lung disease. Curr Psychiatry Rep 11:219–225
PubMedCrossRefJain N, Trivedi MH, Rush AJ et al (2013) Rationale and design of the chronic kidney disease antidepressant Sertraline trial (CAST). Contemp Clin Trials 34:136–144
PubMedCrossRefJaiswal R, Alici Y, Breitbart W (2014) A comprehensive review of palliative care in patients with cancer. Int Rev Psychiatry 26:87–101
PubMedCrossRefJames SP, Mendelson WB (2004) The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry 65:752–755
PubMedCrossRefJeeva F, Dickens C, Coventry P et al (2013) Is treatment of depression cost-effective in people with diabetes? A systematic review of the economic evidence. Int J Technol Assess Health Care 29:384–391
PubMedPubMedCentralCrossRefJiang W, Davidson J (2005) Antidepressant therapy in patients with ischemic heart disease. Am Heart J 150:871–881
PubMedCrossRefJiang M, Qin P, Yang X (2014) Comorbidity between depression and asthma via immune-inflammatory pathways: a meta-analysis. J Affect Disord 166:22–29
PubMedCrossRefJohnson P, St John W, Moyle W (2006) Long-term mechanical ventilation in a critical care unit: existing in an uneveryday world. J Adv Nurs 53:551–558
PubMedCrossRefJohnson B, Eiser C, Young V, Brierley S, Heller S (2013) Prevalence of depression among young people with Type 1 diabetes: a systematic review. Diabet Med 30:199–208
PubMedCrossRefJohnson JA, Al Sayah F, Wozniak L et al (2014) Collaborative care versus screening and follow-up for patients with diabetes and depressive symptoms: results of a primary care-based comparative effectiveness trial. Diabetes Care 37:3220–3226
PubMedCrossRefJones MP (2006) The role of psychosocial factors in peptic ulcer disease: beyond helicobacter pylori and NSAIDs. J Psychosom Res 60:407–412
PubMedCrossRefJones JM, Lawson ML, Daneman D et al (2000) Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study. BMJ 320:1563–1566
PubMedPubMedCentralCrossRefJongen PJ, Ter Horst AT, Brands AM (2012) Cognitive impairment in multiple sclerosis. Minerva Med 103:73–96
PubMedJorge RE, Robinson RG, Arndt S, Starkstein SE (2003) Mortality and poststroke depression: a placebo controlled trial of antidepressants. Am J Psychiatry 160:1823–1829
PubMedCrossRefJorge RE, Acion L, Moser D et al (2010) Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 67:187–196
PubMedPubMedCentralCrossRefKahl KG, Kruse N, Faller H et al (2002) Expression of tumor necrosis factor-alpha and interferon-gamma mRNA in blood cells correlates with depression scores during and acute attack in patients with multiple sclerosis. Psychoneuroendocrinology 27:671–681
PubMedCrossRefKahl KG, Schweiger U, Correll C et al (2015) Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus. Brain Behav 5, e00306
PubMedPubMedCentralCrossRefKan C, Silva N, Golden SH et al (2013) Systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care 36:480–489
PubMedPubMedCentralCrossRefKang HJ, Kim SY, Bae KY et al (2015) Comorbidity of depression with physical disorders: research and clinical implications. Chonnam Med J 51:8–18
PubMedPubMedCentralCrossRefKangas M (2013) DSM-5 trauma and stress-related disorders: implications for screening for cancer-related stress. Front Psychiatry 4:122
PubMedPubMedCentralCrossRefKangas M, Henry JL, Bryant RA (2005) Predictors of posttraumatic stress disorder following cancer. Health Psychol 24:579–585
PubMedCrossRefKanner AM (2008) Mood disorder and epilepsy: a neurobiologic perspective of their relationship. Dialogues Clin Neurosci 10:39–45
PubMedPubMedCentralKanner AM (2009) Depression and epilepsy: a review of multiple facets of their close relation. Neurol Clin 27:865–880
PubMedCrossRefKanner AM (2011) Anxiety disorders in epilepsy: the forgotten psychiatric comorbidity. Epilepsy Curr 11:90–91
PubMedPubMedCentralCrossRefKanner AM (2012) Can neurobiological pathogenic mechanisms of depression facilitate the development of seizure disorders? Lancet Neurol 11:1093–1102
PubMedCrossRefKanner AM (2013a) Do psychiatric comorbidities have a negative impact on the course and treatment of seizure disorders? Curr Opin Neurol 26:208–213
PubMedCrossRefKanner AM (2013b) The treatment of depressive disorders in epilepsy: what all neurologists should know. Epilepsia 1:3–12
CrossRefKanner AM, Hesdorffer DC (2012) Neuropsychiatric complications of epilepsy. Handb Clin Neurol 107:461–482
PubMedCrossRefKanner AM, Trimble M, Schmitz B (2010) Postictal affective episodes. Epilepsy 19:156–158
Kano O, Ikeda K, Cridebring D et al (2011) Neurobiology of depression and anxiety in Parkinson’s disease. Parkinsons Dis 2011:143547
PubMedPubMedCentralKapfhammer HP (1993a) Nieren- und leberinsuffiziente Patienten – ein therapeutisches Problem. In: Möller HJ, Przuntek H (Hrsg) Therapie im Grenzgebiet von Psychiatrie und Neurologie. Springer, Berlin/Heidelberg/New York/Tokio, S 75–92
CrossRefKapfhammer HP (1993b) Epidemiologie der Depression im Rahmen von Tumorerkrankungen. In: Staab HJ, Ludwig M (Hrsg) Depression bei Tumorpatienten. Thieme, Stuttgart, S 29–41
Kapfhammer HP (2002) Organisch depressive Störungen: Koronare Herzerkrankung, Diabetes mellitus, Krebs. In: Laux G (Hrsg) Depression 2000. Springer, Berlin/Heidelberg/New York/Tokio, S 65–86
CrossRefKapfhammer HP (2004) Alkoholismus und Depression in der Konsultations-Liaison-Psychiatrie. J Neurol Neurochir Psychiatr 5:30–36
Kapfhammer HP (2006) Klinische Grundlagen zur Therapie mit Benzodiazepinen. In: Möller HJ (Hrsg) Therapie psychischer Erkrankungen, 3. Aufl. Thieme, Stuttgart, S 692–718
Kapfhammer HP (2008) Posttraumatische Belastungsstörung nach ARDS und septischem Schock. Psychosom Konsiliarpsychiatr 2:220–227
CrossRefKapfhammer HP (2011) Psychische Störungen bei somatischen Krankheiten. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie, Psychosomatik, Psychotherapie, 4. Aufl. Springer, Berlin/Heidelberg/New York, S 1319–1405
Kapfhammer HP (2014a) Depressive und Angststörungen bei neurologischen Erkrankungen in der Perspektive der Multimorbidität. Nervenarzt 85:437–444
PubMedCrossRefKapfhammer HP (2014b) Depressive und Angststörungen bei Patienten mit Epilepsie und Multipler Sklerose – eine Herausforderung für die nervenärztliche Praxis. Neuropsychiatrie 28:142–150
PubMedCrossRefKapfhammer HP (2015) Depressive und Angststörungen bei Krebserkrankungen. Nervenarzt 86:291–301
PubMedCrossRefKapfhammer HP (2016) Depressive und Angststörungen als Langzeitfolgen intensivmedizinischer Behandlung. Nervenarzt (im Druck)
Kapfhammer HP, Dodel R (2014) Multimorbidität: eine zentrale Herausforderung der modernen Medizin – Editorial. Nervenarzt 85:399–400
PubMedCrossRefKapfhammer HP, Rothenhäusler HB, Krauseneck T et al (2004) Posttraumatic stress disorder in long-term survivors of ARDS: results of a psychiatric follow-up study and psychological tests. Am J Psychiatry 161:45–52
PubMedCrossRefKaptein AA, Fischer MJ, Scharloo M (2014) Self-management in patients with COPD: theoretical context, content, outcomes, and integration into clinical care. Int J Chron Obstruct Pulmon Dis 9:907–917
PubMedPubMedCentralCrossRefKarhova M, Treichel U, Malago M et al (2000) Interaction of Hypericum perforatum (St. John’s wort) with ciclosporin. A metabolism in a patient after liver transplantation. J Hepatol 33:853–855
CrossRefKarwowski CA, Keljo D, Szigethy E (2009) Strategies to improve quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis 15:1755–1764
PubMedCrossRefKathol RG, Wenzel RP (1992) Natural history of symptoms of depression and anxiety during inpatient treatment on general medicine wards. J Gen Int Med 7:287–293
CrossRefKathol RG, Mulgi A, Williams J et al (1990) Diagnosis of major depression in cancer patients according to four sets of criteria. Am J Psychiatry 147:1021–1024
PubMedCrossRefKaton W, Ciechanowski P (2002) Impact of major medical depression and chronic medical illness. J Psychosom Res 53:859–863
PubMedCrossRefKaton WJ (2003) Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 54:216–226
PubMedCrossRefKaton W, Simon G, Russo J et al (2004a) Quality of depression care in a population based sample of patients with diabetes and major depression. Med Care 42:1222–1229
PubMedCrossRefKaton WJ, von Korff M, Lin EHB et al (2004b) The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 61:1042–1049
PubMedCrossRefKaton WJ, Rutter C, Simon G et al (2005) The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28:2668–2672
PubMedCrossRefKaton WJ, Unutzer J, Fasn MY et al (2006) Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 29:265–270
PubMedCrossRefKaton W, Lin EHB, Kroenke K (2007a) The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 29:147–155
PubMedCrossRefKaton W, Lozano P, Russo J et al (2007b) The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls. J Adolesc Health 41:455–463
PubMedPubMedCentralCrossRefKaton W, Russo J, Lin EH et al (2009) Depression and diabetes: factors associated with major depression and five-year follow-up. Psychosomatics 50:570–579
PubMedPubMedCentralCrossRefKaton WJ, Lin EHB, Von Korff M et al (2010a) Collaborative care for patients with depression and chronic illness. N Engl J Med 363:2611–2620
PubMedPubMedCentralCrossRefKaton WJ, Russo JE, Heckbert SR et al (2010b) The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes. Int J Geriatr Psychiatry 25:466–475
PubMedCrossRefKaton WJ, Young BA, Russo J et al (2013) Association of depression with increased risk of severe hypoglycemic episodes in patients with diabetes. Ann Fam Med 11:245–250
PubMedPubMedCentralCrossRefKaton W, Pedersen HS, Ribe AR et al (2015) Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiatry 72:612–619
PubMedPubMedCentralCrossRefKatz PP, Morris A, Julian L et al (2010) Onset of depressive symptoms among adults with asthma: results from a longitudinal observational cohort. Prim Care Respir J 19:223–230
PubMedPubMedCentralCrossRefKaufman DM, Smuckler DJ (2006) Parkinson’s disease. In: Blumenfield M, Strain JJ (Hrsg) Psychosomatic medicine. Lippincott, Williams & Wilkins, Philadelphia, S 214–222
Keller W, Pritsch M, von Wietersheim J et al (2004) Effect of psychotherapy and relaxation on the psychosocial and somatic course of Crohn’s disease: main results from the German Prospective Multicenter Psychotherapy Treatment Study on Crohn’s disease. J Psychosom Res 56:687–696
PubMedCrossRefKendler KS, Gardner CO, Fiske A, Gatz M (2009) Major depression and coronary artery disease in the Swedish Twin Registry. Arch Gen Psychiatry 66:857–863
PubMedPubMedCentralCrossRefKent LK, Shapiro PA (2009) Depression and related psychological factors in heart disease. Harv Rev Psychiatry 17:377–388
PubMedCrossRefKerr MP, Mensah S, Besag F et al (2011) International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 52:2133–2138
PubMedCrossRefKessler RC, Berglund P, Demler O et al (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095–3105
PubMedCrossRefKessler RC, Birnbaum H, Bromet E et al (2010) Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psychol Med 40:225–237
PubMedCrossRefKim SE, Choi JY, Choe YS et al (2003) Serotonin transporters in the midbrain of Parkinson’s disease patients: a study with 123I-beta-CIT SPECT. J Nucl Med 44:870–879
PubMedKim HJ, Jeon BS, Paek SH (2015) Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson’s Disease. J Mov Disord 8:83–91
PubMedPubMedCentralCrossRefKimmel PL, Peterson RA (2005) Depression in end-stage renal disease patients treated with hemodialysis: tools, correlates, outcomes, and needs. Semin Dial 18:91–97
PubMedCrossRefKimura M, Robinson RG, Kosier JT (2000) Treatment of cognitive impairment after poststroke depression : a double-blind treatment trial. Stroke 31:1482–1486
PubMedCrossRefKinnucan JA, Rubin DT, Ali T (2013) Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation. Gastroenterol Hepatol 9:718–727
Kiserud CE, Dahl AA, Loge JH, Fosså SD (2014) Cancer survivorship in adults. Recent Results Cancer Res 197:103–120
PubMedCrossRefKissane D (2009) Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psychooncology 18:1–5
PubMedCrossRefKissane DW, Levin T, Hales S, Lo C, Rodin G (2011) Psychotherapy for depression in cancer and palliative care. In: Kissane DW, Maj M, Sartorius N (Hrsg) Depression and cancer. Wiley-Blackwell, Chichester, S 177–206
Kitzlerova E, Anders M (2007) The role of some new factors in the pathophysiology of depression and cardiovascular disease: overview of recent research. Neuroendocrinol Lett 28:832–840
PubMedKlein DF (1993) False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis. Arch Gen Psychiatry 50:306–317
PubMedCrossRefKlepac N, Hajnšek S, Trkulja V (2010) Nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms. J Geriatr Psychiatry Neurol 23:15–26
PubMedKlerman GL (1981) Depression in the medically ill. Psychiatr Clin North Am 4:301–317
PubMedKlötz F, Garrle M, Granath F, Thiblin I (2006) Criminality among individuals testing positive for the presence of anabolic androgenic steroids. Arch Gen Psychiatry 63:1274–1279
PubMedCrossRefKnapp P, Young J, House A, Forster A (2000) Non-drug strategies to resolve psycho-social difficulties after stroke. Age Ageing 29:23–30
PubMedCrossRefKnol MJ, Twisk JW, Beekman AT et al (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis Diabetologia 49:837–845
PubMedKnowles SR, Gass C, Macrae F (2013a) Illness perceptions in IBD influence psychological status, sexual health and satisfaction, body image and relational functioning: a preliminary exploration using Structural Equation Modeling. J Crohns Colitis 7(9):e344–e350
PubMedCrossRefKnowles SR, Monshat K, Castle DJ (2013b) The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: a review. Inflamm Bowel Dis 19:2704–2715
PubMedCrossRefKoch MW, Glazenborg A, Uyttenboogaart M et al (2011) Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst Rev 2, CD007295
PubMedKoch L, Jansen L, Brenner H, Arndt V (2013) Fear of recurrence and disease progression in long-term (≥5 years) cancer survivors – a systematic review of quantitative studies. Psychooncology 22:1–11
PubMedCrossRefKoenig HG, Pappas P, Hoslinger T et al (1995) Assessing diagnostic approaches to depression in medically ill older adults: how reliably can mental health professions make judgements about the cause or symptoms? J Am Geriatr Soc 43:472–478
PubMedCrossRefKoenig HG, Georage LK, Meador KG (1997) Use of antidepressants by nonpsychiatrists in the treatment of medically ill hospitalized depressed elderly patients. Am J Psychiatry 154:1369–1375
PubMedCrossRefKok GD, Bockting CL, Burger H et al (2013) Double trouble: does co-morbid chronic somatic illness increase risk for recurrence in depression? A systematic review. PLoS One 8, e57510
PubMedPubMedCentralCrossRefKomorousova J, Beran J, Rusavy Z, Jankovec Z (2010) Glycemic control improvement through treatment of depression using antidepressant drugs in patients with diabetes mellitus type 1. Neuro Endocrinol Lett 31:801–806
PubMedKorkeila J, Vahtera J, Korkeila K et al (2010) Childhood adversities as predictors of incident coronary heart disease and cerebrovascular disease. Heart 96:298–303
PubMedCrossRefKorostil M, Feinstein A (2007) Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 13:67–72
PubMedCrossRefKotlyar M, Dysken M, Adson E (2005) Update on drug-induced depression in the elderly. Am J Geriatr Pharmacother 4:289–300
Kraepelin E (1910) Psychiatrie, Bd II, 8. Aufl. Barth, Leipzig
Krantz DS, Whittaker KS, Francis JL et al (2009) Psychotropic meciation use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcome from the Women’ s Ischemia Syndrome Evaluation (WISE) study. Heart 95:1901–1906
PubMedPubMedCentralCrossRefKraus MR, Schafer A, Faller H et al (2003) Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry 64:708–714
PubMedCrossRefKrishnan KRR (2013) Neurobiology of depression in later life. Anatomy of melancholia. In: Charney DS, Sklar P, Buxbaum JD, Nestler EJ (Hrsg) Neurobiology of mental illness, 4. Aufl. Oxford University Press, Oxford, S 470–482
Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606–613
PubMedPubMedCentralCrossRefKroenke K, Spitzer RL, Williams JB (2003) The patient health questionnaire-2: validity of a two-item depression screener. Med Care 41:1284–1292
PubMedCrossRefKubzansky LD, Bordelois P, Jun HJ et al (2014) The weight of traumatic stress: a prospective study of posttraumatic stress disorder symptoms and weight status in women. JAMA Psychiatry 71:44–51
PubMedPubMedCentralCrossRefKulisevsky J, Pascual-Sedano B, Barbanoj M et al (2006) Acute effects of immediate and controlled release levodopa on mood in Parkinson’s disease: a double blind study. Mov Disord 22:62–67
CrossRefKumar B, Kalita J, Kumar G, Misra UK (2009) Central poststroke pain: a review of pathophysiology and treatment. Pain Med 108:1645–1657
Kunik ME, Veazey C, Cully JA et al (2008) COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med 38:385–396
PubMedCrossRefKurella M, Kimmel PL, Young BS, Chertow GM (2005) Suicide in the United States end-stage renal disease program. J Am Soc Nephrol 16:774–781
PubMedCrossRefKusztal M, Trafidło E, Weyde W, Klinger M (2010) Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis (HD) patients. Kidney Int 77:646–647
PubMedCrossRefKuyper AMG, Honig A (2008) Treatment of post-myocardial infarction depressive disorder. Expert Rev Neurother 8:1115–1123
PubMedCrossRefKwek SK, Chew WM, Ong KC et al (2006) Quality of life and psychological status in survivors of severe acute respiratory syndrome at 3 months postdischarge. J Psychosom Res 60:513–519
PubMedCrossRefKyrou I, Tsigos C (2009) Stress hormones: physiological stress and regulation of metabolism. Curr Opin Pharmacol 9:787–793
PubMedCrossRefLabad J, Price JF, Strachan MW et al (2010) Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetologia 53:467–471
PubMedCrossRefLabor S, Labor M, Jurić I, Vuksić Z (2012) The prevalence and pulmonary consequences of anxiety and depressive disorders in patients with asthma. Coll Antropol 36:473–481
PubMedLabos C, Dasgupta K, Nedjar H et al (2011) Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 183:1835–1843
PubMedPubMedCentralCrossRefLacasse Y, Beaudoin L, Rousseau L, Maltais F (2004) Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis 61:140–147
PubMedCrossRefLacey CJ, Salzberg MR, Roberts H, Trauer T, D’Souza WJ (2009) Psychiatric comorbidity and impact on health service utilization in a community sample of patients with epilepsy. Epilepsia 50:1991–1994
PubMedCrossRefLadwig KH, Lederbogen F, Albus C et al (2014) Position paper on the importance of psychosocial factors in cardiology: update 2013. Ger Med Sci 12:Doc09
Laird BJ, Boyd AC, Colvin LA, Fallon MT (2009) Are cancer pain and depression interdependent? A systematic review. Psychooncology 18:459–464
PubMedCrossRefLaitinen L (1969) Desipramine in treatment of Parkinson’s disease. Acta Neurol Scand 45:109–113
PubMedCrossRefLambiase MJ, Kubzansky LK, Thurston RC (2014) Prospective study of anxiety and incident stroke. Stroke 45:438–443
PubMedCrossRefLamers F, Jonkers C, Bosma H et al (2011) Treating depression in diabetes patients: does a nurse-administered minimal psychological intervention affect diabetes-specific quality of life and glycaemic control? A randomized controlled trial. J Adv Nurs 67:788–799
PubMedCrossRefLangdon DW (2011) Cognition in multiple sclerosis. Curr Opin Neurol 24:244–249
PubMedCrossRefLaoutidis ZG, Mathiak K (2013) Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis. BMC Psychiatry 13:140. doi:10.1186/1471-244X-13-140
PubMedPubMedCentralCrossRefLaron Z (2009) Insulin and the brain. Arch Physiol Biochem 115:112–116
PubMedCrossRefLarsson K, Sundberg HM, Karlbom U et al (2003) A group-based patient education programme for high-anxiety patients with Crohn’s disease or ulcerative colitis. Scand J Gastroenterol 38:763–769
PubMedCrossRefLaux G, Dietmaier O (2012) Praktische Psychopharmakotherapie, 6. Aufl. Urban & Fischer, München
Lavoie KL, Bacon SL, Barone S et al (2006) What is worse for asthma control and quality of life. Chest 130:1039–1047
PubMedCrossRefLawlor DA, Jüni P, Ebrahim S et al (2003) Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer. J Clin Epidemiol 56:155–163
PubMedCrossRefLeander M, Lampa E, Rask-Andersen A et al (2014) Impact of anxiety and depression on respiratory symptoms. Respir Med 108:1594–1600
PubMedCrossRefLee HB, Lipsey JR (2008) Stroke. In: Lyketsos CG, Rabins PV, Lipsey JR, Slavney PR (Hrsg) Psychiatric aspects of neurologic diseases. Practical approaches to patient care. Oxford University Press, Oxford, S 67–81
Lee K, Otgonsuren M, Younoszai Z et al (2013a) Association of chronic liver disease with depression: a population-based study. Psychosomatics 54:52–59
PubMedCrossRefLee YC, Lin CH, Lin MS et al (2013b) Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study. J Clin Psychopharmacol 33:782–789
PubMedCrossRefLeentjens AF, van den Akker M, Metsemakers JF, Troost J (2003a) The incidence of Parkinson’s disease in the Netherlands: results from a longitudinal general practice-based registration. Neuroepidemiology 22:311–312
PubMedCrossRefLeentjens AF, Vreeling FW, Luijckx GJ, Verhey FR (2003b) SSRIs in the treatment of depression in Parkinson’s disease. Int J Geriatr Psychiatry 18:552–554
PubMedCrossRefLeentjens AFG, Moonen AJH, Dujardin K et al (2013) Modeling depression in Parkinson disease. Neurology 81:1036–1043
PubMedPubMedCentralCrossRefLehrer PM, Karavidas MK, Lu SE et al (2008) Psychological treatment of comorbid asthma and panic disorder: a pilot study. J Anxiety Disord 22:671–683
PubMedCrossRefLeipzig RM (1990) Psychopharmacology in patients with hepatic and gastrointestinal disease. Int J Psychiatry Med 22:109–139
CrossRefLeone D, Menichetti J, Fiorino G, Vegni E (2014) State of the art: psychotherapeutic interventions targeting the psychological factors involved in IBD. Curr Drug Targets 15(11):1020–1029
PubMedCrossRefLeroy M, Loas G, Perez-Diaz F (2010) Anhedonia as predictor of clinical events after acute coronary syndromes: a 3-year prospective study. Compr Psychiatry 51:8–14
PubMedCrossRefLesperance F, Frasure-Smith N, Talajic M, Bourassa MG (2002) Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 108:1049–1053
CrossRefLesperance F, Frasure-Smith N, Koszycki D et al (2007) Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the canadian cardiac randomized evaluation of antidepressant and psychotherapy efficacy (create) trial. JAMA 297:367–379
PubMedCrossRefLespérance F, Frasure-Smith N, Koszycki D et al (2007) Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 297:367–379
PubMedCrossRefLett HS, Sherwood A, Watkins L, Blumenthal JA (2006) Depression and prognosis in cardiac patients. In: Steptoe A (Hrsg) Depression and physical illness. Cambridge University Press, Cambridge, S 87–108
CrossRefLevenson JL, Dwight M (2000) Cardiology. In: Stoudemire A, Fogel BS, Greenberg DB (Hrsg) Psychiatric care of the medical patient, 2. Aufl. Oxford University Press, Oxford/New York, S 717–731
Levenson H, Hales RE (1993) Brief psychodynamically informed therapy for medically ill patients. In: Stoudemire A, Fogel BS (Hrsg) Medical-psychiatric practice, Bd 2. American Psychiatric Press, Washington, DC/London, S 3–37
Levenson H, Servis M, Hales RE (2000) Brief psychodynamic therapy in the medically ill. In: Stoudemire A, Fogel BS, Greenberg DB (Hrsg) Psychiatric care of the medical patient, 2. Aufl. Oxford University Press, Oxford, S 17–30
Levenstein S (1999) Peptic ulcer at the end of the 20th century: biological and psychological risk factors. Can J Gastroenterol 13:753–759
PubMedCrossRefLevenstein S (2000) The very model of a modern etiology: a biopsychosocial view of peptic ulcer. Psychosom Med 62:176–185
PubMedCrossRefLevenstein S (2004) Embracing complexity: what determines quality of life in inflammatory bowel disease? Eur J Gastroenterol Hepatol 16:1253–1255
PubMedCrossRefLevenstein S (2008) Could stress play a role in IBD? Inflamm Bowel Dis 14:206–207
CrossRefLevenstein S (2009) Helicobacter pylori and ulcers. Against reductionism. BMJ 339:b3855
PubMedCrossRefLevenstein S, Prantera C, Scribano ML et al (1996) Psychologic predictors of duodenal ulcer healing. J Clin Gastroenterol 22:84–89
PubMedCrossRefLevenstein S, Kaplan GA, Smith MW (1997) Psychological predictors of peptic ulcer incidence in the Alameda County Study. J Clin Gastroenterol 24:140–146
PubMedCrossRefLevin TT, Alici Y (2010) Anxiety disorders. In: Holland JC, Breitbart W, Jacobsen PB (Hrsg) Textbook of psycho-oncology, 2. Aufl. Oxford University Press, Oxford, S 324–331
CrossRefLevy NB, Cohen LM, Tessier EG (2006) Renal disease. In: Blumenfield M, Strain JJ (Hrsg) Psychosomatic medicine. Lippincott, Williams & Wilkins, Philadelphia, S 157–175
Li S, Li M, Song S (2003) The effect of psychological intervention in treating diabetic patients with negative emotion. Shandong Arch Psychiatry 16:147–148
Li M, Fitzgerald P, Rodin G (2012) Evidence-based treatment of depression in patients with cancer. J Clin Oncol 30:1187–1196
PubMedCrossRefLicht CMM, Vreeburg SA, van Reedt Dortland AKB et al (2010) Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab 95:2458–2466
PubMedCrossRefLichtman J, Bigger JT, Blumenthal JA et al (2008) Depression and coronary heart disease: reccomendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Association. Circulation 118:1768–1775
PubMedCrossRefLichtman JH, Froelicher ES, Blumenthal JA et al (2014) Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 129:1350–1369
PubMedCrossRefLieberman A (2006) Depression in Parkinson’s disease – a review. Acta Neurol Scand 113:1–8
PubMedCrossRefLight RW, Merrill EJ, Despars J et al (1986) Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch Intern Med 146:1377–1380
PubMedCrossRefLillberg K, Verkasalo PK, Kaprio J et al (2003) Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am J Epidemiol 157:415–423
PubMedCrossRefLim WY, Subramaniam M, Abdin E et al (2014) Peptic ulcer disease and mental illnesses. Gen Hosp Psychiatry 36:63–67
PubMedCrossRefLin EHB, Katon W, von Korff M et al (2004) Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 27:2154–2160
PubMedCrossRefLin EH, Rutter CM, Katon W et al (2010) Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 33:264–269
PubMedCrossRefLin EH, Von Korff M, Ciechanowski P et al (2012) Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial. Ann Fam Med 10:6–14
PubMedPubMedCentralCrossRefLincoln NB, Flannaghan T (2003) Cognitive behavioural psychotherapy for depression following stroke. A randomized controlled trial. Stroke 34:111–115
PubMedCrossRefLincoln NB, Francis VM, Lilley SA et al (2003) Evaluation of a stroke family support organiser: a randomized controlled trial. Stroke 34:116–121
PubMedCrossRefLinke SE, Rutledge T, Johnson D et al (2009) Depressive symptom dimensions and cardiovascular prognosis among women with suspected mocardial ischemia. Arch Gen Psychiatry 66:499–507
PubMedPubMedCentralCrossRefLinkins RW, Comstock GW (1990) Depressed mood and development of cancer. Am J Epidemiol 132:962–972
PubMedLipowski Z (1990) Delirium: acute confusional states. Oxford University Press, New York/Oxford
Lipsey JR, Robinson RG, Pearlson GD et al (1984) Nortriptyline treatment of post-stroke depression. Lancet 1:297–300
PubMedCrossRefLivermore N, Sharpe L, McKenzie D (2012) Catastrophic interpretations and anxiety sensitivity as predictors of panic-spectrum psychopathology in chronic obstructive pulmonary disease. J Psychosom Res 72:388–392
PubMedCrossRefLix LM, Graff LA, Walker JR et al (2008) Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis 14:1575–1584
PubMedCrossRefLloyd G (2007a) Understanding psychological reactions to physical illness. In: Lloyd GG, Guthrie E (Hrsg) Handbook of liaison psychiatry. Cambridge University Press, Cambridge, S 64–82
CrossRefLloyd G (2007b) Oncology. In: Guthrie E, Lloyd GG (Hrsg) Handbook of liaison psychiatry. Cambridge University Press, Cambridge, S 547–563
CrossRefLoas G, Krystkowiak P, Godefroy O (2012) Anhedonia in Parkinson’s disease: an overview. J Neuropsychiatry Clin Neurosci 24:444–451
PubMedCrossRefLoerbroks A, Apfelbacher CJ, Bosch JA, Stürmer T (2010) Depressive symptoms, social support and risk of adult asthma in a population-based cohort study. Psychosom Med 72:309–315
PubMedCrossRefLof L, Berggren L, Ahlstrom G (2006) Severely ill ICU patients recall of factual events and unreal experiences of hospital admission and ICU stay- 3 and 12 months after discharge. Intensive Crit Care Nurs 22:154–166
PubMedCrossRefLong MD, Kappelman MD, Martin CF et al (2014) Risk factors for depression in the elderly inflammatory bowel disease population. J Crohns Colitis 8:113–119
PubMedCrossRefLotrich FE, Ferrell RE, Rabinovitz M, Pollock BG (2009) Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism. Biol Psychiatry 65:344–348
PubMedCrossRefLoubinoux I, Kronenberg G, Endres M et al (2012) Post-stoke depression: mechanisms, translation and therapy. J Cell Mol Med 16:1961–1969
PubMedPubMedCentralCrossRefLu X, Lu B, Gu X (2005) Cognitive therapy in combination with electromyographic feedback in treatment of diabetes patients with depression after cerebral infarction. Chin J Clin Pharm 13:215–216
Lublin FD, Whitaker JN, Eidelman BH et al (1996) Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology 46:12–18
PubMedCrossRefLudman E, Katon W, Russo J et al (2006) Panic episodes among patients with diabetes. Gen Hosp Psychiatry 28:475–481
PubMedCrossRefLukaschek K, Baumert J, Kruse J et al (2013) Relationship between posttraumatic stress disorder and type 2 diabetes in a population-based cross-sectional study with 2970 participants. J Psychosom Res 74:340–345
PubMedCrossRefLundin A, Modig K, Halldin J et al (2015) Mental disorder and long-term risk of mortality: 41 years of follow-up of a population sample in Stockholm, Sweden. Epidemiol Psychiatr Sci 1:1–9
Lunn MP, Hughes RA, Wiffen PJ (2014) Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev 1, CD007115
PubMedLuppino FS, de Wit LM, Bouvy PF et al (2010) Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 67:220–229
PubMedCrossRefLustman PJ, Griffith LS, Clouse RE et al (1986) Psychiatric illness in diabetes mellitus: relationship to symptoms and glucose control. J Nerv Ment Dis 174:736–742
PubMedCrossRefLustman PJ, Griffith LS, Clouse RE (1988) Depression in adults with diabetes: results of a 5-year follow-up study. Diabetes Care 11:605–612
PubMedCrossRefLustman PJ, Griffith LS, Clouse RE et al (1997a) Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59:241–250
PubMedCrossRefLustman PJ, Griffith LS, Freedland KE, Clouse RE (1997b) The course of major depression in diabetes. Gen Hosp Psychiatry 19:138–143
PubMedCrossRefLustman PJ, Griffith LS, Freedland KE et al (1998) Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 129:613–621
PubMedCrossRefLustman PJ, Anderson RJ, Freedland KE et al (2000a) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23(434–442):934–942
PubMedCrossRefLustman PJ, Freedland KE, Griffith LS, Clouse RE (2000b) Fluoxetine for depression in diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care 23:618–623
PubMedCrossRefLustman PJ, Clouse RE, Nix BD et al (2006) Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 63:521–529
PubMedCrossRefLustman PJ, Williams MM, Sayuk GS et al (2007) Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care 30:459–466
PubMedCrossRefLutgendorf SK, Sood AK (2011) Biobehavioral factors and cancer progression: physiological pathways and mechanisms. Psychosom Med 73:724–730
PubMedPubMedCentralCrossRefLydiard RB (2001) Irritable bowel syndrome, anxiety, and depression: what are the links? J Clin Psychiatry 62(Suppl 8):38–45
PubMedLydiatt WM, Denman D, McNeilly DP et al (2008) A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer. Arch Otolaryngol Head Neck Surg 134:528–535
PubMedCrossRefMaass SW, Roorda C, Berendsen AJ, Verhaak PF, de Bock GH (2015) The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: a systematic review. Maturitas 82:10010–10018
CrossRefMaercker A, Einsle F, Köllner V (2006) Adjustment disorders as stress response syndromes: a new diagnostic concept and its exploration in a medical sample. Psychopathology 40:135–146
CrossRefMaes M, Yirmyia R, Noraberg J et al (2009) The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 24:27–53
PubMedCrossRefMaes M, Berk M, Goehler L et al (2012) Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 10:66
PubMedPubMedCentralCrossRefMaguire GP, Julier DL, Hawton KE et al (1974) Psychiatric morbidity and referral on two general medical wards. Br Med J 1(5902):268–270
Maguire GP, Lee EG, Bevington DJ et al (1978) Psychiatric problems in the first year after mastectomy. Br Med J 1(6118):963–965
Maguire MJ, Weston J, Singh J, Marson AG (2014) Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev CD010682. doi: 10.1002/14651858.CD010682.pub2
Mahajan S, Avasthi A, Grover S, Chawla YK (2014) Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection. J Psychosom Res 77:109–115
PubMedCrossRefMakrilia N, Indeck B, Syrigos K, Saif MW (2009) Depression and pancreatic cancer: a poorly understood link. J Pancreas 10:69–76
Malt UF, Lloyd GG (2007) Psychopharmacological treatment in liaison psychiatry. In: Llyod GG, Guthrie E (Hrsg) Handbook of liaison psychiatry. Cambridge University Press, Cambridge, S 763–794
CrossRefMangelli L, Fava GA, Grandi S et al (2005) Assessing demoralization and depression in the setting of medical disease. J Clin Psychiatry 66:391–394
PubMedCrossRefMangge H, Becker K, Fuchs D, Gostner JM (2014a) Antioxidants, inflammation and cardiovascular disease. World J Cardiol 6:462–477
PubMedPubMedCentralCrossRefMangge H, Stelzer I, Reininghaus EZ et al (2014b) Disturbed tryptophan metabolism in cardiovascular disease. Curr Med Chem 21:1931–1937
PubMedPubMedCentralCrossRefMansur RB, Brietzke E, McIntyre RS (2015) Is there a „metabolic-mood syndrome“? A review of the relationship between obesity and mood disorders. Neurosci Biobehav Rev 52:89–104
PubMedCrossRefMarcellin P, Lau GK, Zeuzem S et al (2008) Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a. Liver Int 28:477–485
PubMedCrossRefMarkowitz SM, Gonzalez JS, Wilkinson JL, Safren SA (2011) A review of treating depression in diabetes: emerging findings. Psychosomatics 52:1–18
PubMedPubMedCentralCrossRefMarsh L, Williams JR, Rocco M et al (2004) Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology 63:293–300
PubMedCrossRefMartens EJ, de Jonge P, Na B et al (2010a) Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease:the heart and soul study. Arch Gen Psychiatry 67:750–758
PubMedCrossRefMartens EJ, Hoen PW, Mittelhaeuser M et al (2010b) Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med 40:807–814
PubMedCrossRefMartinez C, Assimes TL, Mines D et al (2010) Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ 340:c249
PubMedPubMedCentralCrossRefMartucci M, Balestrieri M, Bisoffi G et al (1999) Evaluating psychiatric morbidity in a general hospital: a two-phase epidemiological survey. Psychol Med 29:823–832
PubMedCrossRefMassie MJ, Greenberg DB (2005) Oncology. In: Levenson JL (Hrsg) Textbook of psychosomatic medicine. American Psychiatric Publishing, Washington, DC/London, S 517–534
Maunder RG, Esplen MJ (2001) Supportive-expressive group psychotherapy for persons with inflammatory bowel disease. Can J Psychiatry 46:622–626
PubMedMaurer J, Rebbapragada V, Borson S et al (2008) ACCP workshop panel on anxiety and depression in COPD: anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 134:43S–56S
PubMedPubMedCentralCrossRefMavrides N, Nemeroff CB (2015) Treatment of affective disorders in cardiac disease. Dialogues Clin Neurosci 17:127–140
PubMedPubMedCentralMayer EA, Tillisch K, Bradesi S (2006) Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther 24:919–933
PubMedCrossRefMayou R, Hawton K, Feldman E (1988) What happens to medical patients with psychiatric disorder? J Psychosom Res 32:541–549
PubMedCrossRefMayr M, Schmid RM (2010) Depression in pancreatic cancer: sense of impending doom. Digestion 82:1–3
PubMedCrossRefMazza M, Lotrionte M, Biondi-Zoccai G et al (2010) Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis. J Psychopharmacol 24:1785–1792
PubMedCrossRefMcCaffery JM, Frasure-Smith N, Dubé MP et al (2006) Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med 68:187–200
PubMedCrossRefMcClintock Greenberg T (2007) The psychological impact of acute and chronic illness. A practical guide for primary care physicians. Springer, New York
CrossRefMcClintock Greenberg T (2009) Psychodynamic perspectives on aging and illness. Springer, New York
CrossRefMcCombie AM, Mulder RT, Gearry RB (2013) Psychotherapy for inflammatory bowel disease: a review and update. J Crohns Colitis 7:935–949
PubMedCrossRefMcCombie AM, Mulder RT, Gearry RB (2015) Coping strategies and psychological outcomes of patients with inflammatory bowel disease in the first 6 months after diagnosis. Inflamm Bowel Dis 21:2272–2280 (im Druck)
McDermott E, Mullen G, Moloney J et al (2015) Body image dissatisfaction: clinical features, and psychosocial disability in inflammatory bowel disease. Inflamm Bowel Dis 21:353–360
PubMedCrossRefMcFarlane A, Kamath MV, Fallen EL et al (2001) Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am Heart J 142:617–623
PubMedCrossRefMcGregor BA, Antoni MH (2009) Psychological intervention and health outcomes among women treated for breast cancer: a review of stress pathways and biological mediators. Brain Behav Immun 23:159–166
PubMedCrossRefMcIntyre CW, Goldsmith DJ (2015) Ischemic brain injury in hemodialysis patients: which is more dangerous, hypertension or intradialytic hypotension? Kidney Int 87:1109–1115
PubMedCrossRefMcIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH (2006) The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Exp Opin Drug Saf 5:157–168
CrossRefMcIntyre RS, Soczynska JK, Konarski JZ et al (2007) Should depressive syndromes be reclassified as „metabolic snydrome type II“? Ann Clin Psychiatry 19:257–264
PubMedCrossRefMcIntyre RE, Kenna HA, Nguyen HT et al (2010) Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders? Adv Ther 27:63–80
PubMedCrossRefMcIntyre RS, Soczynska JK, Liauw SS et al (2012) The association between childhood adversity and components of metabolic syndrome in adults with mood disorders: results from the international mood disorders collaborative project. Int J Psychiatry Med 43:165–177
PubMedCrossRefMcKenzie DP, Clarke DM, Forbes AB, Sim MR (2010) Pessimism, worthlessness, anhedonia, and thoughts of death identify DSM-IV major depression in hospitalized, medically ill patients. Psychosomatics 51:302–311
PubMedMcKercher C, Sanderson K, Jose MD (2013) Psychosocial factors in people with chronic kidney disease prior to renal replacement therapy. Nephrology 18:585–591
PubMedCrossRefMcNally L, Bhagwagar Z, Hannestad J (2008) Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr 13:501–510
PubMedCrossRefMead GE, Hsieh CF, Lee R et al (2012) Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev 11, CD009286
PubMedMehnert A, Vehling S, Scheffold K et al (2013) Prävalenz von Anpassungsstörung, Akuter und Posttraumatischer Belastungsstörung sowie somatoformen Störungen bei Krebspatienten. Ein systematischer Literaturreview und Metaanalyse. Psychother Psychosom Med Psychol 63:466–472
PubMedCrossRefMehnert A, Brähler E, Faller H et al (2014) Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol 32:3540–3546
PubMedCrossRefMehta JR, Ratnani IJ, Dave JD et al (2014) Association of psychiatric co-morbidities and quality of life with severity of chronic obstructive pulmonary disease. East Asian Arch Psychiatry 24:148–155
PubMedMehta PK, Wei J, Wenger NK (2015) Ischemic heart disease in women: a focus on risk factors. Trends Cardiovasc Med 25:140–151
PubMedCrossRefMeijer A, Conradi HJ, Bos EH et al (2011a) Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 33:203–216
PubMedCrossRefMeijer A, Roseman M, Milette K et al (2011b) Depression screening and patient outcomes in cancer: a systematic review. PLoS One 6(11), e27181. doi:10.1371/journal.pone.0027181
PubMedPubMedCentralCrossRefMeijer A, Conradi HJ, Bos EH et al (2013a) Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis. Br J Psychiatry 203:90–102
PubMedCrossRefMeijer A, Zuidersma M, de Jonge P (2013b) Depression as a non-causal variable risk marker in coronary heart disease. BMC Med 11:130
PubMedPubMedCentralCrossRefMeister R, Princip M, Schmid JP et al (2013) Myocardial Infarction – Stress PRevention INTervention (MI-SPRINT) to reduce the incidence of posttraumatic stress after acute myocardial infarction through trauma-focused psychological counseling: study protocol for a randomized controlled trial. Trials 14:329
PubMedPubMedCentralCrossRefMendes FA, Gonçalves RC, Nunes MP et al (2010) Effects of aerobic training on psychosocial morbidity and symptoms in patients with asthma: a randomized clinical trial. Chest 138:331–337
PubMedCrossRefMenza M, Dobkin RD, Marin H et al (2008) A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 92:886–892
Meyer T, Buss U, Hermann-Lingen C (2010) Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality. Psychosom Med 72:9–15
PubMedCrossRefMezuk B, Eaton WW, Albrecht S, Golden SH (2008) Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31:2383–2390
PubMedPubMedCentralCrossRefMezuk B, Heh V, Prom-Wormley E et al (2015) Association between major depression and type 2 diabetes in midlife: findings from the screening across the lifespan twin study. Psychosom Med 77:559–566
PubMedPubMedCentralCrossRefMiehsler W, Weichselberger M, Offerlbauer-Ernst A (2008) Which patients with IBD need psychological interventions? A controlled study. Inflamm Bowel Dis 14:1273–1280
PubMedCrossRefMiguel C, Albuquerque E (2011) Drug interaction in psycho-oncology: antidepressants and antineoplastics. Pharmacology 88:333–339
PubMedCrossRefMikocka-Walus A, Bampton P, Hetzel D et al (2015) Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial. BMC Gastroenterol 15:54
PubMedPubMedCentralCrossRefMiller AH (2009) Norman Cousins Lecture. Mechanisms of cytokine induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 23:149–158
PubMedCrossRefMiller K, Massie MJ (2010) Depressive disorders. In: Holland JC, Breitbart W, Jacobsen PB (Hrsg) Textbook of psycho-oncology, 2. Aufl. Oxford University Press, Oxford, S 311–318
CrossRefMiller MW, McKinney AE, Kanter FS et al (2011a) Hydrocortisone suppression of the fear-potentiated startle response and posttraumatic stress disorder. Psychoneuroendocrinology 36:970–980
PubMedPubMedCentralCrossRefMiller SA, Mancuso CA, Boutin-Foster C et al (2011b) Associations between posttraumatic stress disorder and hemoglobin A1(C) in low-income minority patients with diabetes. Gen Hosp Psychiatry 33:116–122
PubMedCrossRefMiller AH, Haroon E, Raison CL, Felger JC (2013) Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 30:297–306
PubMedPubMedCentralCrossRefMiller-Archie SA, Jordan HT, Ruff RR et al (2014) Posttraumatic stress disorder and new-onset diabetes among adult survivors of the World Trade Center disaster. Prev Med 66:34–38
PubMedCrossRefMinton O, Richardson A, Sharpe M et al (2011) Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis. J Pain Symptom Manage 41:761–767
PubMedCrossRefMitchell PH, Veith RC, Becker KJ et al (2009) Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: randomized, controlled trial. Stroke 40:3073–3078
PubMedPubMedCentralCrossRefMitchell AJ, Chan M, Bhatti H et al (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12:160–174
PubMedCrossRefMitchell AJ, Ferguson DW, Gill J et al (2013) Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol 14:721–732
PubMedCrossRefMittermaier C, Dejaco C, Waldhoer T et al (2004) Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 66:79–84
PubMedCrossRefMiyasaki JM, Shannon K, Voon V et al (2006) Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review). Neurology 66:996–1002
PubMedCrossRefModabbernia A, Poustchi H, Malekzadeh R (2013) Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature review. Hepat Mon 13, e8340
PubMedPubMedCentralCrossRefMoellentine C, Rummans T, Ahskog JE et al (1998) Effectiveness of ECT in patients with parkinsonism. J Neuropsychiatry Clin Neurosci 10:187–193
PubMedCrossRefMoffic HS, Paykel ES (1975) Depression in medical in-patients. Br J Psychiatry 126:346–353
PubMedCrossRefMohapatra PK, Kar N, Kar GC, Behera M (2005) Effectiveness of sertraline in treatment of depression in a consecutive sample of patients with acute myocardial infarction: six month prospective study on outcome. Clin Pract Epidemiol Ment Health 1:26
PubMedPubMedCentralCrossRefMohr DC, Pelletier D (2006) A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain Behav Immun 20:27–36
PubMedCrossRefMohr DC, Boudewyn AC, Goodkin DE et al (2001a) Comparative outcomes for individual cognitive-behavioral therapy, supportive-expressive group psychotherapy and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 69:942–949
PubMedCrossRefMohr DC, Goodkin DE, Islar et al (2001b) Treatment of depression is associated with suppression of nonspecific and antigen-specific TH1 responses in multiple sclerosis. Arch Neurol 58:1081–1086
PubMedCrossRefMohr DC, Hart SL, Julian L et al (2004) Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328:731–735
PubMedPubMedCentralCrossRefMohr DC, Likosky W, Bertagnolli A et al (2005) Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol 68:356–361
CrossRefMols F, Denollet J (2010) Type D personality among noncardiovascular patient populations: a systematic review. Gen Hosp Psychiatry 32:66–72
PubMedCrossRefMols F, Martens EJ, Denollet J (2010) Type D personality and depressive symptoms are independent predictors of impaired health status following acute myocardial infarction. Heart 96:30–35
PubMedCrossRefMorrow GR, Hickok JT, Roscoe JA et al (2003) Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester cancer center community clinical oncology program. J Clin Oncol 21:4635–4641
PubMedCrossRefMoser G (2006) Functional gastrointestinal disorders. Wien Med Wochenschr 156:434–440
CrossRefMossner R, Henneberg A, Schmitt A et al (2001) Allelic variation of serotonin transporter expression is associated with depression in Parkinson’s disease. Mol Psychiatry 6:350–352
PubMedCrossRefMula M (2013a) The interictal dysphoric disorder of epilepsy: a still open debate. Curr Neurol Neurosci Rep 13:355
PubMedCrossRefMula M (2013b) Treatment of anxiety disorders in epilepsy: an evidence-based approach. Epilepsia 54(suppl A):13–18
PubMedCrossRefMula M, Sander JW (2013) Suicide risk in people with epilepsy taking antiepileptic drugs. Bipolar Disord 15:622–627
PubMedCrossRefMula M, Schmitz B (2009) Depression in epilepsy: mechanisms and therapeutic approach. Ther Adv Neurol Disord 2:337–344
PubMedPubMedCentralCrossRefMula M, Jauch R, Cavanna A et al (2010) Interictal dysphoric disorder and periictal dysphoric symptoms in patients with epilepsy. Epilepsia 51:1139–1145
PubMedCrossRefMulle JG, Vaccarino V (2013) Cardiovascular disease, psychosocial factors, and genetics: the case of depression. Prog Cardiovasc Dis 55:557–562
PubMedPubMedCentralCrossRefMüller N, Schwarz M (2007) Immunologische Aspekte bei depressiven Störungen. Nervenarzt 78:1261–1273
PubMedCrossRefMüller N, Kapfhammer HP, Spatz R, Hippius H (1995) Lithiumprophylaxe: Hohe Effizienz und geringes Risiko bei regelmäßiger Überwachung. Dtsch Ärztebl 92:A365–A369
Muller JE, Koen L, Stein DJ (2005) Anxiety and medical disorders. Curr Psychiatry Rep 7:245–251
PubMedCrossRefMullish BH, Kabir MS, Thursz MR, Dhar A (2014) Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation. Aliment Pharmacol Ther 40:880–892
PubMedCrossRefMunger Clary HM (2014) Anxiety and epilepsy: what neurologists and epileptologists should know. Curr Neurol Neurosci Rep 14:445
PubMedCrossRefMurakami T, Hama S, Yamashita H et al (2013) Neuroanatomic pathways associated with poststroke affective and apathetic depression. Am J Geriatr Psychiatry 31:840–847
CrossRefMurray V, von Arbin M, Bartfai A et al (2005) Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry 66:708–716
PubMedCrossRefMussell M, Böcker U, Nagel N et al (2003) Reducing psychological distress in patient with inflammatory bowel disease by cognitive-behavioural treatment: exploratory study of effectiveness. Scand J Gastroenterol 38:755–762
PubMedCrossRefMusselman DL, Evans DL, Nemeroff CB (1998) The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 55:580–592
PubMedCrossRefMusselman DL, Lawson DH, Gumnick JF et al (2001) Paroxetine for the prevention of the depression induced by high dose interferon-alpha. N Engl J Med 344:961–966
PubMedCrossRefMusselman DL, Betan E, Larsen H, Philips LS (2003) The relationship of depression to diabetes – type 1 and type 2. Epidemiology, biology, and treatment. Biol Psychiatry 54:317–329
PubMedCrossRefMusselman DL, Bowling A, Gilles N et al (2006a) The interrelationship of depression and diabetes. In: Steptoe A (Hrsg) Depression and physical illness. Cambridge University Press, Cambridge, S 165–194
CrossRefMusselman DL, Somerset WI, Guo Y et al (2006b) A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry 67:288–296
PubMedCrossRefMusselman DL, Miller AH, Royster EB, McNutt MD (2011) Biology of depression and cytokines in cancer. In: Kissane DW, Maj M, Sartorius N (Hrsg) Depression and cancer. Wiley-Blackwell, Chichester, S 51–79
Nabi H, Hall M, Koskenvuo M et al (2010) Psychological and somatic symptoms of anxiety and risk of coronary heart disease: the health and social support prospective cohort study. Biol Psychiatry 67:378–385
PubMedCrossRefNagler EV, Webster AC, Vanholder R, Zoccali C (2012) Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant 27:3736–3745
PubMedCrossRefNair MG, Pillay SS (1997) Psychiatric disorder in a South African general hospital. Prevalence in general, medical, gynaecological wards. Gen Hosp Psychiatry 19:144–148
PubMedCrossRefNair B (2015) Psychopharmacology in medically ill patients. In: Leigh H, Streltzer J (Hrsg) Handbook of consultation-Liaison psychiatry, 2. Aufl. Springer, Cham/Heidelberg/New York/Dordrecht/London, S 99–114
Nakao H, Konishi H, Mitsufuji S et al (2007) Comparison of clinical features and patient background in functional dyspepsia and peptic ulcer. Dig Dis Sci 52:2152–2158
PubMedCrossRefNarayan SM, Stein MB (2009) Do depression or antidepressants increase cardiovascular mortality? The absence of proof might be more important than the proof of absence. J Am Coll Cardiol 53:950–958
CrossRefNarushima K, Kosier JT, Robinson RG (2002) Preventing of post-stroke depression: a 12 week double-blind randomized treatment trial with 21 month follow-up. J Nerv Ment Dis 190:296–303
PubMedCrossRefNarushima K, Kosier JT, Robinson RG (2003) A reappraisal of post-stroke depression, intra and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci 15:422–430
PubMedCrossRefNarushima K, Paradiso S, Moser DJ, Jorge R, Robinson RG (2007) Effect of antidepressant therapy on executive function after stroke. Br J Psychiatry 190:260–265
PubMedCrossRefNash SS, Kent LK, Muskin PR (2009) Psychodynamics in medically ill patients. Harv Rev Psychiatry 17:389–397
PubMedCrossRefNavinés R, Castellví P, Moreno-España J et al (2012) Depressive and anxiety disorders in chronic hepatitis C patients: reliability and validity of the Patient Health Questionnaire. J Affect Disord 138:343–351
PubMedCrossRefNazem S, Siderowf AD, Duda JE et al (2008) Suicidal and death ideation in Parkinson’s disease. Mov Disord 10:1573–1579
CrossRefNègre-Pagès L, Grandjean H, Lapeyre-Matre M et al (2010) Anxious and depressive symptoms in Parkinson’s disease: the French Cross-Sectional Dopamin Study. Mov Disord 25:157–166
PubMedCrossRefNemeroff CB, Goldschmidt-Clermont PJ (2012) Heartache and heartbreak – the link between depression and cardiovascular disease. Nat Rev Cardiol 9:526–539
PubMedCrossRefNewberg AR, Davydow DS, Lee HB (2006) Cerebrovascular disease basis of depression: post-stroke depression and vascular depression. Int Rev Psychiatry 18:433–441
PubMedCrossRefNg T, Chiam P, Kua E (2007) Mental disorders and asthma in the elderly: a population-based study. Int J Geriatr Psychiatry 22:668–674
PubMedCrossRefNg TP, Niti M, Fones C (2009) Co-morbid association of depression and COPD: a population-based study. Respir Med 103:895–901
PubMedCrossRefNg CG, Boks MP, Zainal NZ, de Wit NJ (2011) The prevalence and pharmacotherapy of depression in cancer patients. J Affect Disord 131:1–7
PubMedCrossRefNicholson A, Kuper H, Hemingway H (2006) Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 27:2763–2774
PubMedCrossRefNiles AN, Dour HJ, Stanton AL et al (2015) Anxiety and depressive symptoms and medical illness among adults with anxiety disorders. J Psychosom Res 78:109–115
PubMedCrossRefNilsson FM, Kessing LV, Bolwig TG (2001) Increased risk of developing Parkinson’s disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 104:380–386
PubMedCrossRefNorman SB, Lang AJ (2005) The functional impact of anxiety sensitivity in the chronically physically ill. Depress Anxiety 21:154–160
PubMedCrossRefNorweg A, Collins EG (2013) Evidence for cognitive-behavioral strategies improving dyspnea and related distress in COPD. Int J Chron Obstruct Pulmon Dis 8:439–451
PubMedPubMedCentralCrossRefNousen EK, Franco JG, Sullivan EL (2013) Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders. Neuroendocrinology 98:254–266
PubMedPubMedCentralCrossRefNouwen A, Winkley K, Twist J et al (2010) Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 53:2480–2486
PubMedPubMedCentralCrossRefNowak Z, Wańkowicz Z, Laudanski K (2015) Denial defense mechanism in dialyzed patients. Med Sci Monit 21:1798–1805
PubMedPubMedCentralCrossRefNuti A, Ceravolo R, Piccinni A et al (2004) Psychiatric comorbidity in a population of Parkinson’s disease patients. Eur J Neurol 11:315–320
PubMedCrossRefO’Byrne PM, Pedersen S, Schatz M et al (2013) The poorly explored impact of uncontrolled asthma. Chest 143:511–523
PubMedCrossRefO’Connor CM, Jiang W, Kuchibhatla M et al (2010) Safety and efficacy of sertraline for depression in patients with heart failure: result of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 56:692–699
PubMedPubMedCentralCrossRefO’Connor CM, Jiang W, Kuchibhatla M et al (2014) Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. Psychol Med 44:2975–2984
CrossRefO’Dell KR, Masters KS, Spielmans GI, Maisto SA (2011) Does type-D personality predict outcomes among patients with cardiovascular disease? A meta-analytic review. J Psychosom Res 71:199–206
PubMedCrossRefO’Toole A, Winter D, Friedman S (2014) Review article: the psychosexual impact of inflammatory bowel disease in male patients. Aliment Pharmacol Ther 39:1085–1094
PubMedCrossRefOerlemans ME, van den Akker M, Schuurman AG et al (2007) A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemiol Ment Health 3:29. doi:10.1186/1745-0179-3-29
PubMedPubMedCentralCrossRefOguru M, Tachibana H, Toda K et al (2010) Apathy and depression in Parkinson disease. J Geriatr Psychiatry Neurol 23:35–41
PubMedCrossRefOhayon MM (2014) Chronic obstructive pulmonary disease and its association with sleep and mental disorders in the general population. J Psychiatr Res 54:79–84
PubMedCrossRefOhayon MM, Schatzberg AF (2003) Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry 60:39–47
PubMedCrossRefOladeji BD, Gureje O (2013) The comorbidity between depression and diabetes. Curr Psychiatry Rep 15:390
PubMedCrossRefOndo WG, Fayle R, Atassi F, Jankovic J (2005) Modafinil for daytime somnolence in Parkison’s diseases. Double blind, Placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 76:1636–1639
PubMedPubMedCentralCrossRefOrive M, Padierna JA, Quintana JM et al (2010) Detecting depression in medically ill patients: comparative accuracy of four screening questionnaires and physicians’ diagnoses in Spanish population. J Psychosom Res 69:399–406
PubMedCrossRefOstuzzi G, Benda L, Costa E, Barbui C (2015a) Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: systematic review and meta-analysis. Cancer Treat Rev 41:714–724
PubMedCrossRefOstuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M (2015b) Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev 6, CD011006
PubMedOtte C, McCaffery J, Ali S, Whooley MA (2007) Association of serotonin transporter polymorphism (5-HTTLPR) with depression. Perceived stress, and norepinephrine in patients with coronary disease: the heart and soul study. Am J Psychiatry 164:1379–1384
PubMedPubMedCentralCrossRefOuzouni S, Kouidi E, Sioulis A, Grekas D, Deligiannis A (2009) Effects of intradialytic exercise training on health-related quality of life indices in haemodialysis patients. Clin Rehabil 23:53–63
PubMedCrossRefOvermier JB, Murison R (2000) Anxiety and helplessness in the face of stress predisposes, precipitates, and sustains gastric ulceration. Behav Brain Res 110:161–174
PubMedCrossRefOwen JA, Levenson JL (2010) Renal and urological disorders. In: Ferrando SJ, Levenson JL, Owen JA (Hrsg) Clinical manual of psychopharmacology in the medically ill. American Psychiatric Publishing, Washington/London, S 149–179
Oxenkrug G (2013) Serotonin-kynurenine hypothesis of depression: historical overview and recent developments. Curr Drug Targets 14:514–521
PubMedPubMedCentralCrossRefPace TW, Heim CM (2011) A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav Immun 25:6–13
PubMedCrossRefPacella ML, Hruska B, Delahanty DL (2013) The physical health consequences of PTSD and PTSD symptoms: a meta-analytic review. J Anxiety Disord 27:33–46
PubMedCrossRefPagonabarraga J, Kulisevsky J, Strafella AP, Krack P (2015) Apathy in Parkinson’s disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol 14:518–531
PubMedCrossRefPaile-Hyvärinen M, Wahlbeck K, Eriksson J (2007) Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial. BMC Fam Pract 8:34
PubMedPubMedCentralCrossRefPalmer S, Vecchio M, Craig JC et al (2013a) Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int 84:179–191
PubMedCrossRefPalmer SC, Vecchio M, Craig JC et al (2013b) Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis 62:493–505
PubMedCrossRefPalomäki H, Kaste M, Berg A et al (1999) Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry 66:490–494
PubMedPubMedCentralCrossRefPan A, Lucas M, Sun Q et al (2010) Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med 170:1884–1891
PubMedPubMedCentralCrossRefPan A, Sun Q, Okereke OI et al (2011) Depression and the risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 306:1241–1249
PubMedPubMedCentralCrossRefPan A, Lucas M, Sun Q et al (2012) Increased mortality risk in women with depression and diabetes mellitus. Arch Gen Psychiatry 68:42–50
CrossRefPanagioti M, Scott C, Blakemore A, Coventry PA (2014) Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 9:1289–1306
PubMedPubMedCentralPanara AJ, Yarur AJ, Rieders B et al (2014) The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. Aliment Pharmacol Ther 39:802–810
PubMedCrossRefPapadopoulou E, Varouktsi A, Lazaridis A et al (2015) Erectile dysfunction in chronic kidney disease: from pathophysiology to management. World J Nephrol 4:379–387
PubMedPubMedCentralCrossRefPaparrigopoulos T, Ferentinos P, Kouzoupis A et al (2010) The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour. Int Rev Psychiatry 22:14–21
PubMedCrossRefParadiso S, Ohkubo T, Robinson RG (1997) Are DSM-IV criteria for major depression useful following stroke? The specificity of depressive symptoms for depressed mood over the first two years after stroke. Int J Psychiatry Med 27:137–157
PubMedCrossRefPark SH, Ishino R (2013) Liver injury associated with antidepressants. Curr Drug Saf 8:207–223
PubMedCrossRefPark M, Katon WJ, Wolf FM (2013) Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review. Gen Hosp Psychiatry 35:217–225
PubMedPubMedCentralCrossRefParker AM, Sricharoenchai T, Raparla S et al (2015) Posttraumatic stress disorder in critical illness survivors: a metaanalysis. Crit Care Med 43:1121–1129
PubMedCrossRefPatten SB, Barbui C (2004) Drug-induced depression: a systematic review to inform clinical practice. Psychother Psychosom 73:207–215
PubMedCrossRefPatten SB, Metz LM, Reimer MA (2000) Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Mult Scler 6:115–120
PubMedCrossRefPatten SB, Beck CA, Williams JV, Barbui C, Metz LM (2003) Major depression in multiple sclerosis: a population-based perspective. Neurology 61:1524–1527
PubMedCrossRefPatten SB, Beck CA, Kassam A et al (2005) Long-term medical conditions and major depression: strength of association for specific conditions in the general population. Can J Psychiatry 50:195–202
PubMedPatten SB, Williams JVA, Lavorato DH et al (2008) Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen Hosp Psychiatry 30:407–413
PubMedCrossRefPatterson ZR, Khazall R, Mackay H et al (2013) Central ghrelin signalling mediates the metabolic response of C57BL/6 male mice to chronic social defeat stress. Endocrinology 154:1080–1091
PubMedCrossRefPattison N (2005) Psychological implications of admission to critical care. Br J Nurs 14:708–714
PubMedCrossRefPauli P, Wiedemann G, Dengler W et al (1999) Anxiety in patients with an automatic implantable cardioverter defibrillator: what differentiates them from panic patients? Psychosom Med 61:69–76
PubMedCrossRefPaumier KL, Siderowf AD, Auinger P et al (2012) Tricyclic antidepressants delay the need fo0r dopaminergic therapy in early Parkinson’s disease. Mov Disord 27:880–887
PubMedCrossRefPaus S, Schmitz-Hubsch T, Wullner U et al (2007) Bright light therapy in Parkinson’s disease: a pilot study. Mov Disord 22:1495–1498
PubMedCrossRefPaz-Diaz H, Montes de Oca M, López JM, Celli BR (2007) Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil 86:30–36
PubMedCrossRefPeacock J, Whang W (2013) Psychological distress and arrhythmia: risk prediction and potential modifiers. Prog Cardiovasc Dis 55:582–589
PubMedPubMedCentralCrossRefPelliccia F, Greco C, Vitale C et al (2014) Takotsubo syndrome (stress cardiomyopathy): an intriguing clinical condition in search of its identity. Am J Med 127:699–704
PubMedCrossRefPenninx BW, Guralnik JM, Pahor M et al (1998) Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 90:1888–1893
PubMedCrossRefPenninx BW, Beekman AT, Honig A et al (2001) Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 58:221–227
PubMedCrossRefPessoa Rocha N, Reis HJ, Vanden Berghe P, Cirillo C (2014) Depression and cognitive impairment in Parkinson’s disease: a role for inflammation and immunomodulation? Neuroimmunomodulation 21:88–94
PubMedPeters SL, Muir JG, Gibson PR (2015) Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther 41:1104–1115
PubMedCrossRefPetrovski S, Szoeke CEI, Jones NC et al (2010) Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients. Neurology 75:1015–1021
PubMedCrossRefPezzella G, Moslinger-Gehmayr R, Contu A (2001) Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat 70:1–10
PubMedCrossRefPiet J, Würtzen H, Zachariae R (2012) The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a systematic review and meta-analysis. J Consult Clin Psychol 80:1007–1020
PubMedCrossRefPiette JD, Richardson C, Himle J et al (2011) A randomized trial of telephonic conselling plus walking for depressed diabetes patients. Med Care 49:641–648
PubMedPubMedCentralCrossRefPinhas-Hamiel O, Hamiel U, Levy-Shraga Y (2015) Eating disorders in adolescents with type 1 diabetes: challenges in diagnosis and treatment. World J Diabetes 6:517–526
PubMedPubMedCentralCrossRefPitceathly C, Maguire P, Fletcher I et al (2009) Can a brief psychological intervention prevent anxiety or depressive disorders in cancer patients? A randomised controlled trial. Ann Oncol 20:928–934
PubMedCrossRefPizzi C, Rutjes AWS, Costa GM et al (2011) Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease. Am J Cardiol 107:972–979
PubMedCrossRefPlack K, Herpertz S, Petrak F (2010) Behavioral medicine interventions in diabetes. Curr Opin Psychiatry 23:131–138
PubMedCrossRefPoder K, Ghatavi K, Fisk JD et al (2009) Social anxiety in a multiple sclerosis clinic population. Mult Scler 15:393–398
PubMedCrossRefPogosova N, Saner H, Pedersen SS et al (2014) Psychosocial aspects in cardiac rehabilitation: from theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol pii:2047487314543075
Polsky D, Doshi JA, Marcus S et al (2005) Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med 165:1260–1266
PubMedCrossRefPompili M, Baldessarini RJ (2010) Epilepsy: risk of suicidal behavior with antiepileptic drugs. Nat Rev Neurol 6:651–653
PubMedCrossRefPompili M, Vanacore N, Macone S, Amore M et al (2007) Depression, hopelessness and suicide risk among patients suffering from epilepsy. Ann Ist Super Sanita 43:425–429
PubMedPompili M, Lester D, Innamorati M et al (2009) Quality of life and suicide risk in patients with diabetes mellitus. Psychosomatics 50:16–23
PubMedCrossRefPompili M, Forte A, Palermo M et al (2012a) Suicide risk in multiple sclerosis: a systematic review of current literature. J Psychosom Res 73:411–417
PubMedCrossRefPompili M, Venturini P, Campi S et al (2012b) Do stroke patients have an increased risk of developing suicidal ideation or dying by suicide? An overview of the current literature. CNS Neurosci Ther 18:711–721
PubMedCrossRefPompili M, Venturini P, Montebovi F et al (2013) Suicide risk in dialysis: review of current literature. Int J Psychiatry Med 46:85–108
PubMedCrossRefPontone GM, Williams JR, Anderson KE et al (2009) Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease. Mov Disord 24:1333–1338
PubMedPubMedCentralCrossRefPoole L, Dickens C, Steptoe A (2011) The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation. J Psychosom Res 71:61–68
PubMedPubMedCentralCrossRefPopkin MK, Callies AL, Colon EA et al (1990) Adjustment disorders in medically ill patients referred for consultation at a university hospital. Psychosomatics 31:410–414
PubMedCrossRefPorcelli P, Sonino N (eds) (2007) Psychological factors affecting medical conditions. A new classification for DSM-V. Adv Psychosom Med, vol 28. Karger, Basel
Pössel P, Adams E, Valentine JC (2012) Depression as a risk factor for breast cancer: investigating methodological limitations in the literature. Cancer Causes Control 23:1223–1229
PubMedCrossRefPouwer F, Kupper N, Adriaanse MC (2010) Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) research consortium. Discov Med 9:112–118
PubMedPrediger RD, Matheus FC, Schwarzbold ML et al (2012) Anxiety in Parkinson’s disease: a critical review of experimental and clinical studies. Neuropharmacology 62:115–124
PubMedCrossRefPrice JL, Drevets WC (2013) Neural circuitry of depression. In: Charney DS, Sklar P, Buxbaum JD, Nestler EJ (Hrsg) Neurobiology of mental illness, 4. Aufl. Oxford University Press, Oxford, S 455–469
Price A, Rayner L, Okon-Rocha E et al (2011) Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry 82:914–923
PubMedCrossRefPujol J, Bello J, Deus J et al (1997) Lesions in the left arcuate fasciculus region and depressive symptoms multiple sclerosis. Neurology 49:1105–1110
PubMedCrossRefPumar MI, Gray CR, Walsh JR et al (2014) Anxiety and depression- important psychological comorbidities of COPD. J Thorac Dis 6:1615–1631
PubMedPubMedCentralPuozzo C, Panconi E, Deprez D (2002) Pharmacology and pharmacokinetics of milnacipran. Int Clin Psychopharmacol 17(suppl 1):25–35
CrossRefPutman-Casdorph H, McCrone S (2009) Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung 38:34–47
PubMedCrossRefQu W, Meng P (2005) Relationship between blood glucose levels in patients with type 2 diabetes mellitus, depression and anxiety and the anti-depression/anxiety intervention. Chin J Clin Rehabil 9:213–215
Quelhas R, Lopes A (2009) Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review. J Psychiatr Pract 15:262–281
PubMedCrossRefQuereshi US, Amspoker AB, Calleo JS et al (2012) Anxiety disorders, physical illnesses, and health care utilization in older male veterans with Parkinson disease and comorbid depression. J Geriatr Psychiatry Neurol 25:233–239
CrossRefRabe KF, Hurd S, Anzeto A et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: gold executive summary. Am J Respir Crit Care Med 176:532–555
PubMedCrossRefRabey JM, Orlow E, Korczyn AD (1996) Comparison of fluvoxamine versus amitriptyline for treatment of depression in Parkinson’s disease. Neurology 46:A374
Raison CL, Miller AH (2003) Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 54:283–294
PubMedCrossRefRaison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunology 27:24–31
CrossRefRamasubbu R, Taylor VH, Samaan Z et al (2012) The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry 24:91–109
PubMedRampello L, Alvano A, Chiechio S et al (2005) An evaluation of efficacy and safety of reboxetine in elderly patients affected by retarded post-stroke depression. Arch Gerontol Geriatr 40:275–285
PubMedCrossRefRasic DT, Belik SL, Bolton JM et al (2008) Cancer, mental disorders, suicidal ideation and attempts in a large community sample. Psychooncology 17:660–667
PubMedCrossRefRaskin S, Durst R (2010) Bupropion as the treatment of choice in depression associated with Parkinson’s disease and it’s various treatments. Med Hypotheses 75:544–546
PubMedCrossRefRasmussen A, Lunde M, Poulsen DL et al (2003) A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 4:216–221
CrossRefRaymond CB, Wazny LD, Honcharik PL (2008) Pharmacotherapeutic options for the treatment of depression in patients with chronic kidney disease. Nephrol Nurs J 35:257–263
PubMedRayner L, Price A, Evans A et al (2010) Antidepressants for depression in physically ill (review). Cochrane Database Syst Rev CD007503
Rayner L, Price A, Evans A et al (2011) Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med 25:36–51
PubMedCrossRefRazavi D, Allilaire JF, Smith M et al (1996) The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand 94:205–210
PubMedCrossRefReder AT, Oger JF, Kappos L, O’Connor P, Rametta M (2014) Short-term and long-term safety and tolerability of interferon β-1b in multiple sclerosis. Mult Scler Relat Disord 3:294–302
PubMedCrossRefReding MJ, Orto LA, Winter SW et al (1986) Antidepressant therapy after stroke. Arch Neurol 43:763–765
PubMedCrossRefRektorova I, Rektor I, Bares M et al (2003) Pramipexole and pergolide in the treatment of depression in Parkinson’s disease: a national multicentre prospective randomized study. Eur J Neurol 10:399–406
PubMedCrossRefRenn BN, Feliciano L, Segal DL (2011) The bidirectional relationship of depression and diabetes: a systematic review. Clin Psychol Rev 31:1239–1246
PubMedCrossRefRentsch D, Dumont P, Borgacci S et al (2007) Prevalence and treatment of depression in a hospital department of internal medicine. Gen Hosp Psychiatry 29:25–31
PubMedCrossRefRichard IH (2005) Anxiety disorders in Parkinson’s disease. Adv Neurol 96:42–55
PubMedRichard IH, McDermott MP, Kurlan R et al (2012) A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology 78:1229–1236
PubMedPubMedCentralCrossRefRichardson LP, Lozano P, Russo J et al (2006) Asthma symptom burden: relationship to asthma severity and anxiety and depression symptoms. Pediatrics 118:1042–1051
PubMedCrossRefRieckmann N, Kronish IM, Shapiro PA et al (2013) Serotonin reuptake inhibitor use, depression, and long-term outcomes after an acute coronary syndrome: a prospective cohort study. JAMA Intern Med 173:1150–1151
PubMedPubMedCentralCrossRefRiedel O, Heuser I, Klotsche J et al (2010) Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD study. J Geriatr Psychiatry Neurol 23:27–34
PubMedCrossRefRief W (2006) Psychische Aspekte bei körperlichen Krankheiten. ZPPP 54:13–22
Robbins E, Guze S (1972) Classification of affective disorders. In: Williams T, Katz M, Shields A (Hrsg) Recent advantages in the psychobiolgy of the depressive illnesses. Government Printing Office, Washington, DC, S 283–293
Roberts BL, Rickard CM, Rajbhandari D, Reynolds P (2006) Patients’ dreams in ICU: recall at two years post discharge and comparison to delirium status during ICU admission. A multicentre cohort study. Intensive Crit Care Nurs 22:264–273
PubMedCrossRefRoberts AL, Agnew-Blais JC, Spiegelman D et al (2015) Posttraumatic stress disorder and incidence of type 2 diabetes mellitus in a sample of women: a 22-year longitudinal study. JAMA Psychiatry 72:203–210
PubMedPubMedCentralCrossRefRobinson RG (1998) The clinical neuropsychiatry of stroke. Cognitive, behavioral and emotional disorders following vascular brain injury. Cambridge University Press, Cambridge
Robinson RG (2006) The clinical neuropsychiatry of stroke. Cognitive, behavioural, and emotional disorders following vascular brain injury, 2. Aufl. Cambridge University Press, Cambridge
Robinson RG, Kukoyi O (2006) Stroke. In: Blumenfield M, Strain JJ (Hrsg) Psychosomatic medicine. Lippincott Williams & Wilkins, Philadelphia, S 255–275
Robinson RG, Schultz SK, Castillo C et al (2000) Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry 157:351–359
PubMedCrossRefRobinson RG, Jorge RE, Clarence-Smith K (2008a) Double-blind randomized treatment of poststroke depression using nefiracetam. J Neuropsychiatry Clin Neurosci 20:178–184
PubMedCrossRefRobinson RG, Jorge RE, Moser DJ et al (2008b) Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 299:2391–2400
PubMedPubMedCentralCrossRefRobinson RG, Jorge RE, Clarence-Smith K, Starkstein S (2009) Double-blind treatment of apathy in patients with poststroke depression using nefiracetam. J Neuropsychiatry Clin Neurosci 21:144–151
PubMedCrossRefRobinson RG, Spalletta G, Jorge RE et al (2010) Poststroke depression: a review. Can J Psychiatry 55:341–349
PubMedPubMedCentralRobinson S, Kissane DW, Brooker J, Burney S (2015) A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research. J Pain Symptom Manage 49:595–610
PubMedCrossRefRobson A, Scrutton F, Wilkinson L, MacLeod F (2010) The risk of suicide in cancer patients: a review of the literature. Psychooncology 19:1250–1258
PubMedCrossRefRocha FL, Murad MG, Stumpf BP et al (2013) Antidepressants for depression in Parkinson’s disease: systematic review and meta-analysis. J Psychopharmacol 27:417–423
PubMedCrossRefRöder C, Schaefer M, Leucht S (2004) Meta-Analyse zu Wirksamkeit und Verträglichkeit der Behandlung der leichten und mittelschweren Depression mit Johanniskraut. Fortschr Neurol Psychiatr 72:330–343
PubMedCrossRefRodin R, Craven J, Littlefield C (1991) Depression in the medically ill. An integrated approach, Brunner/Mazel/New York
Rodin GM, Nolan RP, Katz MR (2005) Depression. In: Levenson JL (Hrsg) Textbook of psychosomatic medicine. American Psychiatric Publishing, Washington, DC/London, S 193–217
Rodríguez-Rodríguez P, Jiménez-García R, Hernández-Barrera V et al (2013) Prevalence of physical disability in patients with chronic obstructive pulmonary disease and associated risk factors. COPD 10:611–617
PubMedCrossRefRoest AM, Martens EJ, Denollet J, de Jonge P (2010) Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med 72:563–569
PubMedCrossRefRoest AM, Zuidersma M, de Jonge P (2012) Myocardial infarction and generalised anxiety disorder: 10-year follow-up. Br J Psychiatry 200:324–329
PubMedCrossRefRoncella A, Pristipino C, Cianfrocca C et al (2013) One-year results of the randomized, controlled, short-term psychotherapy in acute myocardial infarction (step-in-ami) trial. Int J Cardiol 170:132–139
PubMedCrossRefRoose SP, Miyazaki M (2005) Pharmacologic treatment of depression in patients with heart disease. Psychosom Med 67(Suppl 1):54–57
CrossRefRoose SP, Dalack GW, Glassman AH et al (1991) Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 148:512–516
PubMedCrossRefRoose SP, Laghrissi-Thode F, Kennedy JS et al (1998) Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279:287–291
PubMedCrossRefRoscoe JA, Morrow GR, Hickok JT et al (2005) Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 89:243–249
PubMedCrossRefRosenberg SL, Miller GE, Brehm JM, Celedón JC (2014) Stress and asthma: novel insights on genetic, epigenetic, and immunologic mechanisms. J Allergy Clin Immunol 134:1009–1015
PubMedPubMedCentralCrossRefRosenstock S, Jørgensen T, Bonnevie O, Andersen L (2003) Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut 52:186–193
PubMedPubMedCentralCrossRefRoth AJ, Massie MJ (2007) Anxiety and its management in advanced cancer. Curr Opin Support Palliat Care 1:50–56
PubMedCrossRefRothenhäuser HB, Scherr M, Putz-Bankuti C et al (2009) The relationship between emotional distress, cognitive performance and health – related quality of life in patients with hepatitis C prior to antiviral treatment. Fortschr Neurol Psychiatr 77:457–463
CrossRefRothenhäusler HB, Kapfhammer HP (2005) Psychopharmakotherapie bei somatischen Erkrankungen – Behandlungsprinzipien in der medizinischen Routineversorgung. Wien Med Wochenschr 155:303–314
PubMedCrossRefRothenhäusler HB, Ehrentraut S, von Degenfeld G et al (2000) Treatment of depression with methylphenidate in patients difficult to wean from mechanical ventilation in the intensive care unit. J Clin Psychiatry 61:750–755
PubMedCrossRefRoxburgh CS, McMillan DC (2014) Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer 110:1409–1412
PubMedPubMedCentralCrossRefRoy T, Lloyd CE (2012) Epidemiology of depression and diabetes: a systematic review. J Affect Disord 142(suppl):8–21
CrossRefRoy-Byrne PP, Davidson KW, Kessler RC et al (2008) Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 30:208–225
PubMedCrossRefRudisch B, Nemeroff CB (2003) Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 54:227–240
PubMedCrossRefRugulies R (2002) Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 23:51–61
PubMedCrossRefRustad JK, Musselman DL, Nemeroff CB (2011) The relationsip of depression and diabetes: pathophysiological and treatment implications. Psychoneuroendocrinol 36:1276–1286
CrossRefRustad JK, Stern TA, Hebert K, Musselman DL (2013) Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature. Prim Care Companion CNS Disord 15:PCC.13r01511
Rutledge T, Linke SE, Krantz DS et al (2009) Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study. Psychosom Med 71:958–964
PubMedPubMedCentralCrossRefRuttley A, Reid S (2006) Depression in physical illness. Psychiatry 5:89–92
CrossRefSagawa M, Oka M, Chaboyer W (2003) The utility of cognitive behavioural therapy on chronic haemodialysis patients’ fluid intake: a preliminary examination. Int J Nurs Stud 40:367–373
PubMedCrossRefSagna A, Gallo JJ, Pontone GM (2014) Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson’s disease. Parkinsonism Relat Disord 20:708–715
PubMedPubMedCentralCrossRefSakkas GK, Giannaki CD, Karatzaferi C (2015) Current trends in the management of uremic restless legs syndrome: a systematic review on aspects related to quality of life, cardiovascular mortality and survival. Sleep Med Rev 21:39–49
PubMedCrossRefSalter KL, Foley NC, Zhu L et al (2013) Prevention of poststroke depression: does prophylactic pharmacotherapy work? J Stroke Cerebrovasc Dis 22:1243–1251
PubMedCrossRefSander JW (2011) Early treatment does not seem to affect the risk of mortality in epilepsy but the presence of comorbidity may. J Neurol Neurosurg Psychiatry 82:829
PubMedCrossRefSanders R (1988) Suicidal behaviour in critical care medicine: conceptual issues and management strategies. In: Wise M (Hrsg) Problems in critical care medicine. Lippincott, Philadelphia, S 116–133
Sanna L, Stuart AL, Pasco JA et al (2014) Suicidal ideation and physical illness: does the link lie with depression? J Affect Disord 152–154:422–426
PubMedCrossRefSansone RA, Sansone LA (2010) Demoralization in patients with medical illness. Psychiatry 7:42–45
Santoro D, Satta E, Messina S et al (2013) Pain in end-stage renal disease: a frequent and neglected clinical problem. Clin Nephrol 79(suppl 1):2–11
Santos M, Gold G, Kövari E et al (2009) Differential impact of lacunes and microvascular lesions on poststroke depression. Stroke 40:3557–3562
PubMedCrossRefSareen J, Cox BJ, Clara I, Asmundson JG (2005) The relationship between anxiety disorders and physical disorders in the U.S. National comorbidity survey. Depress Anxiety 21:193–202
PubMedCrossRefSarkar S, Schaefer M (2014) Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis. Psychosomatics 55:221–234
PubMedCrossRefSatin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 115:5349–5361
PubMedCrossRefSatta E, Magno C, Galì A et al (2014) Sexual dysfunction in women with diabetic kidney. Int J Endocrinol 2014:346834
PubMedPubMedCentralCrossRefSayuk GS, Gott BM, Nix BD, Lustman PJ (2011) Improvement in sexual functioning in patients with type 2 diabetes and depression treated with bupropion. Diabetes Care 34:332–334
PubMedPubMedCentralCrossRefSchäfer M, Mauss S (2008) Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects. Curr Drug Abuse Rev 1:177–187
Schäfer M, Capuron L, Friebe A et al (2012) Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement. J Hepatol 57:1379–1390
CrossRefSchäfer M, Sarkar R, Diez-Quevedo C (2013) Management of mental health problems prior to and during treatment of hepatitis C virus infection in patients with drug addiction. Clin Infect Dis 57(suppl 2):111–117
CrossRefSchelling G, Stoll GC, Haller M, Kapfhammer HP et al (1999) The effect of stress doses of hydrocortisone during septic shock on post-traumatic stress disorder and health-related quality of life in survivors. Crit Care Med 27:2678–2683
PubMedCrossRefSchelling G, Kilger E, Roozendaal B et al (2004) Stress doses of hydrocortisone, traumatic stress, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized trial. Biol Psychiatry 55:627–633
PubMedCrossRefSchlatter C, Egger SS, Tchambaz L, Krähenbühl S (2009) Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for does adaptation. Drug Saf 32:561–578
PubMedCrossRefSchmidt F, Janssen G, Martin G et al (2009) Factors influencing long-term changes in mental health after interferon alpha treatment of chronic hepatitis C. Aliment Pharmacol Ther 30:1049–1059
PubMedCrossRefSchmitz B (2011) The effects of antiepileptics on behaviour. In: Trimble MR, Schmitz B (Hrsg) The neuropsychiatry of epilepsy, 2. Aufl. Cambridge University Press, Cambridge, S 133–142
CrossRefSchnurr PP (2015) Understanding pathways from traumatic exposure to physical health. In: Schnyder U, Cloitre M (Hrsg) Evidence based treatments for trauma- related psychological disorders. A practical guide for clinicians. Springer International Publishing, Switzerland, S 87–103
Schrag A (2006) Quality of life and depression in Parkinson’s disease. J Neurol Sci 248:151–157
PubMedCrossRefSchramm C, Wahl I, Weiler-Normann C et al (2014) Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis. J Hepatol 60:618–624
PubMedCrossRefSchrempf W, Brandt MD, Storch A, Reichmann H (2014) Sleep disorders in Parkinson’s disease. J Parkinsons Dis 4:211–221
PubMedSchron EB, Exner DV, Yao Q et al (2002) Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105:589–594
PubMedCrossRefSchumann R, Adamaszek M, Sommer N, Kirkby KC (2012) Stress, depression and antidepressant treatment options in patients suffering from multiple sclerosis. Curr Pharm Des 18:5837–5845
PubMedCrossRefSchüßler G (1998) Krankheitsbewältigung und Psychotherapie bei körperlichen und chronischen Erkrankungen. Psychotherapeut 43:382–390
CrossRefSchwab JJ, McGinness NH, Marder L et al (1966) Evaluation of anxiety in medical patients. J Chron Dis 19:1049–1057
PubMedCrossRefScott KM (2014) Depression, anxiety and incident cardiometabolic diseases. Curr Opin Psychiatry 27(4):289–293
PubMedCrossRefScott KM, Bruffaerts R, Tsang A et al (2007a) Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health surveys. J Affect Disord 103:113–120
PubMedCrossRefScott KM, von Korff M, Ormel J et al (2007b) Mental disorders among adults with asthma: results from the world mental health survey. Gen Hosp Psychiatry 29(1):23–133
Scott KM, Alonso J, de Jonge P et al (2013) Associations between DSM-IV mental disorders and onset of self-reported peptic ulcer in the World Mental Health Surveys. J Psychosom Res 75:121–127
PubMedPubMedCentralCrossRefSeldenrijk A, Vogelzangs N, Batelaan NM et al (2015) Depression, anxiety and 6-year risk of cardiovascular disease. J Psychosom Res 78:123–129
PubMedCrossRefSelikhova M, Williams DR, Kempster PA et al (2009) A clinico-pathological study of subtypes in Parkinson’s disease. Brain 132:2947–2957
PubMedCrossRefSemenkovich K, Brown M, Svrakic DM, Lustman PJ (2015) Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs 75:577–587
PubMedCrossRefSerrano-Duenas M (2002) Dosis bajas de amitriptilina frente a dosis bajas de fluoxetine en el tratamiento de la depression de enfermos con Parkinson. Rev Neurol 35:1010–1014
PubMedSeruga B, Zhang H, Bernstein LJ, Tannock IF (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8:887–899
PubMedCrossRefSeymour J, Benning TB (2009) Depression, cardiac mortality and all-cause mortality. Adv Psychiatr Treat 15:107–113
CrossRefShanmugam G, Bhutani S, Khan DA, Brown ES (2007) Psychiatric considerations in pulmonary disease. Psychiatr Clin North 30:761–780
CrossRefSharafkhaneh A, Jayaraman G, Kaleekal T et al (2009) Sleep disorders and their management in patients with COPD. Ther Adv Respir Dis 3:309–318
PubMedCrossRefSharp J, Wild MR, Gumley AI, Deighan CJ (2005) A cognitive behavioural group approach to enhance adherence to hemodialysis fluid restrictions: a randomized controlled trial. Am J Kidney Dis 45:1046–1057
PubMedCrossRefShelton RC (2010) Miller AH (2010) Eating ourselves to death and despair: the contribution of adiposity and inflammation to depression. Prog Neurobiol 91:275–299
PubMedPubMedCentralCrossRefSherbourne CD, Jackson CA, Meredith LS et al (1996) Prevalence of comorbid anxiety disorders in primary care outpatients. Arch Fam Med 5:27–34
PubMedCrossRefShimizu K, Yoshiuchi K, Onishi H (2014) Treatment of anxiety and stress-related disorders. In: Grassi L, Riba M (Hrsg) Psychopharmaclogy in oncology and palliative care. Springer, Berlin/Heidelberg, S 129–144
Siddiqui S (2014) Depression in type 2 diabetes mellitus-A brief review. Diabetes Metab Syndr 8:62–65
PubMedCrossRefSilverstone PH (1996) Prevalence of psychiatric disorders in medical inpatients. J Nerv Ment Dis 184:43–51
PubMedCrossRefSimon AE, Palmer SC, Coyne JC (2006) Cancer and depression. In: Steptoe A (Hrsg) Depression and physical illness. Cambridge University Press, Cambridge, S 211–237
CrossRefSimpson R, Booth J, Lawrence M, Byrne S, Mair F, Mercer S (2014) Mindfulness based interventions in multiple sclerosis – a systematic review. BMC Neurol 14:15
PubMedPubMedCentralCrossRefSimson U, Nawarotzky U, Friese G et al (2008) Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome. Diabet Med 25:206–212
PubMedCrossRefSingh G, Zhang W, Kuo YF, Sharma G (2015) Association of psychological disorders with 30-day readmission rates in patients with chronic obstructive pulmonary disease. Chest. doi:10.1378/chest.15-0449
Singhal A, Ross J, Seminog O et al (2014) Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage. J R Soc Med 107:194–204
PubMedPubMedCentralCrossRefSinoff G, Werner P (2003) Anxiety disorder and accompanying subjective memory loss in the elderly as a predictor of future cognitive decline. Int J Geriatr Psychiatry 18:951–959
PubMedCrossRefSirri L, Fava GA, Sonino N (2013) The unifying concept of illness behavior. Psychother Psychosom 82:74–81
PubMedCrossRefSjodin I, Svedlund J, Ottosson JO, Dotevall G (1986) Controlled study of psychotherapy in chronic peptic ulcer disease. Psychosomatics 27:195–196
CrossRefSkala JA, Freedland KE, Carney RM (2006) Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry 51:738–745
PubMedSlavich GM, Irwin MR (2014) From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 140:774–815
PubMedPubMedCentralCrossRefSmith JR, Mugford M, Holland R et al (2005) A systematic review to examine the impact of psycho-educational interventions on health outcomes and costs in adults and children with difficult asthma. Health Technol Assess 9:1–167
Smith OR, Kupper N, Denollet J, de Jonge P (2011) Vital exhaustion and cardiovascular prognosis in myocardial infarction and heart failure: predictive power of different trajectories. Psychol Med 41:731–738
PubMedCrossRefSmith KJ, Béland M, Clyde M et al (2013) Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res 74:89–99
PubMedCrossRefSmith SM, Sonego S, Ketcheson L, Larson JL (2014) A review of the effectiveness of psychological interventions used for anxiety and depression in chronic obstructive pulmonary disease. BMJ Open Respir Res 1, e000042
PubMedPubMedCentralCrossRefSmith KM, Eyal E, Weintraub D, ADAGIO Investigators (2015) Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability. JAMA Neurol 72:88–89
PubMedCrossRefSmolin B, Klein E, Levy Y, Ben-Shachar D (2007) Major depression as a disorder of serotonin resistance: inference from diabetes mellitus type II. Int J Neuropsychopharmacol 25:1–12
Smoller JW, Pollack MH, Wassertheil-Smoller S et al (2007) Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women’s Health Initiative Observational Study. Arch Gen Psychiatry 64:1153–1160
PubMedCrossRefSmoller JW, Allison M, Cochrane BB et al (2009) Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the women’s health initiative study. Arch Intern Med 169:2128–2139
PubMedCrossRefSoares-Filho GL, Arias-Carrión O, Santulli G et al (2014) Chest pain, panic disorder and coronary artery disease: a systematic review. CNS Neurol Disord Drug Targets 13:992–1001
PubMedCrossRefSockalingam S, Abbey SE (2009) Managing depression during hepatitis C treatment. Can J Psychiatry 54:614–625
PubMedSockalingam S, Links PS, Abbey SE (2011) Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update. J Viral Hepat 18:153–160
PubMedCrossRefSoni RK, Weisbord SD, Unruh ML (2010) Health-related quality of life outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 19:153–159
PubMedPubMedCentralCrossRefSpalletta G, Bossủ P, Ciaramella A et al (2006) The etiology of poststroke depression: a review of the literature and new hypothesis involving inflammatory cytokines. Mol Psychiatry 11:984–991
PubMedCrossRefSpiegel D, Lazar SG (1997) The need for psychotherapy in the medically ill. Psa Inquiry (Suppl) 17:45–50
Spinelli A, Carvello M, D’Hoore A, Pagnini F (2014) Psychological perspectives of inflammatory bowel disease patients undergoing surgery: rightful concerns and preconceptions. Curr Drug Targets 15:1074–1078
PubMedCrossRefSpitzer C, Barnow S, Völzke H et al (2009) Trauma, posttraumatic stress disorder, and physical illness: findings from the general population. Psychosom Med 71:1012–1017
PubMedCrossRefSpitzer C, Gläser S, Grabe HJ et al (2011) Mental health problems, obstructive lung disease and lung function: findings from the general population. J Psychosom Res 71:174–179
PubMedCrossRefSpoletini I, Gianni W, Caltagirone C et al (2011) Suicide and cancer: where do we go from here? Crit Rev Oncol Hematol 78:206–219
PubMedCrossRefStahl SM (2013) Stahl’s essential psychopharmacology. Neuroscientific basis and practical applications. Cambridge University Press, Cambridge
Starkstein SE, Tranel D (2012) Neurological and psychiatric aspects of emotion. Handb Clin Neurol 106:53–74
PubMedCrossRefStarkstein S, Merello M, Jorge R et al (2008) A validation study of depressive syndromes in Parkinson’s disease. Mov Disord 15:538–546
CrossRefStarkstein SE, Brockman S, Hayhow BD (2012) Psychiatric syndromes in Parkinson’s disease. Curr Opin Psychiatry 25:468–472
PubMedCrossRefStefanello S, Marin-Leon L, Fernandes PT et al (2010) Suicidal thoughts in epilepsy: a community-based study in Brazil. Epilepsy Behav 17:483–488
PubMedCrossRefStefanova E, Potrebic A, Ziropadja L et al (2006) Depression predicts the pattern of cognitive impairment in early Parkinson’s disease. J Neurol Sci 248:131–137
PubMedCrossRefStensman R, Sundqvist-Stensman U (1988) Physical disease and disability among 416 suicide cases in Sweden. Scand J Soc Med 16:149–153
PubMedStenzel N, Rief W, Kühl K et al (2012) Progredienzangst und End-of-Life-Ängste bei COPD-Patienten. Pneumologie 66:111–118
PubMedCrossRefSteptoe A (2006a) Integrating clinical with biobehavioural studies of depression and physical illness. In: Steptoe A (Hrsg) Depression and physical illness. Cambridge University Press, Cambridge, S 397–408
CrossRefSteptoe A (2006b) Depression and physical activity. In: Steptoe A (Hrsg) Depression and physical illness. Cambridge University Press, Cambridge, S 348–368
CrossRefStewart BJ, Turnbull D, Mikocka-Walus AA et al (2013) Acceptability of psychotherapy, pharmacotherapy, and self-directed therapies in Australians living with chronic hepatitis C. J Clin Psychol Med Settings 20:427–439
PubMedCrossRefStewart JC, Perkins AJ, Callahan CM (2014) Effect of collaborative care for depression on risk of cardiovascular events: data from the IMPACT randomized controlled trial. Psychosom Med 76:29–37
PubMedCrossRefStickler MR, O’Connell R, Nowak AK et al (2007) Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol 8:603–612
CrossRefStiefel F, Zdrojewski C, Bel Hadj F et al (2008) Effects of a multifaceted psychiatric intervention targeted for the complex medically ill: a randomized controlled trial. Psychother Psychosom 77:247–256
PubMedCrossRefStoudemire A, Fogel BS, Gulley LR (1991) Psychopharmacology in the medically ill: an update. In: Stoudemire A, Fogel BS (Hrsg) Medical psychiatric practice. American Psychiatric Press, Washington, DC/London, S 29–97
Strain JJ (2015) Trauma and stressor-related disorders 2: adjustment disorders. In: Hoyle Leigh H, Streltzer J (Hrsg) Handbook of consultation-liaison psychiatry, 2. Aufl. Springer, Cham/Heidelberg/New York/Dordrecht/London, S 243–258
Strik JJ, Honig A, Lousberg R et al (2000) Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 62:783–789
PubMedCrossRefStrubel T, Birkhofer A, Mößmer G, Förstl H (2010) Blutungsrisiko unter SSRI-Behandlung. Nervenarzt 81:549–555
PubMedCrossRefStuart MJ, Baune BT (2012) Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci Biobehav Rev 36:658–676
PubMedCrossRefSullivan M, LaCroix A, Russo J et al (1999) Depression in coronary heart disease. What is the appropriate diagnostic threshold? Psychosomatics 40:286–292
PubMedCrossRefSullivan MD, O’Connor P, Feeney P et al (2012) Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy. Diabetes Care 35:1708–1715
PubMedPubMedCentralCrossRefSullivan MD, Katon WJ, Lovato LC (2013) Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial. JAMA Psychiatry 70:1041–1047
PubMedPubMedCentralCrossRefSummers KM, Martin KE, Watson K (2010) Impact and clinical management of depression in patients with coronary artery disease. Pharmacotherapy 30:304–322
PubMedCrossRefSuominen K, Isometsa E, Heila H et al (2002) General hospital suicides– a psychological autopsy study in Finland. Gen Hosp Psychiatry 24:412–416
PubMedCrossRefSyrjala KL, Jensen MP, Mendoza ME et al (2014) Psychological and behavioral approaches to cancer pain management. J Clin Oncol 32:1703–1711
PubMedPubMedCentralCrossRefSzigethy E, Youk AO, Gonzalez-Heydrich J et al (2015) Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn’s disease. Inflamm Bowel Dis 21:1321–1328
PubMedPubMedCentralTabák AG, Akbaraly TN, Batty GD, Kivimäki M (2014) Depression and type 2 diabetes: a causal association? Lancet Diabetes Endocrin 2:236–245
CrossRefTang WK, Lu JY, Chen YK et al (2011) Association of frontal subcortical circuits infarcts in poststroke depression: a magnetic resonance imaging study of 591 Chinese patients with ischemic stroke. J Geriatr Psychiatry Neurol 24:44–49
PubMedTang WK, Lau CG, Mok V et al (2013) Impact of anxiety on health-related quality of life after stroke: a cross-sectional study. Arch Phys Med Rehabil 94:2535–2541
PubMedCrossRefTarter RE, Switala J, Carra J et al (1987) Inflammatory bowel disease: psychiatric status of patients before and after disease onset. Int J Psychiatry Med 17:173–181
PubMedCrossRefTaylor D (2010) Venlafaxine and cardiovascular toxicity. BMJ 340:327
CrossRefTaylor CB, Youngblood ME, Catellier D et al (2005) Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 62:792–798
PubMedCrossRefTecuta L, Tomba E, Grandi S, Fava GA (2015) Demoralization: a systematic review on its clinical characterization. Psychol Med 45:673–691 (im Druck)
Tellez-Zenteno JF, Patten SB, Jetté N, Williams J, Wiebe S (2007) Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 48:2336–2344
PubMedTerroni L, Amaro E, Iosifescu DV et al (2011) Stroke lesion in cortical neural circuits and post-stroke incidence of major depressive episode: a 4-month prospective study. World J Biol Psychiatry 12:539–548
PubMedPubMedCentralCrossRefThayer JF, Lane RD (2007) The role of vagal function in the risk for cardiovascular disaes and mortality. Biol Psychol 74:224–242
PubMedCrossRefTheobald DE, Kirsh KL, Holtsclaw E et al (2002) An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage 23:7–8, 442–447
Thomas M, Bruton A, Moffat M, Cleland J (2011) Asthma and psychological dysfunction. Prim Care Respir J 20:250–256
PubMedCrossRefThombs BD, Ziegelstein RC, Pilote L et al (2010) Somatic symptom overlap in Beck Depression Inventory-II scores following myocardial infarction. Br J Psychiatry 197:61–66
PubMedPubMedCentralCrossRefThompson WL, Sullivan SP (2006) Pulmonary disease. In: Blumenfield M, Strain JJ (Hrsg) Psychosomatic medicine. Lippincott, Williams & Wilkins, Philadelphia, S 193–211
Thurston RC, Rewak M, Kubzansky LD (2013) An anxious heart: anxiety and the onset of cardiovascular diseases. Prog Cardiovasc Dis 55:524–537
PubMedCrossRefTiihonen J, Lönnqvist J, Wahlbeck K et al (2006) Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 63:1358–1367
PubMedCrossRefTimmer A, Preiss JC, Motschall E et al (2011) Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev 2, CD006913
PubMedTominaga K, Higuchi K, Iketani T et al (2007) Comparison of gastrointestinal symptoms and psychological factors of functional dyspepsia to peptic ulcer or panic disorder patients. Inflammopharmacology 15:84–89
PubMedCrossRefTraeger L, Greer JA, Fernandez-Robles C et al (2012) Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol 30:1197–1205
PubMedCrossRefTrento M, Trevisan M, Raballo M et al (2014) Depression, anxiety, cognitive impairment and their association with clinical and demographic variables in people with type 2 diabetes: a 4-year prospective study. J Endocrinol Invest 37:79–85
PubMedCrossRefTribbick D, Salzberg M, Ftanou M et al (2015) Prevalence of mental health disorders in inflammatory bowel disease: an Australian outpatient cohort. Clin Exp Gastroenterol 8:197–204
PubMedPubMedCentralCrossRefTrimble MR, Schmitz B (2011) The neuropsychiatry of epilepsy, 2. Aufl. Cambridge University Press, Cambridge
CrossRefTroncoso AL, Gill T (2004) Hypertensive urgency with clonidine and mirtazepine. Psychosomatics 45:449–450
PubMedCrossRefTrzepacz PT, Brenner R, van Thiel DH (1989) A psychiatric study of 247 liver transplantation candidates. Psychosomatics 30:147–153
PubMedCrossRefTsai CS, Wu CL, Chou SY et al (2011) Prevention of poststroke depression with milnacipran in patients with acute ischemic stroke: a double-blind randomized placebo controlled trial. Int Clin Psychopharmacol 26:263–267
PubMedCrossRefTsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T (2011) Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J 20:257–268
PubMedCrossRefTulloch H, Greenman PS, Tassé V (2014) Post-traumatic stress disorder among cardiac patients: prevalence, risk factors, and considerations for assessment and treatment. Behav Sci 5:27–40
PubMedPubMedCentralCrossRefTully PJ, Baker RA, Knight JL (2008) Anxiety and depression as risk factors for mortality after coronary artery bypass surgery. J Psychosom Res 64:285–290
PubMedCrossRefTully PJ, Baker RA, Turnbull DA et al (2009) Negative emotions and quality of life six months after cardiac surgery: the dominant role of depression not anxiety symptoms. J Behav Med 32:510–522
PubMedCrossRefTully PJ, Cosh SM, Baune BT (2013) A review of the affects of worry and generalized anxiety disorder upon cardiovascular health and coronary heart disease. Psychol Health Med 18:627–644
PubMedCrossRefTully PJ, Winefield HR, Baker RA et al (2015) Depression, anxiety and major adverse cardiovascular and cerebrovascular events in patients following coronary artery bypass graft surgery: a five year longitudinal cohort study. Biopsychosoc Med 9:14
PubMedPubMedCentralCrossRefUdina M, Castellví P, Moreno-España J et al (2012) Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry 73:1128–1138
PubMedCrossRefUdina M, Hidalgo D, Navinés R et al (2014a) Prophylactic antidepressant treatment of interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry 75:e1113–e1121
PubMedCrossRefUdina M, Moreno-España J, Capuron L et al (2014b) Cytokine-induced depression: current status and novel targets for depression therapy. CNS Neurol Disord Drug Targets 13:1066–1074
PubMedCrossRefUjeyl M, Müller-Oerlinghausen B (2012) Antidepressiva zur Behandlung der Depression bei Palliativpatienten. Schmerz 26:523–536
PubMedCrossRefUsmani ZA, Carson KV, Cheng JN et al (2011) Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 11, CD008483
PubMedVaccarino V, Goldberg J, Magruder KM et al (2014) Posttraumatic stress disorder and incidence of type-2 diabetes: a prospective twin study. J Psychiatr Res 56:158–164
PubMedPubMedCentralCrossRefValkanova V, Ebmeier KP (2013) Vascular risk factors and depression in later life: a systematic review and meta-analysis. Biol Psychiatry 73:406–413
PubMedCrossRefvan Bastelaar K, Pouwer F, Cuijpers P et al (2011) Web-based depression treatment for type 1 and type 2 diabetic patients. Diabetes Care 34:320–325
PubMedPubMedCentralCrossRefvan der Feltz-Cornelis CM, Nuyen J, Stoop C, Chan J, Jacobson AM, Katon W, Snoek F, Sartorius N (2010) Effect of Interventions for major depressive disorders and significant depressive symptoms in patients with diabetic mellitus systematic review and meta – analysis. Gen Hosp Pshychiatry 32:380–395
CrossRefvan der Kooy K, van Hout H, Marwijk H et al (2007) Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry 22:613–626
PubMedCrossRefvan Dijk S, van den Beukel TO, Dekker FW et al (2012) Short-term versus long-term effects of depressive symptoms on mortality in patients on dialysis. Psychosom Med 74:854–860
PubMedCrossRefvan Dijk S, van den Beukel TO, Kaptein AA et al (2013) How baseline, new-onset, and persistent depressive symptoms are associated with cardiovascular and non-cardiovascular mortality in incident patients on chronic dialysis. J Psychosom Res 74:511–517
PubMedCrossRefvan Dooren FE, Nefs G, Schram MT et al (2013) Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis. PLoS One 8, e57058
PubMedPubMedCentralCrossRefvan Heeringen K, Zivkov M (1996) Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. Br J Psychiatry 169:440–443
PubMedCrossRefvan Lieshout RJ, Bienenstock J, MacQueen GM (2009) A review of candidate pathways underlying the association between asthma and major depressive disorder. Psychosom Med 71:187–195
PubMedCrossRefvan Marwijk HW, van der Kooy KG, Stehouwer CD et al (2015) Depression increases the onset of cardiovascular disease over and above other determinants in older primary care patients, a cohort study. BMC Cardiovasc Disord 15:40
PubMedPubMedCentralCrossRefvan Os E, van den Broek WW, Mulder PG et al (2007) Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 46:1099–1103
PubMedCrossRefvan Straten A, Geraedts A, Verdonck-de Leeuw I et al (2010) Psychological treatment of depressive symptoms in patients with medical disorders: a meta-analysis. J Psychosom Res 69:23–32
PubMedCrossRefvan Vilsteren MC, de Greef MH, Huisman RM (2005) The effects of a low-to-moderate intensity pre-conditioning exercise programme linked with exercise counselling for sedentary haemodialysis patients in The Netherlands: results of a randomized clinical trial. Nephrol Dial Transplant 20:141–146
PubMedCrossRefVataja R, Leppävuori A, Pohjasvaara T (2004) Poststroke depression and lesion location revisited. J Neuropsychiatry Clin Neurosci 16:156–162
PubMedCrossRefVattakatuchery JJ, Rickards H, Cavanna AE (2011) Pathogenic mechanisms of depression in multiple sclerosis. J Neuropsychiatry Clin Neurosci 23:261–276
PubMedCrossRefVázquez I, Romero-Frais E, Blanco-Aparicio M et al (2010) Psychological and self-management factors in near-fatal asthma. J Psychosom Res 68:175–181
PubMedCrossRefVecchio M, Palmer SC, Tonelli M et al (2012) Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need. Nephrol Dial Transplant 27:3420–3428
PubMedCrossRefVerbeeck RK (2008) Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 64:1147–1161
PubMedCrossRefVerbeeck RK, Musuamba FT (2009) Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol 65:757–773
PubMedCrossRefVincent EE, Singh SJ (2007) Review article: addressing the sexual health of patients with COPD: the needs of the patient and implications for health care professionals. Chron Respir Dis 4:111–115
PubMedCrossRefVinik A, Emir B, Cheung R, Whalen E (2013) Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin. Clin Ther 35:612–623
PubMedCrossRefVlachos II, Barbatis C, Tsopanomichalou M et al (2014) Correlation between depression, anxiety, and polymorphonuclear cells’ resilience in ulcerative colitis: the mediating role of heat shock protein 70. BMC Gastroenterol 14:77
PubMedPubMedCentralCrossRefVogelzangs N, Seldenrijk A, Beekman AT et al (2010) Cardiovascular disease in persons with depressive and anxiety disorders. J Affect Disord 125:241–248
PubMedPubMedCentralCrossRefVoican CS, Corruble E, Naveau S, Perlemuter G (2014) Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry 171:404–415
PubMedCrossRefvon Ammon Cavanaugh S (1984) Diagnosing depression in the hospitalized patient with chronic medical illness. J Clin Psychiatry 45:13–16
von Ammon Cavanaugh S (1995) Depression in the medically ill. Critical issues in diagnostic assessment. Psychosomatics 36:48–59
CrossRefvon Känel R (2012) Psychosocial stress and cardiovascular risk : current opinion. Swiss Med Wkly 142:w13502
von Känel R (2014) A psychocardiology update on depression and coronary heart disease. Praxis 103:85–93
CrossRefvon Känel R, Hari R, Schmid JP et al (2011) Non-fatal cardiovascular outcome in patients with posttraumatic stress symptoms caused by myocardial infarction. J Cardiol 58:61–68
CrossRefvon Wietersheim J, Kessler H (2006) Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis 12:1175–1184
CrossRefVriend C, Pattij T, van der Werf YD et al (2014) Depression and impulse control disorders in Parkinson’s disease: two sides of the same coin? Neurosci Biobehav Rev 38:60–71
PubMedCrossRefVroege EM, Zuidersma M, de Jonge P (2012) Vital exhaustion and somatic depression: the same underlying construct in patients with myocardial infarction? Psychosom Med 74:446–451
PubMedCrossRefWagena J, van Amelsvoort LGPM, Kant I, Wouters EFM (2005) Chronic bronchitis, cigarette smoking, and the subsequent onset of depression and anxiety: results from a prospective population-based cohort study. Psychosom Med 67:656–660
PubMedCrossRefWahed M, Corser M, Goodhand JR, Rampton DS (2010) Does psychological counselling alter the natural history of inflammatory bowel disease? Inflamm Bowel Dis 16:664–669
PubMedCrossRefWalker JG, Jackson HJ, Littlejohn GO (2004) Models of adjustment to chronic illness: using the example of rheumatoid arthritis. Clin Psychol Rev 24:461–488
PubMedCrossRefWalker AK, Kavelaars A, Heijnen CJ, Dantzer R (2013a) Neuroinflammation and comorbidity of pain and depression. Pharmacol Rev 66:80–101
PubMedCrossRefWalker J, Holm Hansen C, Martin P et al (2013b) Prevalence of depression in adults with cancer: a systematic review. Ann Oncol 24:895–900
PubMedCrossRefWang L, van Belle G, Kukull WB, Larson EB (2002) Predictors of functional change: a longitudinal study of nondemented people aged 65 and older. J Am Geriatr Soc 50:1525–1534
PubMedCrossRefWatkins CL, Anton MF, Deans CF et al (2007) Motivational interviewing early after acute stroke. A randomized, controlled trial. Stroke 38:1004
PubMedCrossRefWatkins LL, Blumenthal JA, Babyak MA et al (2010) Prospective association between phobic anxiety and cardiac mortality in individuals with coronary heart disease. Psychosom Med 72:664–671
PubMedPubMedCentralCrossRefWatson M, Kissane D (Hrsg) (2011) Handbook of psychotherapy in cancer care. Wiley-Blackwell, Chichester
Watson K, Summers KM (2009) Depression in patients with heart failure: clinical implications and management. Pharmacotherapy 29:49–63
PubMedCrossRefWeeke P, Jensen A, Folke F et al (2012) Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Clin Pharmacol Ther 92:72–79
PubMedCrossRefWeinert C (2005) Epidemiology and treatment of psychiatric conditions that develop after critical illness. Curr Opin Crit Care 11:376–380
PubMedCrossRefWeinert C, Meller W (2006) Epidemiology of depression and antidepressant therapy after acute respiratory failure. Psychosomatics 47:399–407
PubMedCrossRefWeinert C, Meller W (2007) Medical post-traumatic stress disorder. Catching up with the cutting edge in stress research. Crit Care 11:118
Weinstein AA, Kallman Price J, Stepanova M et al (2011) Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics 52:127–132
PubMedCrossRefWeintraub D, Burn DJ (2011) Parkinson’s disease: the quintessential neuropsychiatric disorder. Mov Disord 26:1022–1031
PubMedPubMedCentralCrossRefWeintraub D, Mavandadi S, Mamikonyan E et al (2010) Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology 75:448–455
PubMedPubMedCentralCrossRefWeis F, Kilger E, Roozendaal B, de Quervain DJ et al (2006) Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: a randomized study. J Thorac Cardiovasc Surg 131:277–282
PubMedCrossRefWeisskopf MG, Chen H, Schwarzschild MA et al (2003) Prospective study of phobic anxiety and risk of Parkinson’s disease. Mov Disord 18:646–651
PubMedCrossRefWells KG, Golding JM, Burnham MA (1988) Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 145:976–981
PubMedCrossRefWells KB, Golding JM, Burnam MA (1989) Affective substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. Gen Hosp Psychiatry 11:320–327
PubMedCrossRefWentworth BA, Stein MB, Redwine LS et al (2013) Post-traumatic stress disorder: a fast track to premature cardiovascular disease? Cardiol Rev 21:16–22
PubMedCrossRefWermuth L, Sorensen P, Timm S et al (1998) Depression in idiopathic Parkinson’s disease treated with citalopram: a placebo-controlled trial. Nordic J Psychiatry 52:163–169
CrossRefWernli KJ, Hampton JM, Trentham-Dietz A, Newcomb PA (2009) Antidepressant medication use and breast cancer risk. Pharmacoepidemiol Drug Saf 18:284–290
PubMedPubMedCentralCrossRefWhang W, Kubzansky LD, Kawachi I et al (2009) Depression and risk of sudden cardiac death and coronary heart disease in women. Results from the Nurses’ Health Study. J Am Coll Cardiol 53:950–958
PubMedPubMedCentralCrossRefWhite CA, Trief PM (2005) Psychotherapy for medical patients. In: Gabbard GO, Beck JS, Holmest (Hrsg) Oxford textbook of psychotherapy. Oxford University Press, Oxford, S 393–409
Whitehead D, Perkins-Porras L, Strike PC, Steptoe A (2006) Post-traumatic stress disorder in cardiac patients: predicting vulnerability from emotional responses during admission for acute coronary syndromes. Heart 92:1225–1229
PubMedPubMedCentralCrossRefWhooley MA, Wong JM (2013) Depression and cardiovascular disorders. Annu Rev Clin Psychol 9:327–354
PubMedCrossRefWhyte EM, Mulsant BH (2002) Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 52:253–264
PubMedCrossRefWiart L, Petit H, Joseph PA et al (2000) Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 31:1829–1832
PubMedCrossRefWilhemsen I, Berstad A (2004) Reduced relapse rate in duodenal ulcer disease leads to normalization of psychological distress: twelve-year follow-up. Scand J Gastroenterol 39:717–721
CrossRefWillgoss TG, Yohannes AM (2013) Anxiety disorders in patients with COPD: a systematic review. Respir Care 58:858–866
PubMedWilliams MM, Clouse RE, Nix BD et al (2007) Efficacy of sertraline in prevention on depression recurrence in older versus younger adults with diabetes. Diabetes Care 30:801–806
PubMedCrossRefWilliams SG, Wynn GH (2009) Internal medicine. In: Wynn GH, Oesterheld JR, Cozza KL, Armstrong SC (Hrsg) Clinical manual of drug interaction. Principles for medical practice. American Psychiatric Publishing, Washington/London, S 211–256
Williams JW Jr, Katon W, Lin EHB et al (2004) The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 140:1015–1024
PubMedCrossRefWilliams JE, Mosley TH Jr, Kop WJ et al (2010) Vital exhaustion as a risk factor for adverse cardiac events (from the Atherosclerosis Risk In Communities [ARIC] study). Am J Cardiol 105:1661–1665
PubMedPubMedCentralCrossRefWinokur G (1990) The concept of secondary depression and its relationship to comorbidity. Psychiatr Clin North Am 13:567–583
PubMedWise MG, Rundell JR (2005) Clinical manual of psychosomatic medicine. A guide to consultation-liaison psychiatry. American Psychiatric Publishing, Washington, DC/London
Witjas T, Kaphan E, Azulay JP et al (2002) Nonmotor fluctuations in Parkinson’s disease: frequent and disabling. Neurology 59:408–413
PubMedCrossRefWong JM, Na B, Regan MC, Whooley MA (2013) Hostility, health behaviors, and risk of recurrent events in patients with stable coronary heart disease: findings from the heart and soul study. J Am Heart Assoc 2, e000052
PubMedPubMedCentralWood B, van der Mei IAF, Ponsonby A-L et al (2013) Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler 19:217–224
PubMedCrossRefWright L, Simpson W, Van Lieshout RJ, Steiner M (2014) Depression and cardiovascular disease in women: is there a common immunological basis? A theoretical synthesis. Ther Adv Cardiovasc Dis 8:56–69
PubMedCrossRefWu KK, Chan SK, Ma TM (2005) Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). J Trauma Stress 18:39–42
PubMedCrossRefWu S, Barugh A, Macleod M, Mead G (2014) Psychological associations of poststroke fatigue: a systematic review and meta-analysis. Stroke 45:1778–1783
PubMedPubMedCentralCrossRefWynn GH, Armstrong SC (2009) Neurology. In: Wynn GH, Oesterheld JR, Cozza KL, Armstrong SC (Hrsg) Clinical manual of drug interaction. Principles for medical practice. American Psychiatric Publishing, Washington/London, S 325–351
Wynn GH, Oesterheld JR, Cozza KL, Armstrong SC (2009a) Clinical manual of drug interaction. Principles for medical practice. American Psychiatric Publishing, Washington/London
Wynn GH, Sandson N, Muniz J (2009b) Psychiatry. In: Wynn GH, Oesterheld JR, Cozza KL, Armstrong SC (Hrsg) Clinical manual of drug interaction. Principles for medical practice. American Psychiatric Publishing, Washington/London, S 423–460
Wyszynski AA, Wyszynski B (2005) The patient with cardiovascular disease. In: Wyszynski AA, Wyszynski B (Hrsg) Manual of psychiatric care for the medically ill. American Psychiatric Publishing, Washington, DC, S 49–67
Xue H (2004) Paroxetine for depression in diabetes: a randomized controlled trial. Chin Mental Health J 18:735–737
Yang S, Sajatovic M, Walter BL (2012) Psychosocial interventions for depression and anxiety in Parkinson’s disease. J Geriatr Psychiatry Neurol 25:113–121
PubMedCrossRefYates WR (1999) Epidemiology of psychiatric disorders in the medically ill. In: Robinson RG, Yates WR (Hrsg) Psychiatric treatment of the medically ill. Marcel Dekker, New York/Basel, S 41–64
Yates WR, Bowers WA (2000) Cognitive therapy in the medical-psychiatric patient. In: Stoudemire A, Fogel BS, Greenberg DB (Hrsg) Psychiatric care of the medical patient, 2. Aufl. Oxford University Press, Oxford, S 51–60
Ye Z, Chen L, Yang Z et al (2011) Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials. PLoS One 6, e21551
PubMedPubMedCentralCrossRefYeh ML, Chung YC, Hsu MY, Hsu CC (2014) Quantifying psychological distress among cancer patients in interventions and scales: a systematic review. Curr Pain Headache Rep 18:399
PubMedCrossRefYohannes AM, Connolly MJ (2011) Do antidepressants work in patients with chronic obstructive pulmonary disease with comorbid depression? Expert Rev Respir Med 5:727–729
PubMedCrossRefYohannes AM, Baldwin RC, Connolly MJ (2006) Depression and anxiety in elderly patients with chronic obstructive pulmonary disease. Age Ageing 35:457–459
PubMedCrossRefYorke J, Fleming SL, Shuldham CM (2006) Psychological interventions for adults with asthma. Cochrane Database Syst Rev 1, CD002982
PubMedYoussef NA, Abdelmalek MF, Binks M et al (2013) Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease. Liver Int 33:1062–1070
PubMedCrossRefZabora J, Brintzenhofeszoc K, Curbow B et al (2001) The prevalence of psychological distress by cancer site. Psycho-Oncology 10:19–28
PubMedCrossRefZahodne LB, Fernandez HH (2008) Course, prognosis, and management of psychosis in Parkinson’s disease: are current treatments really effective? CNS Spectr 13:26–33
PubMedPubMedCentralCrossRefZałuska M, Dyduch A (2011) Bupropion in the treatment of depression in Parkinson’s disease. Int Psychogeriatr 23:325–327
PubMedCrossRefZaubler T, Katon W (1998) Panic disorder in the general medical setting. J Psychosom Res 44:25–42
PubMedCrossRefZhang X, Norris SL, Gregg EW et al (2005) Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 161:652–660
PubMedCrossRefZhang CK, Hewett J, Hemming J et al (2013) The influence of depression on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 19:1732–1739
PubMedPubMedCentralCrossRefZimmermann-Viehoff F, Kuehl LK, Danker-Hopfe H et al (2014) Antidepressants, autonomic function and mortality in patients with coronary heart disease: data from the heart and soul study. Psychol Med 44:2975–2984
PubMedCrossRefZitron E, Kiesecker C, Scholz E, Luck S et al (2004) Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone. Naunyn Schmiedebergs Arch Pharmacol 370:146–156
PubMedCrossRefZuidersma M, Ormel J, Conradi HJ, de Jonge P (2012) An increase in depressive symptoms after myocardial infarction predicts new cardiac events irrespective of depressive symptoms before myocardial infarction. Psychol Med 42:683–693
PubMedCrossRefZuidersma M, Conradi HJ, van Melle JP et al (2013) Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality: a randomized controlled trial. J Psychosom Res 74:25–30
PubMedCrossRefZwerink M, Brusse-Keizer M, van der Valk PD et al (2014) Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 3, CD002990
PubMed